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Zusammenfassung
Zusammenfassung
Multizelluläre Organismen, wie beispielsweise der Mensch, besitzen eine Vielzahl an
unterschiedlichen Zelltypen, mit zum Teil höchst unterschiedlichen Funktionen und For-
men. Dennoch haben alle Zellen eines gemeinsam, ihre DNS Sequenz. Offensichtlich ist
die reine Sequenzinformation also nicht ausreichend, um Unterschiede in Morphologie
und Funktion hinreichend zu erklären. Das Forschungsgebiet der Epigenetik beschäftigt
sich mit der Fragestellung, wie dieses Phänomen zustande kommt.
Im Rahmen dieser Doktorarbeit konnte ich unter anderem neuartige Test-Moleküle
etablieren, die für zukünftige epigenetische Studien verwendet werden können. In enger
Zusammenarbeit mit Dr. Arne Schröder konnte ich zeigen, dass 2’-(R)-Fluor modifizierte
DNA-Bausteine von der epigenetischen Maschinerie der Zelle erkannt und prozessiert
werden. Dies galt sowohl für DNA Methyltransferasen, als auch für die erst kürzlich
charakterisierten TET-Enzyme. Die Fluor-modifizierten DNA Bausteine sind darüber
hinaus nicht toxisch und konnten so, für weitere Studien, biologischen Systemen zuge-
führt werden. Hierdurch konnte ich zusammen mit Katharina Iwan und anderen, einen
von Carell et al. postulierten Stoffwechselweg, nämlich die aktive Demethylierung von
mC über einen direkten C-C Bindungsbruch, erstmals in vivo nachweisen. Hier zeigte
sich, dass sowohl 2’-(R)-F-fC, als auch das natürliche Derivat fC direkt umgesetzt wer-
den zu 2’-(R)-F-C bzw. C, ohne dass dabei die klassische DNA Reparaturmaschinerie
zum Einsatz kommt.
Darüber hinaus gelang es mir im Rahmen dieser Promotion Einblicke in die Regulation
von TET Enzymen zu erhalten. Ich etablierte in Zusammenarbeit mit Dr. Benjamin
Hackner ein neuartiges Proteinexpressions- und Aufreinigungs-Protokoll, welches ver-
schiedene Studien innerhalb der Forschungsgruppe Carell ermöglichte. Zusammen mit
Franziska Traube, Dr. Andrea Künzel und anderen zeigte ich, dass ein Netzwerk von
metabolischen Enzymen die Aktivität von TET3 in Hirngewebe steuert. Darüber hin-
aus konnte ich zusammen mit Dr. Andrea Künzel und Franziska Traube Unterschiede im
Protein-Interaktions-Kontext von TET1 und TET3 identifizieren, was Rückschlüsse auf
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deren unterschiedliche Funktionen innerhalb der Zelle erlaubt. Die neuartige Expressions-
Methode erlaubte mir zusammen mit Michael Stadlmeier und Dr. Benjamin Hackner
die post-translationalen Modifikationen von TET Enzymen zu charakterisieren. Ich kon-
nte über Mutations-Studien zeigen, dass einzelne Phosphorylierungen im katalytischen
Zentrum die Aktivität von TET Enzymen beeinflussen können.
Im Rahmen einer Kooperation mit der Gruppe von Dr. Andriy Khobta untersuchte
ich darüber hinaus die Auswirkung epigenetischer Basen auf die Transkription und den
Zusammenhang mit der DNA-Reparatur Maschinerie.
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Summary
Summary
Although all cells present in a multicellular organism share the same DNA sequence,
cells can differ in both function and morphology from each other. Obviously, the se-
quence information alone is not sufficient to explain these differences. Epigenetics tries
to understand, how this phenomenon can be explained.
In the course of this thesis, novel molecular tools were established in order to answer
some of these tempting questions. In close collaboration with Dr. Arne Schröder, I
demonstrated that 2’-(R)-Fluorine modified DNA building blocks are compatible with
the epigenetic machinery inside the cell. Both DNA methyltransferases as well as the re-
cently characterized TET enzymes are able to recognize and process these non-canonical
DNA derivatives. These modified DNA building blocks are non-toxic and could there-
fore be fed to various biological systems. This enabled further studies that could show
that active demethylation of mC can occur through a direct C-C bond cleavage reac-
tion. This pathway was often postulated, but never clearly demonstrated. Together
with Katharina Iwan and others, I could show that this demethylation, occurs in vivo
to a significant extent and that both 2’-(R)-F-fC and the canonical derivative fC are
converted to 2’-(R)-F-C and C, respectively.
Another study focused on investigating the regulation of TET enzymes, which are re-
sponsible for the oxidation of mC. Together with Dr. Benjamin Hackner, I established a
novel expression and purification protocol enabling various studies in the Carell group.
Together with Franziska Traube, Dr. Andrea Künzel and others, I could demonstrate that
a network of metabolic enzymes control the activity of TET3 in brain tissue. Further-
more, different interactomes of TET1 and TET3 were identified. This may give insight
into the distinct functional contexts of TET1 and TET3 within an organism. The new
expression protocol also enabled the characterization of post-translational modifications
of TET enzymes. Together with Michael Stadelmeier and Dr. Benjamin Hackner, I
mapped the phosphorylation sites of these enzymes. I subsequently performed mutation
studies and was able to demonstrate that single phosphorylations in the active center
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can affect the activity of TET enzymes.
In cooperation with the group of Dr. Andriy Khobta I also investigated the functional
impact of epigenetic bases upon transcription and the interplay with DNA repair.
IX
Introduction
Introduction
1 "Cracking the Code" - a historical perspective
"Today, we are learning the language in which God created life."
This quite ardent expression by former US president Bill Clinton was only one of many
stated during a press conference held in June 2000 in the East Room of the White
House. Together with Tony Blair, Craig Venter, Francis Collins and others, the comple-
tion of the first draft of the human genome was announced and celebrated. A wide range
of people, including journalists, politicians and scientists believed that this remarkable
milestone would mark the end of several diseases and pave the way for a more healthful
future and longer lifespans. Unfortunately, these promises could not be kept in their
entirety. As will be discussed in the following chapters, the human genome is far more
complex than its sole sequence, and as outstanding as this scientific breakthrough was,
it neither marked an end of genetic research nor was it the beginning. The history of
genetic research is rich in key discoveries and characters, and the latter are often not
credited enough. It is worth mentioning, for example that the history of genetics or her-
itage did not start with Charles Darwin’s book "On the Origin of Species"[1], nor with
Gregor Mendel’s "Versuche über Pflanzen-Hybriden"[2] as is widely believed. The general
idea of heritage can be traced back to Hippocrates (ca. 460-370 BC).[3] About 410 BC,
Hippocrates outlined a theory later called pangenesis by Charles Darwin. Hippocrates’
theory of the inheritance of acquired characteristics (IAC) assumes that heredity relies
on the production of specific "seeds" by the parents. Both Hippocrates and Darwin
believed that the whole organism participates in the production these seeds, named
"gemmules" by Darwin. These "seeds" are then transferred to the sperm and the egg
and are subsequently transmitted from the parent to the offspring. For a long period of
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time this theory was generally accepted, with Jean-Baptiste de Lamarck only being one
of its most prominent supporters.[3,4] Although Darwin and Lamarck are generally rec-
ognized as opponents, there are many intersections in their studies, and Darwin’s work
on pangenesis complements rather than contradicts his work on natural selection.[5,6]
Although the theory of IAC was widely accepted for about 2000 years, it was almost
completely rejected in the 20th century. Darwin noted on this matter:
"You will think me very self-sufficient, when I declare that I feel sure if
Pangenesis is now still born it will thank God at some future time reappear,
begotten by some other Father, & christened by some other name."[7]
He should be right, as recent research supports the theory of IAC in parts and the
"Lamarckian" ideas are revisited.[8–13] There were two major reasons why pangenesis was
a "stillborn" and rejected. One being due to Darwin’s cousin Francis Galton. He actu-
ally intended to prove his cousin’s theory and aimed to demonstrate that gemmules do
indeed exist in the body. He was convinced that these gemmules circulate in the blood,
hence he performed blood transfusion experiments on rabbits, trying to transfer char-
acteristics from one breed to another. Yet his attempts failed and he claimed: "I have
(...) arrived at definite results, negativing, in my opinion, beyond all doubt the truth of
the doctrine of Pangenesis".[14,15] It should anyway be noted that Darwin himself never
argued that gemmules must be located in the blood, Darwin actually took into account
that gemmules can be located even outside of the body.[16] The second major reason why
Darwin’s theory of pangenesis was not well accepted in the community was due to the
work of the influential German scientist August Weismann. His work on mice ended the
era of pangenesis for a long period of time. In his experiments, Weismann cut the tails of
the animals for many generations and observed that their offspring continued to develop
long tails.[17] Based on his studies Weisman proposed the germ-plasm theory, suggesting
that the hereditary information is only located in sperm and egg cells and is not altered
by environmental influences or affected by other cells. In other words, it is not possible
to inherit "acquired characteristics" from somatic cells, which only carry out ordinary
functions. Weismann therefore rejected the idea of the gemmules and concluded that no
information can pass from the soma to the germ plasm (Weismann barrier). Other sci-
entist like Hugo de Vries modified Darwin’s theory of pangenesis. De Vries proposed that
gemmules do exist, but cannot be transferred between cells; they only travel intracellu-
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Figure 1: Hippocrates proposed the theory of IAC, later named pangenesis by Charles
Darwin. According to this theory, gemmules are produced by somatic cells throughout
the body and transferred to the sperm/egg cells. Weisman and others believed that
only germ cells contribute to heredity, and that acquired characteristics are therefore
not passed on to the offspring. The figure is adapted from Pierce.[18]
larly. Hugo de Vries was also the first scientist to postulate that different phenotypes
have different hereditary carriers/particles. He termed these particles pangenes, a term
that was later altered to genes by Johannsen.[19,20]
These mostly theoretical discussions were accompanied by scientific discoveries that
facilitated further research and enabled the scientific community to develop more and
more sophisticated theories. Some of the most outstanding scientific breakthroughs were
Gregor Mendel’s experiments on plant hybridization in 1865, at a time when DNA was
not yet discovered.[2] Mendel was the first to develop statistical methods in heredity
research. Due to his work being published in a rather obscure scientific journal, it was
unfortunately neglected for many years. In the meantime (1869), Friedrich Miescher
discovered a completely new chemical entity in cells, which he termed nuclein, some-
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thing now known as DNA.[21–23]. The function and nature of this novel ingredient of
cells, however remained elusive. Later, in 1882, chromosomes were identified and ob-
served during cell division by Walther Flemming.[24] Flemming was unfortunately not
familiar with Mendel’s work and thus could not connect his findings with the Mendelian
laws of heredity. It actually took 30 years until Mendel’s work was rediscovered. Three
researchers, Carl Correns, Hugo de Vries and Erich von Tschermak, went on to indepen-
dently reproduce Mendel’s results.[23] At the same time, two scientist made discoveries
that could physically explain the Mendelian laws of heritage, namely Theodor Boveri and
Walter Sutton (1902). Their Boveri-Sutton chromosome theory could for the first time
be used to interpret Mendel’s observations. They could show, among other things, that
sperm and egg both contribute the same number of chromosomes, and that individual
chromosomes impact development in different ways. They proposed that each "individ-
ual chromosome possesses different qualities".[25–27]. This may now sound self-evident,
but the theory remained discussed highly controversial, until Thomas Hunt Morgan and
his student Alfred Sturtevant proved unequivocally that genes (or "qualities") do reside
on chromosomes. They were able to draw the first chromosome map in 1913.[28]. An-
other milestone in genetic research was Griffith’s Experiment in 1928, when Frederick
Griffith was able to demonstrate that the heredity material can be transferred between
two organisms.[29] About 15 years later in 1944, it was clearly proven by Avery, MacLeod
and McCarty that this "transforming particle" is not a protein, as was widely believed,
but actually DNA.[30] Consequently it took about a century from the discovery of DNA
in the year 1869 to ascertain that this molecule did indeed contain the hereditary in-
formation (1944). George Beadle and Edward Tatum tried to connect the concepts of
"genes" and "proteins" more precisely and proposed that one gene is necessary for one
enzyme. This "one gene, one enzyme" theory was later expanded to the central dogma
of molecular biology.[31–33] This concept is briefly summed up by "DNA makes RNA and
RNA makes protein". Yet the discovery of splicing[34] and reverse transcription[35,36] un-
veiled a more complex flow of genetic information.
Having identified DNA as the heritage material, researchers now aimed to gain a more
comprehensive mechanistic understanding of this biopolymer. Erwin Chargaff identified
distinct proportions of the four DNA bases that compose DNA. The amount of adenine
equals the amount of thymine and guanine equals cytosine, something now known as the
Chargaff rules.[37] Chargaff’s findings could be further explained by yet another scientific
breakthrough, solving the molecular structure of DNA. This structure revealed a double
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helical architecture of DNA and C:G/A:T base pairing. The structure was elucidated
through joint efforts of Maurice Wilkins, Rosalind Franklin, James Watson and Francis
Crick and published in several papers 1953.[38–42] In one of these papers Watson and
Crick realized that "the specific pairing (...) immediately suggests a possible copying
mechanism for the genetic material." This "copying mechanism", the semi-conservative
replication mechanism, was demonstrated 1958 by Matthew Meselson and Franklin Stahl
and could explain clearly how heredity is achieved on a molecular level.[43] It remained
elusive, however, how the nucleotide sequence of each gene corresponded to the amino
acid sequence of a protein. In 1961 this genetic code was decrypted by the work of Fran-
cis Crick and others.[44,45] The next logical step for scientists was, to sequence the DNA
and in 1972 Walter Fiers and co-workers were the first to sequence a protein-coding
gene.[46] Later in 1977 Frederick Sanger, Allan Maxam and Walter Gilbert developed
further sequencing methods for DNA.[47–50] In the meantime researchers also became
interested in manipulating DNA. The discovery and utilization of restriction enzymes
or the development of methods like PCR by Mullis further drove research and enabled
novel studies and breakthroughs.[51,52] The generation of designed plasmids and their
subsequent transformation resulted in the first drug developed and produced based on
DNA technology.[53–55]
In the 1990s, sequencing became a more and more dominant tool of molecular genet-
ics and in 1995 the first complete genome of a free living organism was sequenced,
Haemophilus influenzae.[56] Only a year later, the DNA sequence of Saccharomyces cere-
visiae was published, representing the first eukaryotic genome.[57] The first draft of the
human genome was published 2001 by the Human Genome Project and the private com-
pany Celera.[58,59] Only a few years later, the complete (99%) sequence of the human
genome was made public.[60] This sequence revealed that less than 5% of the genome
encodes for proteins (about 20.000 genes). Consequently, this would mean that the vast
majority of the genome is "junk DNA", a term that is actually not suited and leads
to misinterpretations.[61] Follow-up programs of the Human Genome Project aimed to
understand the molecular function of these non-protein-coding sequences. Namely the
ENCODE project (Encyclopedia of DNA Elements) is to be mentioned here, which
aimed to identify all functional elements of the human genome.[62] The extensive collab-
oration of several research groups could show that in fact the vast majority of the human
genome have at least one biochemical function.[63–65] Researchers are just beginning to
understand and connect the results of the ENCODE project and many further studies
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will shed more light on the complex organization of the genome. The next chapter will
introduce yet another layer of complexity that further explains why understanding our
genome is far more complicated than anticipated in June 2000.
Figure 2: The history of genetics is rich in key discoveries, starting with Mendel’s
mathematical description of heritage, through the structural elucidation of the DNA,
resulting in the genomics era. These are selected discoveries.
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2 The Second Layer of Information
Despite the fact that every cell in a multicellular organism shares the same DNA se-
quence, these organisms in general do not appear as a homogenous mass, but have parts
of distinct morphology and function. Various structures are formed by specialized cells
and perform different tasks. The human body for example consists of more than 200
different cell types.[66] It is evident that the sole DNA sequence is not sufficient to de-
scribe these phenomena and another level of information besides the sequence must be
present that controls cell specific patterns. This level is called epigenetics. The idea of
epigenetics (although not the term) was first introduced by C.H. Waddington.[67] He de-
fined epigenetics as "all those events which lead to the unfolding of the genetic program
for development". This definition was later specified by Robin Holliday who described
epigenetics as "nuclear inheritance which is not based on differences in DNA sequence",
a definition coming close to what nowadays is termed as epigenetics.[68] There is another
rather intriguing picture to describe epigenetics. One can image the DNA sequence as a
piece of music. The pattern of notes resembles the patterns of A, G, T and C. Just like
a piece of music, however, this pattern may be interpreted by various artists in different
ways. In the interpretation of the genetic sequence, the modality seems to be based on
non-canonical DNA bases and other epigenetic systems.
Three different epigenetic mechanisms are known to date: chromatin remodeling[69–71],
the chemical modification of histones[72–77] and the chemical modification of DNA. The
latter will be further discussed.
2.1 Chemical Modifications of DNA
For about half a century, 5-methylcytosine (mC) was the only known chemical modifica-
tion in mammalian DNA and the "fifth" base of the genome, besides the four canonical
DNA bases adenine (A), guanine (G), thymine (T) and cytosine (C). In recent years how-
ever more and more chemical derivatives of canonical DNA bases were identified in the
genome of various organisms. 5-hydroxymethylcytosine (hmC)[78,79], 5-formylcytosine
(fC)[80,81] and 5-carboxycytosine (caC)[81,82] were characterized in the DNA from stem
cells and brain tissue. Also a derivate of T, namely 5-hydroxymethyluracil (hmU), could
be identified and quantified in the DNA of murine embryonic stem cells (mESCs).[83]
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This study by Pfaffeneder et al. demonstrated that hmU is generated in a regulated
fashion and is not necessarily a DNA lesion. The most recent addition in the chemi-
cal diversity of eukaryotic DNA is N6-methyladenosine (m6A), although its existence in
mammalian cells is controversially discussed.[84–87]
Figure 3: The vast complexity of life and the ability to form diverse cell types is in part
based on rather simple chemical modifications of DNA (besides the chemical modification
of proteins). Four derivatives of cytosine (mC, hmC, fC and caC) are depicted, which
are studied intensely.
However, despite of massive research efforts, the function of these chemically modified
DNA bases is not yet fully understood. The chemical derivatives of cytosine (see Fig-
ure 3) are most likely involved in embryonic development, memory and diseases like
cancer.[88–94] It seems impressive how rather simple chemical modifications are part of a
machinery that enable diverse expression patterns, resulting in a diverse cell type pop-
ulation, but can also be responsible for cognitive function and diseases.
If not otherwise stated the notation of canonical and non-canonical bases in the following
refers to a DNA context.
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2.1.1 5-Methylcytosine
The DNA base 5-methylcytosine (mC) was first described in the year 1925 and positively
identified 1950.[95–97] The methyl group is transferred from S-adenosyl methionine (SAM)
to the C5 position of cytosine by DNA Methyltransferases (DNMTs).[98,99] In mammals
three DNMTs are known, DNMT1, DNMT3a and DNMT3b. Whereas DNMT1 is a
"maintenance" methyltransferase, DNMT3a and DNMT3b are needed for the de novo
methylation of cytosine.[100,101] The mechanism of this process is depicted in Figure 4B.
SAM acts as a co-substrate and methyl donor. DNMTs are using a "flipping" mechanism
and a thiol as a nucleophile.[102,103] This thiol attacks the C6 position of cytosine. A
protonation of N3 via a glutamate residue facilitates this reaction. Next the C4-C5
double bond of cytosine attacks the methyl group of SAM. Subsequent syn-elimination
re-establishes the aromatic character and results in mC.
Figure 4: A) Crystal structure of mouse DNMT1 in complex with DNA (PDB code
3PT6). B Mechanism of a DNA methyltransferase. First, nucleophilic addition of a
thio group from a cysteine residue occurs at position 6 of the flipped out cytosine. A
glutamate supplies the proton for N3, facilitating this reaction. The C4-C5 double bond
of the base then attacks the methyl group of SAM. A syn elimination yields the product
mC.
In mammals about 4%-5% of all cytosines are methylated.[83,104] Most of the methylation
occurs in a CpG context.[105] This motif occurs frequently in promoter regions, forming so
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called CpG islands, while it is generally underrepresented in the genome.[106,107] About
72% of human promoters are rich in CpGs (GpG islands), which are in general hy-
pomethylated.[105,108,109] In the year 1975, Holliday and Riggs demonstrated that mC
has an epigenetic function and is responsible for gene silencing.[110,111] In general, mC
is necessary for processes like genomic imprinting, or the repression of repetitive ele-
ments.[112,113] Depending on its position, however, mC can have distinct effects, e.g. if
being present inside the gene body functions related to splicing are discussed.[114–116]
Whereas a cytosine methylation at repetitive sequences e.g. centromeres are important
for the stability of chromosomes.[117]
The methyl group points towards the major groove of the DNA double helix, facilitating
an interaction with proteins and therefore allowing biological effects. These effects are,
as mentioned earlier, mainly transcriptional repression, e.g. through the recruitment of
repressing transcription factors like the methyl CpG binding protein 2 (MeCP2).[118,119]
5-methylcytosine is also able to recruit histone modifying enzymes[120,121] and vice versa,
hence controlling the density of DNA and its accessibility for transcription.[122–126] As
tissue specific promoters also contain CpG dinucleotides, the relevance of mC for cell dif-
ferentiation is supported.[127–129] The cells are hereby enabled to influence tissue specific
protein expression and control cell fate.[130] The methylation of cytosine is essential for
normal embryonic development and stem cell differentiation. DNMT1 knockout mice
die only a few days after fertilization.[131] DNMT3a and DNMT3b knockout mice do
develop, but die shortly after birth.[132] It should however be mentioned that the DNA
of some organisms like Caenorhabditis elegans do not contain mC and the presence in
Drosophila is still a matter of disagreement in the community.[133]
Methylation patterns are dynamic and can change due to various stimuli, hence nature
has established mechanisms to remove the methyl group (for details see chapter 3). The
paternal genome for example is heavily demethylated a few hours after fertilization and
before the first cell division.[134,135] The factor needed for this process is contributed by
the oocyte.[136] This demethylation is significantly faster than the demethylation of the
maternal genome. After erasure of the methylation patterns, the DNA is re-methylated
to establish and "program" cell specific patterns.[137,138] It is possible to revert this pro-
gram and to re-program somatic cells into stem cells, a discovery awarded with the
Nobel prize for physiology 2012. John B. Gurdon and Shinya Yamanaka were hon-
ored for their research in re-programming somatic cells into induced pluripotent stem
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cells (iPSC).[139,140] This process involves several methylation and demethylation events,
hence changing the epigenome.[141–143] A comprehensive understanding of this process
could accelerate the process of stem cell therapies without the ethical dilemmas of using
embryonic stem cells.[144–147] Other modified DNA bases seem to be part of the demethy-
lation processes[88,148–150] and the next chapters will discuss possible functions and the
metabolism of these novel DNA modifications.
2.2 Distribution and Functional Context of Oxidized mC
Derivatives
2.2.1 5-Hydroxymethylcytosine
It was only recently in the year 2009 that two groups identified 5-hydroxymethylcytosine
(hmC) as the direct oxidation product of 5-methylcytosine (mC) and thus the "sixth"
base of the genome of higher organisms.[78,79] The DNA base hmC was identified before,
e.g. in phages[97,151], however its presence in higher organisms was in general considered
a oxidative lesions.[152–154] Also, earlier quantification data of hmC in higher organisms
could not be reproduced by others and the quantified values of hmC differed comparing
to novel studies.[104,155–158] These novel quantification studies by Carell and co-workers
were performed in several mouse tissues and revealed that the level of hmC varies in-
between organs.[104,159,160] While in most organs hmC levels make up about 0.05%-0.15%
per C, in brain the levels raise to more than 1% per C. The Carell research group also
demonstrated that the levels of hmC rise, correlating with the age of the organism and
then remain constant. In adult human brain tissue these levels can reach up to 1.2%
of all cytosines.[104,159,161–165] In contrast to mC which is also known to occur non CpG
context[166,167], more than 99% of all hmC is present in this sequence context.[168] In
addition, hmC can, again in contrast to mC[105], be distributed asymmetrically in the
DNA double helix.[168–174] Most of the hmC is positioned in euchromatin regions of the
genome[175,176], hence regions with high gene density and activity.[177,178] In this euchro-
matin regions, especially distal regulatory enhancers, gene promoters, gene bodies, and
the proximity of transcription start sites are regions of high hmC content.[176,179] About
half of the hmC is associated with cis-regulatory elements where transcription factors
bind.[168,180–182] hmC is mostly present in promoters with low to mid CpG levels and as
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the CpG density correlates with gene expressions, hmC is correlated with weak to mid-
expressed genes.[168,183–185] Highly expressed gene promoters do not contain hmC.[168,181]
The positions of hmC are conserved between human and murine tissue and hmC is most
likely connected to the epigenetic control of transcription.[176,179,186] If hmC is present in
the gene body, this seems to correlate with active transcription.[169,187–190] However hmC
is not in general connected to active gene expression. Robertson et al. demonstrated a
repressive effect of hmC in HeLa cells if present in a promoter.[191] Other studies includ-
ing a recently published paper by the Khopta group also revealed a negative effect of
promoter-located hmC on gene expression.[192,193] As mentioned earlier, hmC accumu-
lates during aging. In addition, it seems to be a stable mark in the genome, hence it
is likely that hmC specific reader proteins are expressed.[194–197] The impact of hmC by
a DNA-protein interaction may be due to the perturbation of the DNA binding of pro-
teins or by attraction/rejection of specific binders.[158,175,198] For example, hmC prevents
the binding of several mC-binding proteins, therefore affecting gene expression.[154,190]
Several enzymes have differential binding affinity to hmC and mC, e.g. CXXC contain-
ing enzymes or SRA domain containing enzymes.[199–201] UHRF1, which is essential for
the maintenance of mC, binds both mC and hmC, but conflicting studies were pub-
lished regarding the preferred affinity.[194,202–205] Several studies also discovered hmC
binding proteins with to date unknown functions like THY28, which may be involved
in apoptosis.[194,206,207] Besides that, it is worth mentioning and striking that apparently
hmC is involved in memory formation, learning, and neurological diseases like anxiety,
Alzheimer’s or Huntington disease.[208–213] Other studies suggest that hmC may also be
involved in DNA repair.[214,215] In summary, it seems evident that hmC has diverse bio-
logical roles, although a detailed molecular understanding of this novel DNA base is still
missing and its precise function remains elusive.
2.2.2 5-Formylcytosine and 5-Carboxylcytosine
Only two years after the discovery of hmC, Pfaffeneder et. al and Ito et al. identified the
subsequent oxidation product of hmC in stem cell DNA, 5-formylcytosine (fC).[80,81] He
et al. identified 5-carboxylcytosine (caC) the same year.[82] As depicted in Figure 5 the
levels of fC and caC are significantly lower compared to hmC. Only about 0.02%-0.001%
of all cytosines are fC or caC respectively.[83] Again these levels depend on the age of
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Figure 5: If the area of the landmass of earth would represent the amount of C in the
genome, mC would make up about 4%-6% of this area, or roughly the area of the United
States (without Alaska). Italy would represent hmC and the levels of fC and caC would
be represented by Belgium and Luxemburg with 0.02% and 0.001%.[216]
the organism, but in contrast to hmC, the levels do not rise with age but decline shortly
after birth.[159] The highest levels of fC are found in embryonic stem cells, while hardly
present in somatic cells. The oxidation product caC is not detectable in somatic cells.[83]
Sequencing studies in murine embryonic stem cells and neural progenitor cells were per-
formed in wild type and Thymine-DNA glycosylase (TDG) knockout cell lines, as the
glycosylase TDG is known to process fC and caC (see chapter 3.3.2), therefore removing
it from the genome.[82,217–222] The levels of fC and caC in the TDG knockout cells were
about eight times higher than in the wild type, which may hint towards a dynamic regu-
lation inside the cell.[217–219] Like hmC, fC and caC are also mostly present in regulatory
regions of the genome or inside the gene body. fC is also asymmetrically positioned like
hmC.[170,220] The highest levels of fC and caC are detected in distal regulatory elements,
in the regions of active and bivalent enhancers.[217,219] Bivalent enhancers are inactive
regions of the genome, that can be activated very quickly.[223] It would be intriguing to
interpret this localization at bivalent regions as a cellular mechanism to quickly switch on
a gene after methylation via oxidation reactions and subsequent removal with TDG (or
another mechanism).[222] Indeed Zhu et al. demonstrated very recently that the produc-
tion of fC in promoters precedes the upregulation of gene expression.[224] The function of
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fC and caC, present in gene bodies is not yet fully understood. They may interact with
RNA Polymerase II (RNAPII) and therefore fine-tune gene transcription.[225,226] Splicing
may also be influenced by fC and caC, like for mC.[179] It should be mentioned that some
sequencing studies contradict each other, which may be due to the low abundance of
fC and caC. While Raiber et al. and the group of Neri et al. found high levels of fC
and caC in promoters of highly expressed genes[218,221], Shen et al. found increases fC
levels in promoters with low to medium activity.[217] Improved sequencing methods may
clarify these discrepancies in the future.
As mentioned levels of fC and caC rise in TDG knockouts, supporting the idea that
maybe oxidative mC derivatives are necessary to prevent hypermethylation and there-
fore protect from transcriptional repression. For example, caC is accumulates at OCT4,
NANOG, SOX2 and ESRRB binding sites in TDG-knockout mESCs.[217] These sites
are perhaps regions of high oxidation and subsequent removal.[217] fC and caC are most
likely connected with gene transcription and/or cell differentiation, which is supported
by studies on neural progenitors and their differentiation to neurons or glia.[227] While
cell specific promoters in progenitors cells are heavily methylated (causing these genes
to be inactive) during differentiation neuron specific promoters get demethylated and
therefore activated. This demethylation is TET and fC and caC dependent and a TDG
knockdown causes an accumulation of fC and caC in these regions.[227]
Like hmC the oxidation products fC and caC may also recruit specific binders, as at
least fC seems to be a partially stable mark in the genome.[194,197,228] Also, fC levels
can reach high levels at specific local regions.[220] fC interacting partners, identified by
the Carell/Vermeulen group[194] and the Reik group[197] include proteins like TDG or
members of the NuRD complex, a histone deacetylase complex that represses gene ex-
pression.[229,230] Forkhead-box-proteins (FOX) were also identified as fC binders. FOX
proteins are eukaryotic transcription factors, that influence the local chromatin struc-
ture and are connected to embryonic development and metabolic processes.[231,232]. In
addition, fC positions in the genome correlate with the binding sites of the transcription
factor p300, which supports the idea of fC being a distinct epigenetic mark.[219] It is
unclear whether fC is perturbing the DNA structure and hence influence binding of pro-
teins to the DNA, as contradicting studies are published.[233,234] In general, the formyl
group of fC would be an attractive position for protein-DNA interactions. In vitro, the
formation of a Schiff base could be shown for fC[235], hence a reaction with lysine rich
histones would be intriguing, especially since the lysines in histone tails are subject to
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post-translational modifications, which have the potential to fine-tune this reaction (e.g.
by mono- or dimethylation). Indeed two recent studies identified DNA-Protein cross-
links between fC and the nucleosome core particles, both in vitro and in vivo.[236,237]
The biological relevance of these cross-links has yet to be studied in more detail. Not
much has been published so far for caC, probably due to its very low abundance. An
interaction with DNMT1 was identified by Carell and co-workers, although the relevance
of this finding has yet to be assessed.[194] In addition the CXXC domain of TET3 has
been identified as a specific reader for caC.[238]
2.3 TET Enzymes
The enzymatic oxidation of mC to hmC, fC and caC is catalyzed by ten-eleven-transloca-
tion enzymes (TET enzymes).[78,80–82] In vertebrates, three isoforms of TET enzymes are
known[239] and all of them are capable of oxidizing mC up to caC. Initially, the human
TET1 enzyme was identified as a fusion partner of KMT2A (MLL) in cancer.[240,241] In
2009 it was then characterized as an orthologue of Trypanosoma brucei base J-binding
protein (JBP1, JBP2).[78,239,242–244] TET enzymes are key players in the pluripotency
network during embryonic development and their expression is crucial.[245] For example
TET1 and TET2 are regulated by OCT4 and while the levels of these enzymes decrease
during differentiation, the levels of TET3 rise.[246,247]
2.3.1 Mechanism and Substrates
The exact mechanism of TET enzymes is not yet fully understood, however similarities
to other oxygenase enzymes are to be expected.[186,248–253] Mechanistically the process
can be described as two single electron reductions of iron (see Figure 6). The reaction
starts with the coordination of α-ketoglutarate to the iron (II) species. The substrate
mC facilitates the coordination of molecular oxygen in the active center of the enzyme,
resulting in a decarboxylation of α-ketoglutarate and an active iron (IV)-oxo species. A
proton is then abstracted from mC via a radical process. The substrate is subsequently
hydroxylated, again via a radical mechanism. Whether or not the oxidation of mC up
to caC occurs in an iterative or processive fashion is currently debated as contradicting
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studies have been published.[254,255] This chemical processivity, however, has to be dis-
tinguished from genetic processivity. The latter describes the genetic outcome in vivo,
hence whether a genomic regions is oxidized to hmC or further to fC and caC. This
genetic processivity is depending on the chromatin state and accessibility, as well as
transcription factors and the supply with α-ketoglutarate.[170,171,217,256–258]
Figure 6: Mechanism of iron dependent dioxygenases. α-ketoglutarate coordinates the
iron in the active center of the enzyme and replaces a prior coordinated water molecules.
One water molecule completes the octahedral structure of the complex. The substrate
(mC) weakens the binding of the water molecule to iron, enabling molecular oxygen to
coordinate. The subsequent decarboxylation is not yet fully understood, but results in
an active ferryl-oxo species. This reacts in a radical manner with the substrate. In the
last step of the reaction cycle the product (hmC) and succinate are released.
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The substrate specificity of TET enzymes was studied by Hu and colleagues.[259] They
demonstrated in their study that TET enzymes prefer mC compared to hmC or fC as
a substrate. It should also be mentioned that TET enzymes prefer mCpG dinucleotides
rather than a mCpA, mCpT or mCpC context.[249,251] TET proteins are able to oxidize
several combinations of substrates e.g. mC, hmC or fC paired with various modified
bases.[257,260,261] Carell and co-workers showed in 2014 that TET enzymes also recognize
thymine as a substrate and oxidize it to hmU in a controlled and regulated manner.[83]
The oxidation of mC in a RNA context is also possible.[262]
2.3.2 Structural Properties of TET Enzymes
The C-terminal domains of TET enzymes harbor the catalytic active center. It is formed
from a double stranded beta-helix (DSBH) and a cysteine-rich domain, wrapping around
the DSBH and stabilizing the structure.[249–252]. The DSBH motif is important for
DNA and substrate binding and brings together the three components, iron (II), α-
ketoglutarate and mC. A conserved arginine enables the binding of α-ketoglutarate,
while the iron itself is coordinated by two histidines and one aspartate.[249,251] TET en-
zymes have a variable insert in their DSBH region, pointing away from the catalytic cen-
ter.[249] These motifs differ in their length and resemble the C-terminal domain (CTD)
of RNA Polymerase II (RNAPII) and are dispensable for catalytic activity.[263] The
catalytic domain of TET enzymes alone, is sufficient for oxidation and nuclear localiza-
tion.[78,245,264] The full length TET1 and TET3 enzymes also have a CXXC domain. It
consists of about 60 amino acids and is located at the N terminus. Splicing versions
without the CXXC domain are however also expressed.[265,266] Notably, these isoforms
are expressed in different tissue and show different activities.[238,265,266] A chromosomal
inversion in TET2 led to a loss of its CXXC domain. This motif is now a distinct gene,
called IDAX.[267]
2.3.3 Non-Enzymatic Effects of TET Enzymes and their Regulation
Besides their enzymatic function as oxidizing enzymes, TET enzymes can influence cellu-
lar processes by other mechanisms.[88,186,268] For example, it is interesting that TET pro-
teins prefer regions of the genome that do not correspond to regions of high mC and hmC
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levels.[105,109,188,269] TET enzymes also influence transcription differently. While TET1
and TET3 repress gene expression in mESCs[188] TET2 is activating transcription.[270]
These differences can be explained by the recruitment of diverse binding partners, e.g.
TET1 recruits the repressive SIN3 or NuRD complex[188,271–274], while TET2 can acti-
vate gene expression by the interaction with O-GlcNAc transferase (OGT), which can
activate gene expression by influencing the chromatin.[270,275–277]. TET enzymes are also
involved in telomere elongation and chromatin stability.[278,279]
TET enzymes themselves can be regulated in various ways, e.g. by controlling the supply
of their co-substrate. α-ketoglutarate is produced from isocitrate by IDH1, IDH2 and
IDH3.[280] Overexpression of IDH1 and IDH2 result in elevated hmC levels and downregu-
lation in decreased levels.[281,282] Mutated IDH versions produce 2-hydroxglutarate which
inhibits TET enzyme by competing with α-ketoglutarate.[281,283] Other small molecules
like fumarate, succinate, glutamate or glutamine also can decrease or increase hmC lev-
els.[256,284,285] Vitamin C is known as a stimulating agent for TET activity. This effect
may be due to vitamin C acting as a "co-substrate" (as stated by minor et al.[286]) and di-
rectly interacting with the catalytic domain of TET enzymes. In addition it may promote
the recycling of iron(II).[257,286–288] Other pathways of regulation include the supply with
molecular oxygen[285,289–291] and iron[292], both affecting the oxidation of mC. TET en-
zymes may furthermore be regulated post-translationally (will also be discussed in chap-
ter 10) and post-transcriptionally. Several microRNAs regulate TET enzymes[293–297] and
the translation of TET1 mRNA is facilitated by the protein DAZL.[298] After translation
TET enzymes are modified by post-translational modifications, e.g. monoubiquitina-
tion, acetylation, GlcNacylation, PARylation and phosphorylation.[299–302] Last but not
least, the amount of TET enzymes, and hence indirectly the activity, may be regulated
by protein-protein interaction and proteolysis. If IDAX is overexpressed, TET2 degra-
dation is increased, while depletion results in increased TET2 levels.[267] On the other
hand TET activity may be enhanced by UHRF2.[194] The degradation of TET enzymes
seems to be calpain dependent proteolysis in murine ESC, while in cancer cells, the
ubiquitin-proteasome pathways could regulate TET levels.[247,303]
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3 Demethylation of 5-Methylcytosine
In mammals demethylation of mC is required at several developmental stages and
time points.[179] In consequence, formerly repressed genes are able to be expressed
again.[304–306] This demethylation process can either be global[305,307–309] or occur at spe-
cific loci.[198,310–313] Global demethylation mainly occurs during embryogenesis whereas
locus-specific demethylation of mC is a process that is crucial e.g. for neural plastic-
ity.[198,310–312]
Demethylation of mC is in principle possible via two pathways; active and passive
demethylation. Passive in this context describes the dilution of mC during cell di-
vision and DNA replication respectively. In this case the methyl information is not
passed on to the daughter DNA strand by DNMT1.[314] In theory a passive demethyla-
tion is also possible via the dilution of hmC, fC or caC.[315] Several studies showed that
DNMT1 is less efficient in a hmC/C, fC/C and caC/C context compared to the native
mC/C.[202,316–319] If this replication dependent dilution is repeated several times, mC
(and possibly hmC, fC and caC) will get diluted over time, resulting in a demethylated
region of the genome.[316,320] The active demethylation pathway is not coupled to DNA
replication and will be described in more detail in chapter 3.3.[304]
3.1 Global Demethylation of 5-Methylcytosine
As mentioned, global demethylation events take place during embryogenesis. Only very
few DNA loci are excluded from this event.[307] This process takes places during the zy-
gote phase and establishes the totipotent character of the cell.[137] Later during develop-
ment a second global demethylation wave is necessary for the development of primordial
germ cells (PGCs).[307,321–323]
The global demethylation event during the zygote phase is replication independent as
it occurs before the first cell division. Here the paternal pronucleus is rapidly demethy-
lated.[134,135] In fact studies by Iqbal et al. and others showed that this demethylation
event is coupled to an oxidation of mC to hmC and further to fC and caC.[320,324,325]
This oxidation is carried out by TET3, which is in contrast to TET1 and TET2 highly
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expressed in the zygote.[326] Therefore it is not surprising that a TET3 knockdown or
knockout perturb correct embryonic development, as essential genes for totipotency like
OCT4 or NANOG are not demethylated in the paternal pronucleus.[326,327] It should be
noted, that in contrast to mC, no mechanism is known to date that passes on hmC, fC
or caC to the daughter DNA strand. Therefore these epigenetic marks are diluted hand
in hand with cell division and hence the genome gets demethylated.[316] It is surpris-
ing that although TET3 is present in the zygote and the nuclei are no longer confined
to seperate cell, it oxidizes only the paternal mC. The maternal pronucleus seems to
be protected of this reaction. Several protection mechanism, e.g. proteins like Stella
and histone modifications (H3K9me2) work hand in hand to prevent the oxidation of
maternal mC.[327–329] The maternal mC is therefore removed in a replication dependent
manner.[330] It is still not clear why the paternal and maternal DNA are demethylated
differently. It should be noted, however that the methylation levels of the paternal and
maternal DNA differ. While the paternal DNA is hypermethylated with about 90% of
the CpGs being methylated, the maternal mC level in CpG context accounts for only
about 40%.[331]
As mentioned above, embryogenesis is not the only phase of global demethylation.
The formation of primordial germ cells (PGCs) also involves global demethylation of
mC.[321–323,332] This process can be characterized in two phases. The first one being
a passive demethylation[333,334] and a subsequent active demethylation.[321,332,335] This
second, active demethylation seems to involve TET1.[304]
3.2 Locus Specific Demethylation of 5-Methylcytosine
Demethylation is not limited to embryonic or germ cell development. Also somatic cells
undergo demethylation at specific DNA loci.[336–341] This process and detailed mechanism
is still under investigation and possible pathways will be discussed in chapter 3.3.[306]
One main somatic system is prone for loci dependent demethylation, neurons.[310,342–344]
It is very exciting that these events occur at promoter regions of genes like BDNF
(Brain-derived neurotrophic factor), involved in neural plasticity and learning.[310,338,345]
Demethylation can occur after e.g. electric stimulation[346,347] and is at least in some
cases a TET1 dependent oxidation to hmC and maybe fC/caC.[346] Also more complex
stimuli can trigger demethylation, e.g. contextual fear conditioning results in locus spe-
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cific demethylation in the promoter region of BDNF.[310,348] It becomes evident, that
both, synaptic plasticity and the establishment of memory is a complex clockwork of
demethylation, de novo methylation and also histone modifications in neurons.[310,349,350]
3.3 Active Demethylation Pathways
In plants, the demethylation of mC is carried out by the base excision repair (BER)
machinery. A family of glycosylases, namely Demeter (Dme) recognize mC and remove
it from the genome.[351] This process results in the replacement of mC by C. Dme enzymes
are capable of demethylating mC not only in the CpG context, but also in a CpNpG
and CpNpN (N = A, T or C) sequence context in vitro.[352] In mammals, no Dme
orthologues have been identified to date. Nevertheless, a similar glycosylase activity has
been proposed for the Thymine-DNA Glycosylase (TDG) and the Methyl-CpG-Binding
Protein 4 (MBD4). However, their activity was significantly lower compared to their
native substrates (T-G mismatches).[353–356] Also MBD4 deficient mice are vital and do
not exhibit strong effects on demethylation of the paternal DNA in the zygote.[357,358]
These data suggest a minor role for DNA glycosylase activity for the demethylation of
mC. Other possibilities were therefore proposed, but it remained an unsolved question
how demethylation in mammals occurs in detail. The discovery of hmC and the TET
enzymes moved the research field in a new direction. It seems plausible that hmC may be
an intermediate in an active oxidative demethylation pathway (described in chapter 3.3.2
and 3.3.3). Three pathways for active demethylation will be discussed in the following
(see Figure 7). Two involve the base excision repair system, the other one is based on a
direct C-C bond cleavage reaction.[90,179,304,315]
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Figure 7: Besides passive demethylation three active pathways for the removal of mod-
ified cytosines were proposed. One being the direct removal of the chemical modification
from the base (upper pathway). This pathway avoids the BER-machinery and results
in unmodified cytosine. The two other possible pathways (down) would utilize the BER
machinery, in case of fC and caC directly or following a deamination of mC or hmC,
respectively.
3.3.1 Active Demethylation via Deamination
One possible pathway for the active removal of mC from genomic DNA starts with a
deamination of mC to T. The resulting T-G mismatch is then repaired by the glyco-
sylase TDG or MBD4. Deaminases like the Activation-Induced Deaminase (AID) and
the Apolipoprotein B pre-mRNA Editing enzyme catalytic polypeptide(APOBEC) have
been proposed as mC deaminases.[359–363] Both enzymes are capable of deaminating mC
to T in vitro and in an E. coli assay.[361,364] Some studies suggest, that deamination is ini-
tiating demethylation e.g. in zebrafish or Primordial Germ Cells (PCGs).[365] However,
there are also studies showing only minor contributions of deamination to demethylation
of mC, e.g. bisulfite sequencing studies revealed a small contribution of deamination to
the active demethylation of mC in PGCs.[366] Also several studies demonstrated a strong
22
Introduction
correlation in the activity of the deaminases, depending on the size of the substituent
at C5, making mC worse a substrate than C.[367,368] In addition the deamination of mC
to T could not be reproduced for dsDNA, making it at least unlikely that this mecha-
nism is relevant in vivo.[364] Another class of enzymes that are reported to be capable of
deaminating mC are DNA methyltransferases.[340] In general it seems attractive to have
an enzyme that is able to catalyze both, the methylation and demethylation (via deam-
ination) of cytosine. This would facilitate the cell to rapidly and dynamically regulate
its mC levels.[340] One proposed mechanism for the deamination reaction is depicted in
Figure 8 (right). Chemically the saturation of the C5-C6 bond in the covalent protein-
DNA intermediate would facilitate the nucleophilic attack of water at the C4 position.
The stabilized amino group would act as a leaving group and its substitution by water
would result in T.[369] The observed deamination, however, was only proven indirectly by
Figure 8: AID and APOBEC might deaminate mC or hmC respectively. The resulting
T or hmU mismatch (T:G, hmU:G) would subsequently be repaired by the DNA glyco-
sylase TDG followed by the BER machinery. A nucleophilic attack at C6 would saturate
the C5-C6 bond. The subsequent attack of water at C4 would result in the deaminated
species.
a Ligation-mediated-PCR assay after potential deamination and AP-site cleavage. Also,
the reaction took place at very low SAM concentrations.[340] Therefore the biological
relevance of this setup remains unclear, as SAM is ubiquitous in the cell and necessary
for various biological processes, while this process would require rapid spatial changes
in the SAM-level.[370,371]
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Besides mC also hmC could potentially be deaminated and then further processed as
hmU. Studies showed that overexpression of AID or other members of the AID/APOBEC
family did decrease hmC levels in HEK cells.[346] But also contradicting studies are pub-
lished showing only minor effects of AID/APOBEC on oxidative mC derivatives.[372]
Also the Carell research group could demonstrate that the steady-state level of hmU is
not dependent on hmC deamination. Instead hmU is enzymatically produced via the
oxidation of T by TET enzymes in a regulated manner.[83] Last but not least, as men-
tioned the deamination activity is very weak in case of a large C5 substituent, hence the
weak activity towards mC is even lower for hmC.[367,368,372] In summary, these results
at least challenge the idea of active demethylation through deamination of mC to T or
hmC to hmU.
3.3.2 Active Demethylation via TDG Excision
Although mC, as a substrate would ease the complexity of active demethylation, it is
unlikely that TDG is a mC glycosylase.[373] TDG is known to function as a Thymine-
DNA-glycosylase and repairs T-G mismatches. However the repair of mutagenic mC
to T deaminations seems to be only one part of the story and TDG’s relevance for ac-
tive demethylation is more prominent.[179,373,374] In contrast to other glycosylases, TDG
interacts with transcription factors, de novo methyltransferases, histone modifying en-
zymes and also TET enzymes.[260,375–378] The association of DNMTs with TDG influences
their activity.[377] Methylation activity of DNMT3a is for example reduced upon TDG
interaction, whereas the activity of TDG is enhanced. These interactions suggest a
more prominent function of TDG in epigenetics. The importance of TDG for normal
development is supported by the fact that TDG knock-out mice die after several days
of development and cell lines derived from these organisms have a dysfunctional gene
expression profile. It is worth mentioning that the the lethality occurs after the time of
active demethylation.[218,379,380]
TDG as a "demethylating" enzymes gained much more attention after the discovery
of fC and caC, as it could be demonstrated that TDG is capable of processing these
bases.[82,222,374,381–383] It should be noted that TDG removes fC more efficiently from
DNA than caC, although its affinity towards caC seems to be higher.[222,384] TDG is
capable of recognizing various combinations of substrates at a CpG site, e.g. caC/mC,
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caC/hmC or caC/caC.[260] These studies are the foundation of a putative demethylation
pathway depicted in Figure 9. mC is oxidized by TET enzymes to hmC and further to
fC and caC. These two non-canonical DNA bases are then removed from the genome by
TDG.[82,222] The resulting abasic site is repaired by the BER machinery.[385] However,
as described in chapter 3.1, embryonic development goes hand in hand with the rapid
removal of mC, a process that involves TET dependent oxidation.[134,135,320,324] The de-
scribed pathway through TDG involves the BER machinery and therefore introduces
strand breaks, which would be potentially mutagenic. Elevated levels of DNA strand
breaks are observed during differentiation[386], but the removal of fC and caC does not
result in an accumulation of intermediates of the BER pathway.[387] This would argue
either for a TDG independent pathway, which also has been proposed[388] or that TDG
acts in a complex with other enzymes, therefore rapidly processing abasic sites and
avoiding harmful intermediates.[389] The potential mutagenic behavior of strand breaks
could be bypassed by an active demethylation pathway as described in the following
section.
Figure 9: TET enzymes oxidize mC to hmC and further to fC and caC. The last two
oxidation products of mC are recognized and processed by the mismatch specific glyco-
sylase TDG. The resulting abasic site is repaired by the BER machinery and cytosine is
reincorporated. This pathway includes potentially mutagenic strand breaks.
3.3.3 Active Demethylation via direct C-C Bond Cleavage
From a chemical perspective, fC and caC are prone for a direct C-C bond cleavage
reaction at the C5 position. In theory, also an hmC-based bond cleavage is possible.
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These reactions would generate an unmodified cytosine residue without the need of the
BER machinery and the generation of abasic sites, hence avoiding potentially mutagenic
strand breaks. The putative enzyme would therefore be a dehydroxylase, deformylase
or decarboxylase. In this scenario, the decarboxylation of caC is the most favorable
reaction, as Carell and co-workers could demonstrate.[390] The proportion of reactivity
between caC, fC and hmC is roughly estimated as 30:3:1. A nucleophilic attack at the C6
position, e.g. by a cysteine could facilitate the decarboxylation/deformylation reaction
depicted in Figure 10. Several studies could show that these dehydroxylation, deformy-
Figure 10: A nucleophilic attack, e.g. by a cysteine at C6 would facilitate the demethy-
lation reaction. For the deformylation an additional attack at the aldehyde is necessary,
e.g. by water. The figure is adapted from Schiesser et al.[390]
lation and decarboxylation reactions are in principle possible. A mutated version of the
DNA methyltransferase HhaII could add or remove aldehydes, also on hmC.[391] This
reactivity was also shown for DNMT3a and DNTM3b. Catalyzing this reaction would
enable DNMTs to add and remove the methyl group without the need of another en-
zyme.[392] Last but not least it was demonstrated that DNMTs can directly demethylate
mC to C.[393]. This direct removal of the chemical modification could also be detected
for caC.[394] However these studies were mostly artificial and the contribution of these
reactions to a native systems is not clear.
In general oxidative demethylation reactions are known to occur in a native context,
however with other substrates. Lysine residues for example, can be demethylated in
an oxidative fashion by Jumonji and amine oxidases, however in this case the reac-
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tion takes place at a C-N bond.[395–397] ALKBH5/FTO are enzymes that are capable
of demethylating RNA bases by oxidation reactions.[398,399] Also for DNA, an oxidative
demethylation pathway is known. Thymine can be oxidized by the enzyme Thymin-7-
hydroxlase to hmU, fU and caU which is then processed by the Isoorotat decarboxylase
(IDCase, Cordyceps militaris), resulting in uracil.[400,401] This enzyme is in vitro also
capable of directly forming cytosine from carboxylcytosine, however only on the free
DNA base.[402] A similar decarboxylation activity could be shown by Carell and cowork-
ers in stem cell lysate. The study utilized isotopically labeled caC and incorporated
the base in a synthetic oligonucleotide. After incubation with stem cell lysate heavy
labeled cytosine could be detected via mass spectrometry.[403] It is not clear, if this was
a specifically, biochemically catalyzed reaction and no enzyme could so far be linked to
this process. A recent study by the Carell group further supports the idea of a direct
C-C bond cleavage in vivo. This new data suggest rather a deformylation reaction than
a decarboxylation reaction. Iwan et al. demonstrated that fC is directly deformylated to
cytosine in various cell types.[404] Like decarboxylations also deformylations are known to
occur in nature, yet again for other substrates. Lanosterin for example, an intermediate
of the cholesterol biosynthesis, is deformylated. Also during the degradation of fatty
acids deformylation reactions are observed.[405–408]
Figure 11: Possible conversion of hmC, fC and caC to C by a direct C-C bond cleavage
reaction, releasing formaldehyde, formic acid or carbon dioxide. This pathway would
avoid potentially mutagenic strand breaks.
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4 Synthesis of (R)-Configured 2′-Fluorinated mC,
hmC, fC, and caC Phosphoramidites and
Oligonucleotides
Investigating the metabolism and function of novel epigenetic bases can be facilitated
by the use of stable analogues that are easy to detect and bioisostere. The present study
reports the synthesis of 2′-fluorinated phosphoramidite analogous of 5-methylcytosine
(mC), 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC), and 5-carboxycylcytosine
(caC). They are not cleaved by thymine-DNA glycosylase (TDG) and M.SsI, a DNA
Methyltransferase is capable of methylating 2′-fluorinated cytosine, demonstrating that
the 2′-fluorination does not alter epigenetic recognition.
For this study, I performed the in vitro methylation assay and subsequent sample prepa-
ration for the LC-MS/MS analysis of the reaction. I further participated in the data
evaluation of the analysis.
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ABSTRACT: Investigation of the function of the new epigenetic bases requires the development of stabilized analogues that are
stable during base excision repair (BER). Here we report the synthesis of 2′-(R)-fluorinated versions of the phosphoramidites of
5-methylcytosine (mC), 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC), and 5-carboxycytosine (caC). For
oligonucleotides containing 2′-(R)-F-fdC, we show that these compounds cannot be cleaved by the main BER enzyme
thymine-DNA glycosylase (TDG).
Fluorine is an element that is used in medicinal chemistry toreplace H atoms in pharmaceutically active molecules with
astonishing effects. Fluorine substitution stabilizes molecules to
extend their lifetimes in the bloodstream, and often it increases
the affinities of molecules for their biological targets by
increasing their lipophilicities.1 In nucleoside chemistry, for
example, fluorination of dC at the 2′ position creates molecules
like gemcitabine (1), which are used as antimetabolites in
modern cancer therapy.2 The 2′-F substitution has several
effects. Most importantly, a 2′-(R)-configuration as in 2′-(R)-F-
dC (2) stabilizes the C3′-endo conformation of the ribose sugar
so that the base becomes RNA-like.3 A fluorine at C2′ also
blocks the activity of glycosylases, thereby stabilizing the base
during base excision repair (BER).4 We are currently
investigating the chemistry that occurs at the nucleoside 2′-
deoxycytidine (dC, 3) that leads to the formation and removal
of the methylated and subsequently oxidized epigenetic dC
derivatives 5-methyl- (mdC, 4), 5-hydroxymethyl- (hmdC, 5),
5-formyl- (fdC, 6), and 5-carboxy-2′-deoxycytidine (cadC, 7)
(Figure 1).5 Nucleosides 5−7 are products of consecutive
enzymatic oxidation of 4 by the action of ten-eleven-
translocation enzymes (Tet enzymes), which use molecular
oxygen and α-ketoglutarate to perform the oxidation
chemistry.6 Current data suggest that fdC and cadC are
removed from the genome by BER via the enzyme thymine-
DNA glycosylase (TDG).5d,7 Other data predict that the bases
may undergo some kind of deformylation/decarboxylation
reaction, which would convert fdC and cadC directly back into
the canonical base dC.8 In order to distinguish these processes,
it is important to have tool molecules that cannot be repaired
by BER. This would allow one to decipher chemical processes
at fdC and cadC beyond BER. Here we report the synthesis of
the 2′-(R)-fluorinated versions of mdC (8), hmdC (9), fdC
(10), and cadC (11). We have developed phosphoramidite
building blocks for the incorporation of these bases into DNA
strands, and we show that these nucleosides are indeed stable
during BER. With the plan in mind to investigate epigenetic
processes directly in the genome of stem cells, we realized that
the 2′-arabino-configured compound 2′-(S)-F-dC (12) might
be too toxic. Indeed, when we evaluated the toxicity of the ribo-
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Figure 1. Overview of epigenetically relevant nucleosides and 2′-fluoro
nucleosides that are important in this context.
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configured compound 2′-(R)-F-dC against 12 in stem cells (see
the Supporting Information), we noted a strongly reduced
toxicity for 2′-(R)-F-dC. This is already interesting because it is
believed that the 2′-(S)-F configuration has a much smaller
impact on the overall DNA structure.3,9 Our stem cell data are,
however, in full agreement with toxicity studies in rats and
woodchucks showing that feeding of 2′-(R)-F-dC at up to 500
mg kg−1 day−1 is possible without considerable toxicity
effects.10
For the synthesis of the 2′-(R)-F-xdC nucleosides and
phosphoramidites 15, 18, 21, and 24 (see Scheme 1), we
started with 2′-(R)-F-dC (2), which was iodinated at C5 with
elemental iodine and m-CPBA.11 Subsequent silylation yielded
TBS-protected 5-iodo-2′-(R)-F-dC 13. The needed methyl-
ation was best carried out under Kumada conditions with
trimethylaluminum.12 This furnished the 2′-(R)-F-mdC com-
pound in 79% yield. Notably, the use of other methyl-
transferring agents such as MeMgCl resulted in a 1:1 mixture of
methylated and dehalogenated products. We believe that the
exocyclic amine requires complete deprotonation to avoid a
1,3-proton shift from the exocyclic amine to the Pd-activated
C5-position. Further protection with BzCl and silyl depro-
tection with Olah’s reagent furnished 2′-(R)-F-mdC derivative
14, which was converted into the 2′-(R)-F-mdC phosphor-
amidite building block 15 using standard procedures.13
For the synthesis of the 2′-(R)-F-hmdC phosphoramidite 18,
we started from intermediate 13. Carbonylative Stille coupling
with tributyltin hydride and reduction of the formyl group
under Luche conditions yielded 2′-(R)-F-hmdC derivative 16.14
The exocyclic amine together with the hydroxyl group was
protected as a carbamate using p-nitrophenyl chloroformate.15
Efficient conversion required full deprotonation of both
functional groups with NaH prior to addition of the protecting
reagent. Final silyl deprotection, DMT protection, and
synthesis of the hmdC phosphoramidite building block 18
with Bannwarth’s reagent furnished the 2′-(R)-F-hmC
phosphoramidite in high yield (34% over six steps from 13).
Regarding 2′-(R)-F-fdC phosphoramidite building block 21,
we performed a carbonylative Stille coupling reaction of 13
with tributyltin hydride (see Scheme 2). Subsequent masking of
the formyl group as a 1,3-dioxane unit with 1,3-propanediol and
TiCl4 as the activating Lewis acid provided compound 19. For
the protection of the exocyclic amine, we chose p-
MeOC6H4COCl as recently reported.
16 The electron-pushing
methoxy unit strongly enhances the stability of the amine
protecting group during solid-phase DNA synthesis, and this is
Scheme 1. Synthesis of 2′-(R)-F-mdC and 2′-(R)-F-hmdC
Phosphoramidite Building Blocks 15 and 18
Scheme 2. Synthesis of 2′-(R)-F-fdC and 2′-(R)-F-cadC
Phosphoramidite Building Blocks 21 and 24
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strictly required in order to obtain oligonucleotides in high
yields. Again, satisfactory yields were obtained only when the
exocyclic amine was deprotonated with NaH prior to addition
of p-MeOC6H4COCl. Final silyl deprotection yielded 20, which
was converted into 2′-(R)-F-fdC phosphoramidite building
block 21 using standard procedures.
Starting from intermediate 13, we next developed the
synthesis of the 2′-(R)-F-cadC phosphoramidite building
block. The synthesis of the methyl ester was achieved using
Pd0-mediated CO insertion in methanol.17 Because of the
electron-withdrawing nature of the ester moiety, we decided to
use p-MeOC6H4COCl for stable protection of the exocyclic
amine. Conversion of 23 using standard procedures delivered
2′-(R)-F-cadC phosphoramidite building block 24 in just five
steps in an overall yield of 36% starting from 13.
To examine the ability to prepare oligonucleotides
containing 2′-(R)-F-xdC, we prepared the corresponding
ODN1a−d (see Figure 2). The modified nucleotides were
placed in a CpG context. The solid-phase syntheses were
performed using standard phosphoramidite conditions.18 For
the 2′-(R)-F nucleosides, the coupling times were increased
from 30 to 180 s to ensure good coupling yields. For
deprotection of the oligonucleotides containing 2′-(R)-F-mdC
and 2′-(R)-F-fdC, including cleavage from the solid support, we
first treated the solid-phase material with saturated aqueous
ammonia solution (18 h, 25−28 °C). Subsequently, the
oligonucleotide containing 2′-(R)-F-fdC was exposed to
aqueous acetic acid (80%) at 20 °C until MALDI-TOF/MS
analysis indicated complete hydrolysis of the 1,3-dioxane unit
(∼6 h). Because of the carbamate and ester units, the
oligonucleotides containing 2′-(R)-F-hmdC and 2′-(R)-F-
cadC were deprotected with NaOH (0.4 M in 4:1 methanol/
water) for 18 h. This procedure avoided the formation of
aminomethyl and amide moieties.11,17a Analytical reversed-
phase HPLC directly after deprotection showed in all cases just
one major product. After purification, the corresponding
oligonucleotides were obtained in 20−52% yield and high
purity (>95%). MALDI-TOF/MS spectra showed the expected
masses, confirming the presence of the 2′-(R)-F-xdC bases in
the ODNs. In summary, the synthesized 2′-(R)-F-xdC
phosphoramidite building blocks enabled the synthesis of
oligonucleotides containing the corresponding fluorinated
nucleosides.
We next started to evaluate the extent to which the 2′-(R)-F
substitution would affect typical epigenetic processes. First, we
wanted to know whether the H-to-F chemical mutation
influences the activity of methyltransferases (see Figure 3).
To study this, we synthesized ODN2 having either dC or 2′-
(R)-F-dC in a CpG context. After hybridization of ODN2 with
ODN3, they were incubated with methyltransferase M.SssI. To
determine the level of mdC or 2′-(R)-F-mdC, we digested the
DNA strands to the nucleoside level and performed UHPLC-
MS/MS (QQQ) analysis. As the verification of our hypothesis,
we observed methylation of dC (48%) and 2′-(R)-F-dC (50%).
This demonstrates that the 2′-(R)-F substitution does not affect
the native behavior of the DNA and that 2′-(R)-F-xdC
nucleosides are suitable tools for the investigation of the active
demethylation beyond base excision repair.
In 2011 and 2012, the groups of Drohat7a and Cheng19
showed that fdC and cadC are excised by human TDG
(hTDG). Previously, glycosylase activity was blocked with
fluorinated DNA bases (2′-F-(S)-cadC, 2′-F-(S/R)-dU).4a,c In
order to determine whether the 2′-(R)-F-fdC compounds
would block hTDG activity, we synthesized oligonucleotides
ODN4 with either the fdC or F-fdC nucleoside at a central
position and hybridized the strands to the complementary
oligonucleotide ODN5. After hybridization and incubation with
hTDG, the DNA strand was treated with piperidine.7a,19,20
Subsequently, we analyzed the products by HPLC (see Figure
4). As expected, we detected complete strand cleavage for the
fdC-containing ODN4. However, in the case of the ODN4
containing 2′-(R)-F-fdC, we did not observe any strand
cleavage products. Thus, we proved that the 2′-(R)-F label
indeed inhibits the hTDG activity, blocking BER of fdC.
In summary, we have synthesized 2′-(R)-F phosphoramidite
building blocks of the epigenetically relevant nucleosides. These
building blocks enabled the synthesis of oligonucleotides
Figure 2. (A) Sequence of the synthesized ODN1a−d with
incorporation of the corresponding 2′-(R)-F-xdC phosphoramidite
building blocks. (B−D) Reversed-phase HPL chromatograms and
MALDI-TOF data for the corresponding purified ODN1a−d after
basic and, in the case of 2′-(R)-F-fdC, acidic cleavage from the resin
and deprotection.
Figure 3. (A) Sequences of the synthesized ODN2 and ODN3 with
incorporation of dC or 2′-(R)-F-dC nucleoside. (B) The methylation
assay of ODN2 and ODN3 with methyltransferase M.SssI showed that
the fluoro label in 2′-(R)-F-dC has no influence on the level of
methylation.
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containing 2′-(R)-F-mdC, 2′-(R)-F-hmdC, 2′-(R)-F-fdC, and
2′-(R)-F-cadC in high yields and quality. Furthermore, we
showed that a 2′-(R)-F label on fdC blocks the activity of the
critical TDG enzyme, thus inhibiting base excision repair of this
base. The 2′-(R)-F label is consequently the ideal tool for
analysis of the epigenetic metabolism beyond base excision.
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München) for practical assistance. Furthermore, we thank the
Deutsche Forschungsgemeinschaft (SFB749), the Fonds der
Chemischen Industrie (predoctoral fellowship for A.S.S.), and
the Excellence Cluster (CiPSM, EXC114 and GRK 2062) for
support.
■ REFERENCES
(1) (a) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.;
Meanwell, N. A. J. Med. Chem. 2015, 58, 8315−8359. (b) Purser, S.;
Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37,
320−330.
(2) Parker, W. B. Chem. Rev. 2009, 109, 2880−2893.
(3) (a) Sinnott, M. L. Chem. Rev. 1990, 90, 1171−1202. (b) Williams,
A. A.; Darwanto, A.; Theruvathu, J. A.; Burdzy, A.; Neidigh, J. W.;
Sowers, L. C. Biochemistry 2009, 48, 11994−12004. (c) Berger, I.;
Tereshko, V.; Ikeda, H.; Marquez, V. E.; Egli, M. Nucleic Acids Res.
1998, 26, 2473−2480.
(4) (a) Dai, Q.; Lu, X.; Zhang, L.; He, C. Tetrahedron 2012, 68,
5145−5151. (b) Schaerer, O. D.; Verdine, G. L. J. Am. Chem. Soc.
1995, 117, 10781−10782. (c) Schar̈er, O. D.; Kawate, T.; Gallinari, P.;
Jiricny, J.; Verdine, G. L. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 4878−
4883.
(5) (a) Kriaucionis, S.; Heintz, N. Science 2009, 324, 929−930.
(b) Tahiliani, M.; Koh, K. P.; Shen, Y.; Pastor, W. A.; Bandukwala, H.;
Brudno, Y.; Agarwal, S.; Iyer, L. M.; Liu, D. R.; Aravind, L.; Rao, A.
Science 2009, 324, 930−935. (c) Pfaffeneder, T.; Hackner, B.; Truß,
M.; Münzel, M.; Müller, M.; Deiml, C. A.; Hagemeier, C.; Carell, T.
Angew. Chem., Int. Ed. 2011, 50, 7008−7012. (d) He, Y.-F.; Li, B.-Z.;
Li, Z.; Liu, P.; Wang, Y.; Tang, Q.; Ding, J.; Jia, Y.; Chen, Z.; Li, L.;
Sun, Y.; Li, X.; Dai, Q.; Song, C.-X.; Zhang, K.; He, C.; Xu, G.-L.
Science 2011, 333, 1303−1307.
(6) (a) Loenarz, C.; Schofield, C. J. Chem. Biol. 2009, 16, 580−583.
(b) Ito, S.; Shen, L.; Dai, Q.; Wu, S. C.; Collins, L. B.; Swenberg, J. A.;
He, C.; Zhang, Y. Science 2011, 333, 1300−1303.
(7) (a) Maiti, A.; Drohat, A. C. J. Biol. Chem. 2011, 286, 35334−
35338. (b) Raiber, E.-A.; Beraldi, D.; Ficz, G.; Burgess, H. E.; Branco,
M. R.; Murat, P.; Oxley, D.; Booth, M. J.; Reik, W.; Balasubramanian,
S. Genome Biol. 2012, 13, R69. (c) Zhang, L.; Lu, X.; Lu, J.; Liang, H.;
Dai, Q.; Xu, G.-L.; Luo, C.; Jiang, H.; He, C. Nat. Chem. Biol. 2012, 8,
328−330.
(8) (a) Schiesser, S.; Hackner, B.; Pfaffeneder, T.; Müller, M.;
Hagemeier, C.; Truss, M.; Carell, T. Angew. Chem., Int. Ed. 2012, 51,
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Results and Publications
5 2′-(R)-Fluorinated mC, hmC, fC and caC
triphosphates are substrates for DNA
polymerases and TET-enzymes
In order to gain a more comprehensive insight in the metabolism and function of novel
epigenetic DNA bases, test molecules are necessary to dissect various pathways. These
molecules should be non-toxic and bioisostere. In the present study 2′-fluorinated
triphosphates were synthesized and incorporated via polymerase chain reaction into long
double stranded oligonucleotides. It could be demonstrated that these 2′-fluorinated
derivatives are good substrates for DNA polymerases and TET enzymes.
For this study I supported the synthesis and purification of the PCR products. Further,
I developed and optimized the expression and purification protocol for TET enzymes
out of HEK cells. In addition, I established the in vitro TET assay and performed the
sample preparation for the subsequent LC-MS/MS analysis.
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20-(R)-Fluorinated mC, hmC, fC and caC
triphosphates are substrates for DNA polymerases
and TET-enzymes†
A. S. Schröder,‡ E. Parsa,‡ K. Iwan, F. R. Traube, M. Wallner, S. Serdjukow and
T. Carell*
A deeper investigation of the chemistry that occurs on the newly
discovered epigenetic DNA bases 5-hydroxymethyl-(hmdC), 5-formyl-
(fdC), and 5-carboxy-deoxycytidine (cadC) requires chemical tool
compounds, which are able to dissect the different potential reaction
pathways in cells. Here we report that the 20-(R)-fluorinated deriva-
tives F-hmdC, F-fdC, and F-cadC, which are resistant to removal by
base excision repair, are good substrates for DNA polymerases and
TET enzymes. This result shows that the fluorinated compounds are
ideal tool substances to investigate potential C–C-bond cleaving
reactions in the context of active demethylation.
While all cells of a multicellular organism have an identical
DNA sequence, their morphology and function differ to a great
extent (i.e. neurons vs. adenocytes). This is possible because
these cells have different sets of genes in active and passive
states.1 This programming of the individual genomes occurs on
the DNA level by the chemical modification of deoxycytidine
(dC, 1), which is potentially methylated to give 5-methyldeoxycytidine
(mdC, 2). In the years 20092,3 and 20114,5 it was shown that
mdC is additionally oxidized by the action of TET-enzymes6 to
give 5-hydroxymethyl-(hmdC, 3), 5-formyl-(fdC, 4), and 5-carboxy-
deoxycytidine (cadC, 5). Although the exact function of these
oxidized deoxycytidine derivatives is not clear, it is believed that
they play a fundamental role during the epigenetic programming
of the genome that leads to activated and passivated genes.7
Although it is unclear how this is mechanistically achieved we
have learned that fdC and cadC are substrates of the base
excision repair (BER) process.8–10 The glycosylase TDG is able to
recognize fdC and cadC (but not hmdC) upon which cleavage of
the glycosidic bond occurs that transforms fdC and cadC into
abasic sites (6), which are repaired via the insertion of ‘‘fresh’’
dC to give finally a demethylated position as shown in Fig. 1.
From a chemical point of view a direct deformylation of fdC
or decarboxylation of cadC are attractive alternative pathways
(C–C bond cleavage pathway, red arrows in Fig. 1) that would
allow the direct conversion of fdC and cadC into dC, without the
need to create potentially harmful abasic sites.11–13 These sites are
especially dangerous when they are generated on both strands in
the duplex because then harmful double strand breaks are
generated. In order to study the potential C–C bond cleavage
pathway we need tool substances that are TET substrates but
resist repair by BER. Recently we reported that 20-fluorinated
versions of fdC and cadC are BER resistant.14 Here, we report
that the triphosphates of F-mdC (7), F-hmdC (8), F-fdC (9) and
F-cadC (10), in which the 20-center is (R)-configured, are good
substrates for various DNA polymerases and that this property
can be used to generate long DNA strands containing multiple
20-(R)-fluorinated mdCs, hmdCs, fdC, and cadCs using only
slightly adapted PCR protocols. We finally show that the
20-fluorinated compounds are also good substrates for the
Fig. 1 Putative active demethylation pathways. DNMT: DNA methyltransferase,
TET: ten-eleven-translocation methylcytosine dioxygenase, TDG: thymine
DNA glycosylase. Red arrows: deformylation/decarboxylation, blue arrow:
BER based active demethylation.
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TET enzymes and this together makes them ideal tool substances
to study active demethylation via the putative C–C bond cleavage.
For the synthesis of the 20-(R)-F-xdC triphosphates 11a–d (see
Scheme 1), we started with the corresponding, silyl protected
20-(R)-F-xdC nucleosides 12a–d.14 Silyl deprotection of 11a–c
with Olah’s reagent furnished the 20-(R)-fluorinated nucleosides
of mdC (7), hmdC (8) and fdC (9) in good yields between 62%
and 98%. Regarding the nucleoside 20-(R)-F-cadC (10), we first
deprotected the silyl groups prior to saponification with LiOH in
H2O/MeCN (1 : 1). Using Eckstein conditions, it was possible to convert
the nucleosides 7–10 into the corresponding 20-(R)-fluorinated
triphosphate mdCTP (11a), hmdCTP (11b), fdCTP (11c) and
cadCTP (11d) in one-pot-reactions.15–17 After extensive purifica-
tion by preparative HPL chromatography, we obtained yields in
the range of 3–9%. These yields are remarkable, particularly in
light of the fact that no protecting groups were used, e.g. on the
benzylic hydroxyl group of 20-(R)-F-hmdC (8).
We next examined if the triphosphates are able to function
as substrates for DNA polymerases. For this purpose, we started
with primer extension studies to screen for suitable polymerases
(see ESI†).18,19 Remarkably, all triphosphates with the exception
of 20-(R)-F-cadCTP (11d) were accepted by the DNA-polymerase
Phusion. This is surprising, because Phusion exhibits robust
proof-reading activity and as such may hinder incorporation of
unnatural triphosphates. The here examined triphosphates have
not only a chemical group on the base but feature in addition a
fluorine atom at C20. The result suggests that the 20-(R)-F deriva-
tives mimic the natural situation quite closely.17 The fluorine atom
is bioisosteric to a H-atom20 and it seems that its (R)-configuration,
which most likely leads to a C30-endo conformation of the sugar
pucker does not hinder DNA polymerase based incorporation.21–24
The incorporation of 20-(R)-F-hmdCTP (11b) and 20-(R)-F-fdCTP
(11c) was furthermore possible with the polymerase KOD-XL,
and here the yield were slightly higher. Incorporation of 20-(R)-
F-cadCTP (11d) was finally achieved with the polymerase
Therminator. We believe that the problems associated with this
base are caused by the carboxylic acid at the 5-position of the
base, which carries a negative charge.17
With the 20-(R)-F-xdCTP (11a–d) and the knowledge of which
polymerases to use at hand, we next searched for appropriate
conditions for the PCR (see Fig. 2). As a template, we selected a
fragment of the OCT4 promoter sequence (see Fig. 2A). This
sequence is known for its high density of epigenetically relevant
nucleosides and, due to the high amount of CpG units it is
usually considered to be a difficult template for PCR. The
primers for the PCR were designed to yield an 81 base pair
product containing 14–15 20-(R)-F-xdC bases depending on the
primer. 4–5 dCs are present in the primer and these are of course
not exchanged during PCR. For the reaction, we fully replaced
the dC triphosphate by the corresponding 20-(R)-F-xdCTP. Hence,
full length PCR products can only be formed if the appropriate
20-(R)-F-xdCTP is accepted and incorporated by the polymerase.
Forward and reverse primer were annealed to the template at
55 1C. The elongation of the primers was best performed at 72 1C
for only 25 seconds. For complete extension of the primer, we
extended the final elongation time to 5 min. The experimental
results of the PCR are shown in Fig. 2B. For gel electrophoresis
analysis, we had to use a tris-borate buffer system instead of tris-
acetate to avoid ‘‘smearing’’ of the 20-(R)-F-cadC product caused
by the additional carboxyl groups present at this base.
Remarkably, we obtained full length PCR products for all
20-(R)-F-xdCTPs showing again that a 20-(R)-F-substitution hardly
affects the procession of the polymerase. Further proof of the
correct incorporation of 20-(R)-F-xdCTP was gained by LC-MS/MS
analysis. To this end, the PCR products were fully digested
to the nucleoside level. The sugar phosphate backbone was first
cleaved with nuclease S1 and Antarctic phosphatase, resulting in
the oligo- and 50-monophosphates as well as nucleosides. Further
hydrolysis down to the nucleoside level was realized with snake
venom phosphodiesterase I.25–28 The resulting nucleoside mixture
was subsequently analyzed by UHPLC-MS/MS (QQQ) (see Fig. 2C
and D). As an example, the UV-trace of the digested 20-(R)-F-fdC
PCR product is shown. The clean chromatogram shows only
the expected nucleosides dA, dT, dG, dC (from the primer)
and the 20-(R)-F-fdC compound. The quantification of the
20-(R)-F-nucleosides using exact calibration curves of the synthe-
sized nucleosides confirms the incorporation. Most importantly,
Scheme 1 Synthesis of 20-(R)-F-substituted triphosphates of mdC (11a;
20-(R)-F-mdCTP), hmdC (11b; 20-(R)-F-hmdCTP), fdC (11c; 20-(R)-F-fdCTP)
and cadC (11d; 20-(R)-F-cadCTP).
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we did not detect any side products during the PCR reaction.
Overall, the data show, that the 20-(R)-F-xdCTPs can be incorporated
despite the 20-(R)-fluoro label via PCR into long oligonucleotides.
We next turned our attention to the question, if 20-(R)-F-xdCs
can be oxidized by TET enzymes despite the presence of the
20-(R)-fluoro substituent. To this end, we overexpressed fused
constructs of GFP and the catalytic domain of TET1 (TET1cd)
in HEK293T cells and isolated functional TET1cd with the help
of agarose beads coated with anti-GFP-antibodies. To obtain
sufficient amounts of the enzyme we treated the cells with
sodium butyrate. This compound acts as an HDAC inhibitor
which leads to increased protein expression.29 High concentra-
tions of benzonase and rigorous washing yielded pure and
functional TET1cd. This was confirmed by incubation with
an ODN containing mdC in which mdC was efficiently oxidized
(see ESI†).
We then added the 81 basepair long OCT4 promoter fragment
containing 14–15 20-(R)-F-mdCs, depending on forward or reverse
strand, respectively. After incubating the PCR-product with TET1cd
in a reducing buffer (see ESI†) for 3 h at 37 1C, we isolated the
fragment, digested it down to the nucleoside level as described
above and analyzed the obtained nucleoside mixture using
UHPLC-MS/MS (QQQ). As shown in Fig. 3B the MS-trace showed
clearly that the 20-(R)-F-mdC starting material was not only oxi-
dized to 20-(R)-F-hmdC but also to the higher oxidized species
20-(R)-F-fdC and 20-(R)-F-cadC. Exact quantification data show that
TET1cd oxidation produced 7.9% 20-(R)-F-hmdC, 3.3% 20-(R)-F-fdC
and 0.2% 20-(R)-F-cadC. Again, no side products like deamination
to 20-(R)-F-dT or background C–C bond cleavage, which would
provide 20-(R)-F-dC, were detected. In order to study if the TET
protein oxidizes the 20-F-mdC with an efficiency comparable to the
non-fluorinated mdC, we added the same 81 basepair long OCT4
promoter fragment containing mdC instead of 20-(R)-F-mdC to
pure and functional TET1cd. After digestion and LC-MS/MS
analysis, we detected now only fdC and cadC but no hmdC
showing that the non-fluorinated mdC is the slightly better sub-
strate (see ESI,† Table S2). However, we see for mdC and 20-F-mdC
oxidation up to the fdC and cadC level. This shows that the
20-(R)-fluoro analogs can report TET activity, although the F-atom
does reduce the TET activity to some extent.
In summary, here we show that the 20-(R)-F triphosphates
of the epigenetically relevant nucleosides mdC, hmdC, fdC and
cadC can be efficiently incorporated into long oligonucleotides
Fig. 2 Synthesis of 20-(R)-F-xdC containing OCT4 promoter fragments
by PCR. (A) Sequence of the template and primers used for the PCR (FW:
forward, RV: reverse). (B) Result of the PCR analyzed by gel electro-
phoresis. The retention of the band corresponds to the expected PCR products.
(Control: PCR with all NTP, but without a polymerase. 20-(R)-F-xdC: PCR
with all NTP except dCTP but with corresponding 20-(R)-F-xdC.) (C) UV
trace of UHPL-chromatogram after enzymatic digestion of the 20-(R)-F-fdC
PCR-product. (D) Quantification data of 20-(R)-F-xdC PCR-products after
enzymatic digestion and UHPLC-MS/MS analysis.
Fig. 3 TET1cd oxidation assay. (A) Scheme of the TET1cd dependent
oxidation reaction. (B) UHPL-MS/MS-trace of 20-(R)-F-xdC nucleosides
after enzymatic digestion of the DNA fragment. (C) Quantification data of
the product after complete enzymatic digestion and UHPLC-MS/MS
(QQQ) analysis.
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using PCR. This provides oligonucleotides of sufficient length
for detailed mechanistic studies. Importantly, while the 20-(R)-F
substituent blocks the BER-based removal of fdC and cadC it is
a good substrate for the TET enzymes.
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A. S. Schröder, J. Steinbacher, G. Kashiwazaki, G. Höfner, K. T. Wanner,
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and S. Klimašauskas, J. Am. Chem. Soc., 2014, 136, 5884–5887.
13 S. Schiesser, B. Hackner, T. Pfaffeneder, M. Müller, C. Hagemeier,
M. Truss and T. Carell, Angew. Chem., Int. Ed., 2012, 51, 6516–6520.
14 A. S. Schröder, O. Kotljarova, E. Parsa, K. Iwan, N. Raddaoui and
T. Carell, Org. Lett., 2016, 18, 4368–4371.
15 J. Ludwig and F. Eckstein, J. Org. Chem., 1989, 54, 631–635.
16 J. Caton-Williams, M. Smith, N. Carrasco and Z. Huang, Org. Lett.,
2011, 13, 4156–4159.
17 B. Steigenberger, S. Schiesser, B. Hackner, C. Brandmayr, S. K. Laube,
J. Steinbacher, T. Pfaffeneder and T. Carell, Org. Lett., 2013, 15,
366–369.
18 T. Ono, M. Scalf and L. M. Smith, Nucleic Acids Res., 1997, 25,
4581–4588.
19 C. G. Peng and M. J. Damha, Can. J. Chem., 2008, 86, 881–891.
20 R. S. Rowland and R. Taylor, J. Phys. Chem., 1996, 100, 7384–7391.
21 M. L. Sinnott, Chem. Rev., 1990, 90, 1171–1202.
22 A. A. Williams, A. Darwanto, J. A. Theruvathu, A. Burdzy,
J. W. Neidigh and L. C. Sowers, Biochemistry, 2009, 48, 11994–12004.
23 I. Berger, V. Tereshko, H. Ikeda, V. E. Marquez and M. Egli, Nucleic
Acids Res., 1998, 26, 2473–2480.
24 S. Lee, B. R. Bowman, Y. Ueno, S. Wang and G. L. Verdine, J. Am.
Chem. Soc., 2008, 130, 11570–11571.
25 T. Ando, Biochim. Biophys. Acta, Nucleic Acids Protein Synth., 1966,
114, 158–168.
26 M. Rina, C. Pozidis, K. Mavromatis, M. Tzanodaskalaki, M. Kokkinidis
and V. Bouriotis, Eur. J. Biochem., 2000, 267, 1230–1238.
27 T. Nihei, G. L. Cantoni and With the technical assistance of
Rachelle Rothenberg, J. Biol. Chem., 1963, 238, 3991–3998.
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6 5-Formylcytosine to Cytosine Conversion by C-C
Bond Cleavage in vivo
The methylation of cytosine is crucial for various cellular processes. It is an essen-
tial part of the epigenetic network. However, a comprehensive understanding of the
demethylation of 5-methylcytosine is still missing. To date the best studied path-
way for the demethylation is based on the oxidation of 5-methylcytosine (mC) to 5-
hydroxymethylcytosine (hmC), 5-formylcytosine (fC) and 5-carboxylcytosine (caC). Through
a base excision repair it is possible to replace fC and caC with unmodified cytosine. The
present study investigates an alternative pathway that does not involve potential muta-
genic base excision repair. By using 2′-fluorinated DNA building blocks it was possible
to demonstrate that 5-formylcytosine is converted to cytosine by a direct C-C bond
cleavage reaction.
For this study, I participated in processing the DNA for subsequent LC-MS/MS analy-
sis.
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Modification of genomic cytosine modulates the interaction of DNA-binding factors with the genome, thus affecting gene expression and chromatin structure1,2. The primary 
and most prevalent modification is methylation to mdC, which 
in mammals is catalyzed by the DNA methyltransferases Dnmt1, 
Dnmt3a and Dnmt3b, at least partly in co-operation with the cata-
lytically inactive Dnmt3l3. Because Dnmt1 is a maintenance methyl-
transferase that copies the methylation pattern during replication, 
the information that this pattern conveys is inherited through cell 
division. Genomic mdC can be iteratively oxidized to hmdC4,5, 
fdC6,7 and cadC7,8 by the Ten-eleven translocation (Tet) family of 
α-ketoglutarate-dependent dioxygenases (Fig. 1a). These oxidized 
cytidine derivatives are prominently detected in DNA isolated from 
neuronal tissues5,9,10 and in the genome of embryonic stem cells 
(Fig. 1b), in which their levels change during differentiation4,7,11. For 
example, hmdC can reach levels of up to 1.3% per deoxyguanosine 
(dG) in DNA isolated from brain12. Although the presence of mdC 
and hmdC is believed to influence the transcriptional activity of 
genes13,14, no clear function has yet been assigned to the higher oxi-
dized modifications fdC and cadC. Recent reports, however, show 
that fdC is a stable15, or at least semi-stable16, base in the genome. 
These discoveries and the identification of specific reader proteins 
that recognize fdC and cadC suggest that they might have regulatory 
purposes as well17–20. So far, however, fdC and cadC are mainly con-
sidered to be intermediates of an active demethylation process that 
allows cells to replace mdC by a canonical dC nucleotide20–22. One 
such scenario involves fdC and cadC as substrates of the thymine-
DNA glycosylase (Tdg), which cleaves the corresponding glyco-
sidic bond. This converts fdC and cadC into abasic sites, which are 
further processed through base excision repair (BER) as depicted 
in Figure 1a. This Tdg-initiated process establishes an active de- 
methylation pathway, ultimately incorporating unmodified dC 
nucleotides at former fdC and cadC sites8,23. A problem associated 
with this mechanism is that the removal of every mdC creates a 
potentially harmful single-strand break intermediate. If an mdC is 
close to the first in the opposite DNA strand, even double strand 
breaks may be generated. In addition to these concerns, it was shown 
that both maternal and paternal genomes of mouse zygotes undergo 
active demethylation independently of Tdg24. To explain such an 
excision-independent demethylation and provide an alternative to 
generating harmful repair intermediates, it was suggested that fdC 
and cadC may directly deformylate and decarboxylate, respectively, 
under C–C bond cleavage (Fig. 1a)9,25. Indeed, chemical pathways 
that allow such a direct deformylation and decarboxylation of fdC 
and cadC have been described26,27. These pathways involve addi-
tion of a helper nucleophile to the C6 position of fdC and cadC 
in a Michael-addition-type reaction followed by deformylation or 
decarboxylation and final elimination of the helper nucleophile26. 
The chemistry is therefore quite similar to the known reaction 
mechanisms employed by the Dnmt proteins3. Although chemically 
plausible, it is unclear whether such direct C–C bond cleavage reac-
tions occur within the genome28. This process would provide a new 
and harmless way to convert mdC back into dC in the genome with-
out forming potentially harmful abasic site intermediates.
Here we report a sensitive MS-based isotope tracing study inves-
tigating whether a C–C bond cleavage reaction occurs on fdC bases 
(Fig. 1c). We supplemented the medium of cultured mammalian 
cells with synthetic isotope- and fluorine-labeled fdC derivatives to 
metabolically integrate the nucleosides as reporter molecules into 
their genome. After isolation of the genomic DNA, the levels of the 
modified dC derivatives were measured by ultra-high performance 
liquid chromatography coupled to tandem mass spectrometry 
(UHPLC–MS/MS), thereby tracing isotopically or fluorine-labeled 
dC derivatives.
RESULTS
Isotopically labeled fdC is directly converted into dC
We started the study with a [13C5][15N2]fdC (1; Fig. 2a), in which all 
five C-atoms of the ribose ring were exchanged with 13C and the two 
in-ring nitrogen atoms replaced with 15N (Supplementary Note). 
This provides compound 1, which is seven mass units heavier than 
naturally occurring fdC and hence easily distinguishable by MS. The 
large mass difference allows exact tracing of all transformations that 
may take place on this base with high sensitivity, because the natural 
1center for integrated protein Science Munich cipSM at the department of chemistry, ludwig-Maximilians-universität München, Munich, Germany. 
2these authors contributed equally to this work. *e-mail: thomas.carell@lmu.de
5-Formylcytosine to cytosine conversion by C–C 
bond cleavage in vivo
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Olesea Kosmatchev1, shqiponja Ferizaj1, Jessica steinbacher1, edris parsa1, Markus Müller1    
& thomas Carell1* 
Tet enzymes oxidize 5-methyl-deoxycytidine (mdC) to 5-hydroxymethyl-dC (hmdC), 5-formyl-dC (fdC) and 5-carboxy-dC 
(cadC) in DNA. It was proposed that fdC and cadC deformylate and decarboxylate, respectively, to dC over the course of 
an active demethylation process. This would re-install canonical dC bases at previously methylated sites. However, whether 
such direct C–C bond cleavage reactions at fdC and cadC occur in vivo remains an unanswered question. Here we report the 
incorporation of synthetic isotope- and (R)-2′-fluorine-labeled dC and fdC derivatives into the genome of cultured mammalian 
cells. Following the fate of these probe molecules using UHPLC–MS/MS provided quantitative data about the formed reaction 
products. The data show that the labeled fdC probe is efficiently converted into the corresponding labeled dC, most likely after 
its incorporation into the genome. Therefore, we conclude that fdC undergoes C–C bond cleavage in stem cells, leading to the 
direct re-installation of unmodified dC.
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abundance of such highly isotopically modified dC derivatives is 
essentially null. Possible transformations are the deformylation of 
1 to [13C5][15N2]dC (2) and its deamination to [13C5][15N2]dU (3), 
followed by methylation of 3 to [13C5][15N2]dT (4). Alternatively, 
compound 1 can deaminate to [13C5][15N2]fdU (5) and, finally, the 
deformylated compound 2 can be methylated to [13C5][15N2]mdC 
(6). Analysis of the MS pattern of 1 showed that cleavage of the 
glycosidic bond is the dominant fragmentation pathway. This leads 
to a clearly detectable fingerprint mass transition of m/z = 263.1 
to m/z = 142.1 (Fig. 2b). Detection of the demodified product 
dC 2 would be possible on the basis of its mass transition from 
m/z = 235.1 to m/z = 114.0. For the experiment, we added 1 to the 
medium of mouse embryonic stem cells (mESCs) under prim-
ing conditions. After 3 d, the genomic DNA was isolated using a 
standard protocol and digested to the individual nucleosides. The 
obtained nucleoside mixture was analyzed by UHPLC coupled to a 
triple quadrupole mass spectrometer. We noted that 1 was indeed 
metabolically incorporated into the genome of mESCs. The mass 
transition of 1 (m/z = 263.1 to m/z = 142.1) was clearly detectable 
at a retention time of 5.50 min under our conditions (Fig. 2b). By 
using the mass transitions specific for all the expected natural dC 
derivatives, we were also able to detect next to 1, natural mdC, 
hmdC and fdC (Fig. 1b).
Analysis of the nucleoside mixtures revealed the presence of a 
new isotope-labeled dC derivative at a retention time of 1.95 min 
displaying the expected mass transition (m/z = 235.1 to m/z = 114.0) 
for 2, showing that [13C5][15N2]fdC is indeed demodified (Fig. 2c). 
To unequivocally prove the identity of 2, an even heavier isotopically 
modified dC isotopologue, [13C9][15N3]dC (7), with a characteristic 
MS transition of m/z = 240.1 to m/z = 119.1 (Supplementary Results, 
Supplementary Fig. 1), was used as an internal standard. Compound 
7 was added to the nucleoside mixture and it eluted at the same reten-
tion time as 2 (Fig. 2c), confirming that the UHPLC–MS/MS signal at 
1.95 min is caused by 2. Exact quantification of the conversion 
showed that when 1 was supplied to mESC cultures at 50 μM for 3 d, 
steady state incorporation levels of about 3–5 × 10−7 of [13C5][15N2]fdC 
per deoxynucleoside (dN) in genomic DNA were reached (Fig. 2d). 
We observed higher levels of product 2 (up to a factor of 10), as 
shown in Figure 2d.
Whereas we can exclude spontaneous deformylation of 1 based 
on previous stability studies26, 2 can in principle form either by 
C–C bond cleavage in the genome or at the level of the soluble 
nucleoside/nucleotide pool. Conversion of 1 in the soluble pool 
to 2 would then be followed by metabolic incorporation of the 
2-triphosphate into the genome. It is known that soluble 2 is the 
substrate for other metabolic processes such as deamination to 3 
(catalyzed by cytidine deaminase and deoxycytidylate deaminase), 
which is followed by methylation by thymidylate synthase to give 4 
(refs. 29,30). To distinguish the two possible conversion scenarios 
(genomic DNA or soluble pool), we reasoned that if 1 is converted 
into 2 in the soluble pool, we would find compounds 3 and, particu-
larly, 4 in the genome.
To investigate the behavior of soluble dC, we cultured mESCs 
in the presence of an isotopically labeled dC derivative, [13C9][15N3]
dC, and indeed detected the expected presence of the correspond-
ing isotopically labeled deamination products [13C9][15N2]dT and 
[13C9][15N2]dU (8 and 9, respectively) in the genome (Fig. 2e). In con-
trast, when 1 was supplied to mESC cultures, we detected next to 2 
only the direct deamination product 5 in the genome, but not 3 and 
4 (Fig. 2d). Even after three consecutive days of feeding compound 
1 to mESCs, we were unable to detect even traces of 4 in the genome. 
This argues against formation of 2 in the soluble pool. We next 
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analyzed the soluble nucleoside/nucleotide pool directly for the 
content of 2 after feeding of 1 (Supplementary Fig. 2). To this end, 
we fed 1 to mESCs over 3 d. The cells were washed extensively and 
finally resuspended in 50% (v/v) MeCN to extract soluble meta-
bolites. After further purification by solid-phase extraction, the 
nucleotides were dephosphorylated to nucleosides. Analysis of this 
solution by UHPLC–MS/MS did not give any signal for 2. All these 
control experiments suggest that 1 undergoes C–C bond cleavage to 
2 directly in the genome and not in the soluble pool, although the 
latter scenario cannot be fully ruled out because of the complexity 
of the metabolic pathways (Supplementary Fig. 3). Interestingly, 
we also noted the presence of the remethylated product 6 in the 
genome of mESCs fed with 1, but because of the low signal intensity 
we were unable to obtain quantitative data (Fig. 2d).
2′-fluorinated cytosines detect biochemical conversions
To reach higher sensitivity, we experimented with various other iso-
tope-labeled fdC derivatives, and finally found that 2′-fluorinated 
dC derivatives 10–17 are excellent probe molecules (Fig. 3a and 
Supplementary Fig. 4). The exchange to an F-atom makes the 
compound 18 atom units heavier. The compounds also have a 
slightly shifted retention time (Fig. 3b) and give sharp signals in 
the UHPLC–MS/MS analysis because of a glycosidic bond that is 
more labile in the MS-fragmentation step. Furthermore, the 2′-(R)-
configured compounds are well tolerated by the cells used for this 
study. The F-substituent does affect the ability of the molecule to 
undergo further biochemical conversions, but the effect is small. 
(R)-2′-F-dC (10), for example, is efficiently methylated by DNA 
methyltransferases31 and (R)-2′-F-mdC (11) is also oxidized to (R)-
2′-F-hmdC (12) by the Tet enzymes (Fig. 3a,c), although a reduced 
speed of oxidation is observed32.
To show that the fluorinated compounds are valid probe 
molecules, we first added 10 to the mESC culture at 0.5 μM, 1.0 μM 
or 2.5 μM for 3 d. Under these conditions, UHPLC–MS/MS analysis 
of the isolated genomic DNA showed a clear dose-dependent 
integration of 10 into the genome, up to 1 × 10−3 per dN. We next 
searched for other 2′-fluorinated pyrimidine nucleosides and 
detected a dose-dependent presence of (R)-2′-F-dU (13) and (R)-
2′-F-dT (14), which was formed by deamination of 10 to 13 fol-
lowed by methylation to 14 (Fig. 3c). In addition, we detected a 
dose-dependent formation of (R)-2′-F-mdC and (R)-2′-F-hmdC, 
confirming that compound 10 is biochemically converted, as 
expected (Fig. 3c).
To quantify the levels of methylation, we synthesized the isotope-
labeled compounds (R)-2′-[D3]F-mdC (18), (R)-2′-[15N2]F-dC (19) 
and (R)-2′-[15N2]F-fdC (20) and used them as internal standards for 
quantification (Fig. 3a). Upon feeding mESCs with 1 μM 10 for 3 d, 
we detected around 3% (±0.5%) of 11 relative to 10, which is similar to 
proportions observed for the natural bases (Supplementary Fig. 5).
(R)-2′-F-fdC is converted into (R)-2′-F-dC in mESCs
To study the direct C–C bond cleavage process, we again cultured 
mESCs in the presence of (R)-2′-F-fdC (15; 350 μM for 3 d), iso-
lated the DNA and analyzed the nucleoside composition. Next to 
genomic (R)-2′-F-fdC (5.7 × 10−7/dN), we detected (R)-2′-F-dC at a 
level of 7.3 × 10−6/dN (Fig. 3d). Because the nucleosides 13 and 14 
were not detected, we suspected again that the observed reaction of 
15 to 10 occurs directly within the genome. The detection limit of 
13 and 14 is, however, around 5 fmol, and so the compounds may 
just escape observation.
To substantiate the conclusion that genomic 15 undergoes 
intragenomic C–C bond cleavage to 10, we first assessed whether 
15 can spontaneously deformylate. To investigate this possibility, we 
heated an aqueous solution of 15 to 60 °C for 3 d; however, we did 
not detect compound 10. We also incubated 15 in culture medium 
for 3 d and were unable to detect any 10. Finally, we added a 28-mer 
oligonucleotide containing a single 15 to culture medium for 3 d, 
then re-isolated the DNA strand and searched for 10. Formation 
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of 10 was again not detected. Together, these experiments exclude 
background deformylation.
We next analyzed the possibility that 15 is contaminated with 
traces of 10. To this end, the purity of 15 was checked by MS, and 
indeed, 10 was not found. To exclude the presence of even traces 
of 10 below the detection limit, we performed three consecutive 
HPLC purifications of 15. This compound 15 is well separable 
from 10 because 10 elutes 7.50 minutes earlier than 15 during the 
HPLC purification (Fig. 3e). Feeding of the material 15 obtained 
from three consecutive purifications resulted in unchanged values 
of genomic 10, arguing against the possibility that the detected 10 is 
an accumulated impurity (Fig. 3f).
To further substantiate that the C–C bond cleavage does not 
occur in the soluble nucleoside/nucleotide pool, we added 10 to the 
mESC culture for 3 d. UHPLC–MS/MS analysis of the soluble pool 
allowed us to detect 10, 14 and, in traces, 13 (Fig. 3g). However, 
when we repeated the study with 15 (Fig. 3h), we detected just 15 in 
the soluble pool plus the deaminated compound (R)-2′-F-fdU (17), 
but not 10. We next determined the medium concentration of 10 
that would be needed to reach the measured value for genome-inte-
grated 10 (7.3 × 10−6/dN; Fig. 3d) and found that a concentration of 
5–10 nM would be required (Supplementary Fig. 6) in the soluble 
pool. With a detection limit of 30 amol for 10 (40 μL injection), this 
is a concentration at which 10 is unambiguously detectable.
All of these control experiments support the idea that the C–C 
bond cleavage to F-dC occurs within the genome. Interestingly, upon 
feeding of 15 to mESCs, we also detected the methylated derivative 
11, demonstrating that the demodified product 10 is methylated 
to 11 in the genome. Using the isotopically labeled internal stan-
dards (R)-2′-[D3]F-mdC, (R)-2′-[15N2]F-dC and (R)-2′-[15N2]F-fdC 
(Fig. 3a), we found that remethylation of 10 results in levels of 2.8% 
(±0.3%) F-mdC (Fig. 3d), which is only slightly lower compared to 
the level observed with direct feeding of 10 (Supplementary Fig. 5).
To study the time dependence of the C–C bond cleavage process, 
we fed compound 15 and measured the genome-integrated levels of 
15, 10 and 11. Already at 0.5 h, we detected a stable incorporation 
of 15 (Fig. 4a). The C–C bond cleaved product 10 appeared after 
about 1 h and the levels increased steadily (Fig. 4b). After about 4 h, 
we saw the first remethylated product 11 (Fig. 4c). If 10 was a con-
tamination in the preparation of 15, we would expect faster incor-
poration kinetics. When we fed both 15 and 10 simultaneously, a 
steady increase in the level of 10 was already observed after 5 min 
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(Supplementary Fig. 7), confirming that our probe nucleosides are 
quickly incorporated into the genome. These data show that the 
C–C bond cleavage is a rapid process.
Dnmt or Tet enzymes are not required for demodification
To investigate whether the remethylation of 10 is driven by the 
known DNA methyltransferases and whether these are involved 
in demodification, we added 15 (350 μM for 3 d) to mESCs defi-
cient in all active DNA methyltransferases Dnmt1, Dnmt3a and 
Dnmt3b (Dnmt triple knockout (TKO)) and analyzed the DNA. In 
this experiment, the demodified product 10 is again detected, but 
the methylated product 11 is not seen (Fig. 4d and Supplementary 
Fig. 8), showing that DNA methyltransferases are responsible for 
methylation of 10 and are not required for demodification of 15. 
We finally investigated whether the Tet enzymes are involved in 
demodification of 15. However, repeating the feeding experiment 
with mESCs lacking all three members of the Tet family (Tet TKO) 
resulted in full demodification activity (Fig. 4e and Supplementary 
Fig. 9). The fact that the conversion of 15 to 10 does not change 
in the absence of Tet proteins is particularly noteworthy. Because 
Tet enzymes were shown to accept 11 as a substrate and convert 
it into 12, 15 and (R)-2′-F-cadC 16 (ref. 32), we can exclude the 
possibility that the observed C–C bond cleavage is in fact a Tet-
dependent decarboxylation of 16. Indeed, this result implies either 
that 15 is directly deformylated to 10 or that factors other than Tet 
enzymes can oxidize 15 to 16, which would then be decarboxy-
lated to 10. Ascorbic acid has been shown to increase Tet enzymatic 
activity in vitro and the levels of oxidized mdC derivatives in vivo33–35. 
Ascorbic acid treatment of mESC cultures fed with 15 indeed 
resulted in increased levels of naturally occurring fdC and cadC, 
but had no effect on conversion of 15 into unmodified product 10 
(Supplementary Fig. 10). This further supports that demodifica-
tion of 15 to 10 does not depend on the enzymatic activity of the 
Tet enzymes.
Finally, we tested whether conversion of 15 into 10 occurs in 
nonpluripotent cells by feeding 15 to cell lines representing a variety 
of cell types (Fig. 4f and Supplementary Fig. 11). Albeit to various 
degrees, we detected the conversion of 15 to 10 in all these cell lines, 
arguing that this is rather widespread in mammalian cell types. 
In summary, our data prove that fdC is converted into dC in vivo 
through C–C bond cleavage and strongly suggest that this conver-
sion is an intragenomic process.
DISCUSSIoN
In recent years, several mechanisms for active erasure of cytosine 
methylation from the genome have been proposed25. Among these, 
the best-established mechanism entails Tet-mediated iterative oxi-
dation of mdC to fdC or cadC followed by the replacement of these 
higher oxidized derivatives with unmodified dC through BER36. 
Considering the frequent occurrence of mdC in high-density clus-
ters and prevalent symmetrical configuration at CpG sites in verte-
brate genomes, a BER-based erasure mechanism poses a substantial 
risk of creating clustered single and double strand breaks with 
potentially deleterious consequences. It is possible that excision of 
fdC and cadC by Tdg, processing of the abasic site and insertion of 
unmodified dC are orchestrated by a single multimolecular com-
plex, thus allowing tight control of strand breaks. Alternatively, it is 
also conceivable that to minimize the potentially deleterious conse-
quences of BER, complementary mechanisms are in place to remove 
fdC and cadC that do not involve DNA repair. In this context, it 
should be kept in mind that Tet3-dependent active demethylation of 
maternal and paternal genomes in the mouse zygote may not require 
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Tdg24. With an isotope-tracing experiment using labeled dC-derived 
nucleosides in combination with highly sensitive UHPLC–MS/MS 
detection, we show here that in mammalian cells fdC is converted 
to dC while the glycosidic bond is kept intact. Evidence is provided 
to support the theory that the C–C bond cleavage reaction hap-
pens when fdC is located inside the genome. This establishes an 
intragenomic demodification process independent of DNA repair. 
We also show that this process does not require any of the Tet-family 
enzymes. Therefore, unless other factors are able to oxidize fdC to 
cadC, this demodification process is likely a direct deformylation of 
fdC. Although we have firmly established the occurrence of a C–C 
bond cleavage of fdC or cadC to dC, the mechanism of this process 
remains to be defined, including the identification of the factors that 
mediate the demodification reactions.
We would like to emphasize that in our approach the probe 
nucleosides are randomly incorporated into the genome through 
DNA replication. Consequently, we cannot determine the sequence 
and genomic context wherein the demodification of fdC or cadC to 
dC takes place. Obviously, this would require a sequencing approach 
that allows identification of the converted dC bases. In addition, we 
detected conversion of 2′-fluorinated fdC to 2′-fluorinated dC in 
mESCs and different somatic cell types. This indicates that the abil-
ity to carry out the demodification reaction may be widespread in 
mammalian cells and tissues rather than being restricted to events of 
active genomic demethylation known to occur in specific develop- 
mental and tissue contexts. Assuming that the deformylation of 
fdC to dC establishes an active demethylation pathway, we need to 
emphasize that deformylation reactions and deformylases are wide-
spread in nature. A prominent example is the enzyme lanosterol 
14α-demethylase (CYP51A1), which oxidizes the C14α methyl 
group of lanosterol to a formyl group to achieve deformylation under 
concomitant introduction of a double bond (dehydrating deformy-
lation). This enzyme, a P450-type monooxygenase, contains a heme 
cofactor that seems to utilize a nucleophilic Fe peroxyl anion species 
to attack the substrate37,38. Another well studied enzyme that cata-
lyzes deformylation is the aldehyde-deformylating deoxygenase, 
which again uses a nucleophilic metal bond peroxyl anion radical 
as the attacking species. This enzyme shortens fatty acid chains by 
oxidizing the terminal methyl group to a formyl group, which is fol-
lowed by deformylation39,40. In contrast to fdC, these deformylation 
reactions take place on formyl groups attached to saturated C atoms, 
whereas in fdC the formyl group is linked to an aromatic hetero-
cycle. Such structures are known for decarboxylations, and they are 
catalyzed by the enzymes orotate41 and isoorotate42 decarboxylase. 
Indeed, it was suggested that the isoorotate decarboxylase could be 
a blueprint for a putatively existing cadC decarboxylase43. Our data 
now support the idea that fdC and possibly also cadC are converted 
to dC by a direct C–C bond cleavage. The questions as to when and 
where these reactions occur in vivo now require the identification of 
putative catalytic factors.
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Chemical synthesis. Synthetic schemes, detailed procedures and characteriza-
tion of synthesized products can be found in the Supplementary Note. Unless 
noted otherwise, all reactions were performed using flame- or oven-dried 
glassware under an atmosphere of nitrogen. Compounds 7 (B.A.C.H. UG) and 
10 (Carbosynth) were commercially available. 15 was synthesized as previously 
described in the literature32. Identities of these compounds were confirmed 
by NMR and LC–MS/MS. Molsieve-dried solvents were used from Sigma-
Aldrich, and chemicals were bought from Sigma-Aldrich, TCI, Carbolution 
and Carbosynth. Technical grade solvents were distilled before extraction or 
chromatography of compounds. Reaction controls were performed using TLC 
Plates from Merck (Merck 60 F254), flash-column chromatography purifica-
tions were performed on a Merck Geduran Si 60 (40–63 μM). Visualization 
of the developed TLC plates was achieved through UV absorption or through 
staining with Hanessian’s stain. NMR spectra were recorded in deuterated sol-
vents on Varian VXR400S, Varian Inova 400, Bruker AMX 600, Bruker Ascend 
400 and Bruker Avance III HD. HR–ESI–MS spectra were obtained from a 
Thermo Finnigan LTQ FT-ICR. Infrared (IR) spectroscopic measurements 
were performed on a PerkinElmer Spectrum BX FT-IR spectrometer with a 
diamond ATR (attenuated total reflection) unit. HPLC purifications were 
performed on a Waters Breeze system (2487 dual array detector; 1525 binary 
HPLC pump) using a Nucleosil VP 250/10 C18 column from Macherey Nagel, 
HPLC-grade MeCN was purchased from VWR.
Cell culture. Basal medium for mESC culture was DMEM high glucose contain-
ing 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 
1× MEM Non-essential Amino Acid Solution and 0.1 mM β-mercaptoethanol 
(all from Sigma). All mESC lines were maintained in their naïve state on gela-
tin-coated plates by supplementing basal medium with 1,000 U/mL LIF (ORF 
Genetics), GSK3 inhibitor CHIR99021 at 3 μM and Mek inhibitor PD0325901 
1 μM (“2i”). Metabolic labeling experiments with fluorine- or isotope-labeled 
nucleosides were performed by plating mESCs in priming conditions consist-
ing of basal mESC medium supplemented with 3 μM CHIR99021 and Wnt 
pathway inhibitor IWR1-endo at 2.5 μM as previously reported44. Under these 
conditions primed cells remained pluripotent for at least seven days as deter-
mined by epifluorescence with an Oct4-YFP knock-in cell line45. Priming and 
labeling was performed for 3 d. Over this period naturally occurring genomic 
mdC and hmdC (Fig. 1b) reached levels similar to those recently reported 
for epiblast-like cells, which are regarded as the closest in vitro counterpart 
to noncommitted post-implantation epiblast46,47. All inhibitors were pur-
chased from Selleckchem. Dnmt TKO J1 mESCs were described in ref. 48. Two 
independent sets of Tet TKO and respective wt mESC lines were used: wt #17 
and Tet TKO #3 were reported in ref. 49 and wt #4 and Tet TKO #29 were 
described in ref. 50. J1 mESCs are from the 129/Sv/Jae strain, while all Tet TKO 
and corresponding wt mESC lines are from mixed genetic backgrounds.
The time-course experiment was performed by culturing J1 mESCs under 
priming conditions for 48 h. The medium was exchanged to priming medium 
containing 350 μM F-fdC and cells were harvested after 0.5, 1.0, 2.0, 4.0, 8.0, 
16 and 24 h, as described.
RBL-2H3, HeLa, NIH3T3 and Neuro-2a cells were cultured in DMEM 
high glucose containing 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, 
100 μg/mL streptomycin. CHOK1 cells were maintained in DMEM/F12 sup-
plemented as reported above for the other somatic cell lines. ENC1 neural stem 
cells were cultured as previously described51. Cells were exposed to labeled 
nucleosides for 4 (RBL-2H3 and NIH3T3), 5 (CHO-K1), 6 (Neuro-2a) and 
7 d (HeLa and ENC1).
Labeled nucleosides were added to the culture medium at the following 
concentrations: F-fdC (15), 350 μM; F-dC (10), 0.5, 1.0 and 2.5 μM; [13C5][15N2]
fdC (1), 50 μM; [13C9][15N3]dC (7), purchased from B.A.C.H. UG), 100 μM.
Isolation of genomic DNA. Cultures were washed with PBS and lysed by 
adding RLT buffer (Qiagen) containing 400 μM each of 2,6-di-tert-butyl-4-
methylphenol (BHT) and desferoxamine mesylate (DM) directly to the plates. 
Isolation of genomic DNA was performed with Zymo-Spin V, V-E or IIC-XL 
columns according to the instruction of the ZR-Duet DNA/RNA MiniPrep Kit 
(Zymo Research) with the following modifications. DNA was sheered by bead 
milling in 2 mL microfuge tubes using one 5-mm diameter stainless steel bead 
per tube and a MM400 bead mill (Retsch) set at 30 Hz for 1 min. Lysates were 
then loaded onto spin columns and the bound material was first incubated 
for 15 min with Genomic Lysis Buffer (Zymo Research) supplemented with 
0.2 mg/mL RNase A (Qiagen). After washing genomic DNA fragments were 
eluted with water containing 0.4 μM of each BHT and DM.
DNA digestion. 0.5–10 μg of genomic DNA in 35 μL H2O were digested as 
follows: An aqueous solution (7.5 μL) of 480 μM ZnSO4, containing 42 U 
nuclease S1 (Aspergillus oryzae, Sigma-Aldrich), 5 U Antarctic phosphatase 
(New England BioLabs) and specific amounts of labeled internal standards 
were added, and the mixture was incubated at 37 °C for 3 h. After addition 
of 7.5 μL of a 520 μM [Na]2-EDTA solution, containing 0.2 U snake venom 
phosphodiesterase I (Crotalus adamanteus, USB corporation), the sample was 
incubated for 3 h at 37 °C or overnight and then stored at −20 °C. Prior to 
UHPLC–MS/MS analysis, samples were filtered by using an AcroPrep Advance 
96 filter plate 0.2 μm Supor (Pall Life Sciences).
LC/MS-MS analysis of DNA samples. Quantitative UHPLC–MS/MS analy-
sis of digested DNA samples was performed using an Agilent 1290 UHPLC 
system equipped with a UV detector and an Agilent 6490 triple quadru-
pole mass spectrometer. Prior to every measurement series, external cali-
bration curves were measured to quantify the levels of the F-nucleosides 
(Supplementary Fig. 12). Additionally, (R)-2′-[15N2]F-dC (19), (R)-2′-[15N2]
F-hmdC (37) and (R)-2′-[15N2]F-fdC (20) were used to validate the result-
ing peaks by co-injection. For exact quantification of fluorinated nucle-
osides also internal quantification with stable isotope dilution techniques for 
F-fdC, F-dC and F-mdC were developed (Supplementary Fig. 13). Natural 
nucleosides were quantified with the stable isotope dilution technique. An 
improved method, based on earlier published work26,28,52–54 was developed, 
which allowed the concurrent analysis of all nucleosides in one single ana-
lytical run11. The source-dependent parameters were as follows: gas tem-
perature 80 °C, gas flow 15 L/min (N2), nebulizer 30 psi, sheath gas heater 
275  °C, sheath gas flow 11 L/min (N2), capillary voltage 2,500 V in the positive 
ion mode, capillary voltage −2,250 V in the negative ion mode and nozzle volt-
age 500 V. The fragmentor voltage was 380 V/ 250 V. Delta EMV was set to 500 
(positive mode) and 800 (negative mode). Compound-dependent parameters 
are summarized in Supplementary Tables 1–4. Chromatography was per-
formed by a Poroshell 120 SB-C8 column (Agilent, 2.7 μm, 2.1 mm × 150 mm) at 
35 °C using a gradient of water and MeCN, each containing 0.0085% (v/v) formic 
acid, at a flow rate of 0.35 mL/min: 0–4 min; 0– 3.5% (v/v) MeCN; 4–7.9 min; 
3.5–5% MeCN; 7.9–8.2 min; 5–80% MeCN; 8.2–11.5 min; 80% MeCN; 11.5– 
12 min; 80–0% MeCN; 12–14 min; 0% MeCN. The effluent up to 1.5 min 
and after 12 min was diverted to waste by a Valco valve. The autosampler was 
cooled to 4 °C. The injection volume was 39 μL.
Quantification of nucleosides. Prior to every sample set, calibration curves 
to quantify all fluorine labeled nucleosides were measured under the same 
conditions and settings. All calibration curves are valid within the range of 
1-500 fmol with five measuring points and measured as technical triplicates. 
Supplementary Fig. 12 shows representative calibration curves for all Fluoro-
nucleosides used for the quantification.
To obtain the internal calibration curves for exact quantification, we 
analyzed each standard, namely (R)-2′-[15N2]F-fdC (20; n = 205 fmol), 
(R)-2′-[15N2]F-dC (19; n = 793 fmol) and (R)-2′-[D3]F-mdC (18; n = 461 fmol), 
in comparison to the corresponding nonlabeled nucleoside with constant 
concentration. Technical triplicates were measured, and the linear regres-
sion was applied using Origin 6.0 (Microcal). Therefore, the ratio of the 
area under the curve of unlabeled nucleoside (A) to the labeled standard 
(A*) was plotted against the ratio of the amount of unlabeled nucleoside 
(n) to the labeled one (n*) (see Supplementary Fig. 13). Acceptable preci-
sion (<20% relative s.d. within each triplicate) and accuracy (80%–120%) 
was achieved for all three calibration curves. The accuracy is calculated as 
the ratio of the measured to the calculated ratios of the areas (A/A*) under 
the curves in percent. The ratios of the areas (A/A*) can be calculated by 
using the linear equations for the corresponding ratio of amount (n/n*). 
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The lower limit of detection was defined as the detected amount, which 
is three times higher than the blank response (LOD). The lower limit of 
detection (LLOQ) and the upper limit of detection (ULOQ) are the lowest 
and the highest amounts (n) and the ratio of the amounts (A/A*) fulfilling the 
requirements of the corresponding linear equation, respectively.
Nucleoside stability test. Compounds 1 and 15 were incubated at 100 μM in 
mESC culture medium at 37 °C and 5% CO2 for 3 d. For the recovery of the nucl-
eosides Supel-Select SPE HLB cartridges from Sigma-Aldrich were used. Prior 
to use, the cartridges were equilibrated with MeOH, followed by acidified H2O 
(with HCl to pH = 4). The pH of the samples was adjusted to 4, and the acidic 
solution was loaded on the cartridges. After washing with 10 mL of H2O, the 
cartridges were dried in vacuo. The nucleosides were eluted with MeOH/MeCN 
(1:1), evaporated to dryness via speedvac and resuspended in H2O.
Oligonucleotide stability test. An oligonucleotide (6.9 pmol) containing one 
F-fdC (28-mer) was incubated in mESC culture medium at 37 °C and 5% CO2 
for 3 d. For the recovery of the oligonucleotide, Oligo Clean & Concentrator 
from Zymo Research was used according to the manual. The resulting oligonu-
cleotide was dissolved in H2O and digested as described for genomic DNA.
Extraction of nucleoside/nucleotide soluble pools. J1 mESCs were plated 
under priming conditions (as described above) for 3 d. The culture medium 
was supplemented with 1.0 μM F-dC (10), 50 μM [13C5][15N2]fdC (1) or 350 μM 
F-fdC (15). Cells were washed twice with PBS (Sigma-Aldrich), harvested 
by trypsinization and pelleted by centrifugation for 3 min at 300g. 500 
μL ice-cold 50% (v/v) acetonitrile was added dropwise to the pellet and 
vortexed55. The mixture was incubated on ice for 10 min. The insoluble 
fraction was then separated from the soluble pool by centrifugation for 
10 min at 21,000 × g at 0 °C. The supernatant was removed and used for 
nucleoside isolation. The soluble fraction containing the nucleosides was 
dried by lyophilization and metabolites were purified using Supel-Select 
SPE HLB cartridges (as described in the nucleoside stability test) before 
UHPLC–MS/MS analysis.
Life Sciences Reporting Summary. Further information on experimental 
design and reagents is available in the Life Sciences Reporting Summary.
Data availability. The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
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7 Functional impacts of 5-hydroxymethylcytosine,
5-formylcytosine, and 5-carboxycytosine at a
single hemi-modified CpG dinucleotide in a gene
promoter
Enzymatic oxidation of mC to hmC, fC and caC is connected to active DNA demethy-
lation and epigenetic reprogramming in mammals. However, it is yet not clear whether
the mC oxidation products have autonomous epigenetic or regulatory functions in the
genome. This study used an artificial upstream promoter constituted of one cAMP re-
sponse element (CRE) to measure the impact of mC in a hemi-methylated CpG on the
promoter activity and further explored the consequences of hmC, fC, and caC in the
same system. All modifications induced mild impairment of the CREB transcription
factor binding. The decrease of the gene expression by mC or hmC was proportional
to the impairment of CREB binding and had a steady character over at least 48 hours.
In contrast, promoters containing single fC or caC underwent further progressive loss
of activity, up to almost complete repression. This decline was strongly (caC) or partly
(fC) dependent on TDG. The results thus indicate that fC and caC can provide a signal
for perpetuation and enhancement of the repressed transcriptional state by a mechanism
that requires base excision repair.
For this study, I synthesized and purified the highly modified oligonucleotides containing
mC, hmC, fC and caC. These were then used for the generation of the CRE element.
In addition, I participated the synthesis and purification of the 2′-fluorinated oligonu-
cleotides.
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ABSTRACT
Enzymatic oxidation of 5-methylcytosine (5-mC) in
the CpG dinucleotides to 5-hydroxymethylcytosine
(5-hmC), 5-formylcytosine (5-fC) and 5-
carboxycytosine (5-caC) has central role in the
process of active DNA demethylation and epigenetic
reprogramming in mammals. However, it is not
known whether the 5-mC oxidation products have
autonomous epigenetic or regulatory functions in
the genome. We used an artificial upstream promoter
constituted of one cAMP response element (CRE) to
measure the impact of 5-mC in a hemi-methylated
CpG on the promoter activity and further explored
the consequences of 5-hmC, 5-fC, and 5-caC in
the same system. All modifications induced mild
impairment of the CREB transcription factor binding
to the consensus 5′-TGACGTCA-3′ CRE sequence.
The decrease of the gene expression by 5-mC
or 5-hmC was proportional to the impairment of
CREB binding and had a steady character over at
least 48 h. In contrast, promoters containing single
5-fC or 5-caC underwent further progressive loss
of activity, up to an almost complete repression.
This decline was dependent on the thymine-DNA
glycosylase (TDG). The results thus indicate that
5-fC and 5-caC can provide a signal for perpetuation
and enhancement of the repressed transcriptional
state by a mechanism that requires base excision
repair.
INTRODUCTION
DNA methylation at cytosine residues plays essential roles
in transcriptional regulation and genome maintenance in
vertebrates (1–3). Most abundant and best studied context
in which 5-methylcytosine is present in the genomes is sym-
metric methylation of CpG dinucleotides. CpG methylation
can be copied to daughter DNA strands during replica-
tion and thus constitutes an epigenetic mark propagated
through cell division (4,5). CpG methylation in the pro-
moter regions regulates transcriptional activity of genes
by at least two mechanisms. One is direct modulation of
binding of the methylation-sensitive transcription factors
to the regulatory motifs containing methylated CGs (6–
8). Another is reinforcement and long-term propagation
of chromatin-mediated gene silencing by recruitment of
the methyl-CpG-binding domain (MBD) proteins and, in
turn, histone deacetylases (1,2). Both these modes of ac-
tion appear to be important for silencing and transcrip-
tional repression of genes whose promoters contain long-
range arrays rich in CpG dinucleotides, known as CpG is-
lands (CGIs). In the non-CGI promoters, functions of CpG
methylation are even more complex and the outcomes for
transcriptional activity may be very variable for genes con-
trolled by different transcription factors and in different cell
lineages (9–11). DNA demethylation mechanisms add an-
other complexity level to the regulation of gene transcrip-
tion by erasing 5-methylcytosine or converting it to other
types of base modifications whose regulatory functions still
have to be explored (12–15). Thus, currently the best char-
acterized DNA demethylation pathway in vertebrates me-
diated by the ten eleven translocation (TET) family oxyge-
nases (16–21) generates 5-hmC, 5-fC and 5-caC, which may
have independent functions in the regulation of gene expres-
sion (13,22). However, understanding of functional conse-
quences of cytosine demethylation products at specific reg-
ulatory elements is hindered by the extremely low levels of
these modifications in the genome (17,19,23) and by the dy-
namic character of 5-fC and 5-caC which are efficiently re-
moved by DNA repair mechanisms (15,18,24).
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Transitions between the methylated and unmethylated
states of CpG dinucleotides require hemi-modified states in
which 5-mC or its oxidation products are present in only
one DNA strand (25). Functional impact of such modifi-
cations on the regulation of gene expression is unknown
because deliberate hemi-modification of chosen cytosine
residues in DNA cannot be generated enzymatically. To
overcome this hurdle, we have previously proposed an effi-
cient procedure for a site-specific incorporation of synthetic
oligonucleotides containing various base modifications into
plasmid-borne reporter genes with the help of sequence-
specific nicking endonucleases (26). With these tools, we
have already obtained important insights into the mech-
anisms of excision repair of several types of structurally
defined DNA lesions in functional reporter genes (27–29).
Here, we applied an analogous approach to measure the
functional impacts of 5-mC, 5-hmC, 5-fC and 5-caC on the
regulation of gene transcription. Our strategy was to gen-
erate expression constructs containing each of these cyto-
sine modifications in a CpG dinucleotide within an artifi-
cial promoter composed of a cyclic adenosine monophos-
phate (cAMP) response element (CRE) upstream from a
TATA box-containing RNA polymerase II basal promoter.
We chose CRE because it contains a CpG dinucleotide in
the consensus sequence and because it was known that bind-
ing of the specific transcription factors (e.g., CREB and
C/EBP alpha) and the induced transcription can be either
negatively or positively regulated by the symmetric CpG
methylation (8,30). Moreover the presence of 5-mC and 5-
hmC in just one DNA strand significantly reduce, whereas
the C>U substitution in either one or both DNA strands
increase the affinity of CREB binding (31,32). The aim of
present work was to compare the functional significance of
CpG hemi-methylation and hemi-hydroxymethylation for
the CRE-driven gene expression and to investigate the im-
pacts of the DNA demethylation intermediates 5-fC and 5-
caC on the promoter activity.
MATERIALS AND METHODS
Cell lines and reporter vectors
Isogenic HeLa-derived cell lines in which TDG, SMUG1
or UNG1/2 DNA glycosylases were knocked down
by stable expression of the specific shRNA and the
corresponding control HeLa/pEpS cell line were gen-
erated and characterised by western blotting and the
specific DNA glycosylase activity testing previously (29).
The sequence cloned into the pENTR/pSuper+ vector
(Addgene, Cambridge, MA, USA) for expression of
shRNA which efficiently targets human TDG was 5′
GATCCGGGAACGAAATATGGACGTTCAACTCG
AGTTGAACGTCCATATTTCGTTCTTTTTGGAAA.
The parental vector pENTR/pSuper+ was used as a scram-
bled transcript control. Vectors pCRE-uno with a unique
full-length 5′-TGACGTCA-3′ consensus CRE sequence
upstream from the RNA polymerase II transcription ini-
tiation region of the reporter EGFP gene and pCMV1111
with four CRE sequences were described previously (33).
The vectors contain tandem sites for the Nb.BsrDI nicking
endonuclease spaced with the 18-nucleotide interval around
the 5′-TGACGTCA-3′ consensus CRE sequence (Figure
Figure 1. Impact of CpG hemi-methylation in the minimal CRE promoter
on the CREB binding and the reporter EGFP gene expression. (A) Artifi-
cial CRE-uno promoter: transcription start (broken arrow), CRE sequence
(bold), AatII site (underlined), Nb.BsrDI nicking positions (vertical ar-
rows), and positions of 5-mC/5-hmC/5-fC/5-caC in the incorporated syn-
thetic oligonucleotides (asterisks). (B) Inhibition of the AatII restriction
endonuclease by the M.SssI methylation of the central CG-dinucleotide in
CRE. Agarose gel electrophoresis of pCRE-uno incubated with AatII. Ar-
rows indicate migration positions of the linearized vector (4408 bp) and of
the covalently closed (cc) and nicked (nc) forms of circular vector DNA.
(C) Verification of the incorporation of synthetic oligonucleotides contain-
ing one or three 5-mC (1 × 5mC, 3 × 5mC) by inhibition of the AatII
cleavage. (D) Scheme of the PciI/BmtI digest of the pCRE-uno vector and
electrophoretic mobility shift assay (EMSA) of the PciI/BmtI fragments
under the indicated CREB:DNA molar ratios. The shorter (180 bp) frag-
ment contains CRE with no or one 5-mC in the central CG-dinucleotide.
The right panel shows control CRE-less vector (pCRE-zero) incubated
with CREB in parallel. (E) EGFP expression in HeLa cells transfected
with pCRE-uno containing none, one (in the central CG-dinucleotide of
CRE) or three 5mC. Representative FACS data and relative EGFP expres-
sion values (mean ± SD, n = 7). Expression in the absence of an EGFP-
coding vector (DsRed) denotes the lower detection limit. CRE-less vector
(pCRE-zero) was included in two experiments as a reference for the basal
expression level. P-values calculated by the Student’s t-test.
1A). The derived vectors pCRE-uno-C (with inverse
orientation of the Nb.BsrDI sites but otherwise identical to
pCRE-uno) and pCRE-zero (in which CRE was mutated
to produce an inert 5′-ACTGACTG-3′ sequence) were
generated by PCR with the overlapping primers using
PfuTurbo® polymerase (Agilent Technologies, Wald-
bronn, Germany). The template DNA was digested with
DpnI (Thermo Fischer Scientific, Darmstadt, Germany)
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followed by direct repair in the ultracompetent Escherichia
coli scs-8 (Agilent Technologies).
Synthetic oligonucleotides
DNA CE-phosphoramidites Bz-dA, Bz-dC, iBu-dG, T and
Bz-mC were obtained from Glen Research (Sterling, VA) or
Link Technologies (Bellshill, Scotland). 5-HmC, 5-fC and
5-caC phosphoramidites were synthesized and solid-phase
synthesis of the 18-mer 5′-CATTGCGTGACGTCAGCG
deoxyribo-oligonucleotides was performed using the stan-
dard protocols described previously (22). Underlined cy-
tosines show positions in which 5-mC/5-hmC/5-fC/5-caC
were incorporated, as specified in the text. Synthesized
DNA chains were HPLC-purified with VP 250/10 Nucle-
osil 100-7 C 18 columns (Macherey-Nagel, Düren, Ger-
many) and the quality determined by MALDI-MS (22).
2′-(R)-fluorinated derivatives of 5-fC and 5-caC were syn-
thetised and handled as described previously (34). The se-
quence for incorporation of the 2′-fluorinated nucleotides
was 5′-CATTGCGTGACGTCAGCG. Oligonucleotides
5′-CATTGCGTGA[THF/S-THF]GTCAGCG containing
the abasic site analog tetrahydrofuran with either phos-
phodiester (THF) or phosphorothioate (S-THF) 5′-linkage
as well as 5′-CATTGCGTGAC[8-oxoG]TCAGCG con-
taining 8-oxo-7,8-dihydroguanine were purchased from
BioSpring GmbH (Frankfurt am Main, Germany).
Generation of the reporter constructs with 5-mC/5-hmC/5-
fC/5-caC specifically positioned in the CRE sequence
Site-specific double nicks on both sides of the CRE se-
quence in the vectors pCRE-uno (‘top’ strand), pCRE-uno-
C (‘bottom’ strand) or pCMV1111 were generated by the
Nb.BsrDI endonuclease (NEB GmbH, Frankfurt am Main,
Germany). Synthetic 18-mer oligonucleotides containing 5-
mC/5-hmC/5-fC/5-caC, the 2′-(R)-fluorinated derivatives
of 5-fC/5-caC or THF/S-THF in the specified positions
were used to displace the excised native DNA strand frag-
ment and seamlessly ligated into vector DNA by the strand
exchange protocol described previously (26). The respective
control oligonucleotide without modifications was always
ligated in parallel for every independent vector preparation.
The presence of 5-mC/5-hmC/5-fC/5-caC in the covalently
closed vector DNA was verified by the inhibition of cleav-
age by the AatII restriction endonuclease (NEB).
Electrophoretic mobility shift assays
Vectors pCRE-uno and pCRE-zero were digested with PciI
and BmtI (both NEB) to produce the CRE-less 4228 bp
fragment and the 180 bp fragment with one (pCRE-uno)
or no CRE (pCRE-zero) and cleaned up. Binding reac-
tions contained 10 nM DNA (400 ng in 15 l reaction
volume) and proportional variable amounts of the purified
CREB protein (BioCat, Heidelberg, Germany) in the bind-
ing buffer composed of 20 mM Tris-HCl (pH 8.0), 50 mM
KCl, 5 mM MgCl2, 1 mM dithiothreitol and 5% glycerol
(all reagents from Sigma-Aldrich, Seelze, Germany) supple-
mented with 1 mg/ml bovine serum albumin (NEB). After
30-min incubation at 37◦C reactions were chilled on ice and
fragments separated by agarose gel electrophoresis in the
0.5 × TBE buffer (Bio-Rad Laboratories, Dreieich, Ger-
many) under cooling conditions, as described previously
(35). Band intensities were quantified following the ethid-
ium bromide staining with the help of GelDocTM XR+
molecular imager and the Image LabTM software (Bio-
Rad).
Transfections and gene expression analyses
Exponentially growing in six-well plates cells were trans-
fected with the help of Effectene (QIAGEN, Hilden, Ger-
many) with the EGFP reporter constructs (with or without
the specified modifications) in combination with the tracer
pDsRed-Monomer-N1 vector (Clontech, Saint-Germain-
en-Laye, France), 400 ng each vector. The method for quan-
titative determination of EGFP expression in transiently
transfected cells by flow cytometry was validated by titra-
tion of the EGFP-encoding vector and described in detail
previously (36). Briefly, formaldehyde-fixed cells were equi-
librated in phosphate buffered saline (PBS) and analysed us-
ing FACSCalibur™ and the CellQuest™ Pro software (Beck-
ton Dickinson GmbH, Heidelberg, Germany). FSC/SSC
gating was routinely used to exclude fragmented and aggre-
gated cells and DsRed signal (FL2-H) was applied as addi-
tional gating marker to select for the effectively transfected
cells. After the exclusion of untransfected cells, EGFP fluo-
rescence (FL1-H) distribution plots were generated and av-
erage EGFP expression per cell determined as the median of
the distribution. To assess variability between independent
experiments, expression levels of constructs with cytosine
modifications were calculated in each experiment relative to
the expression of the control construct (without modifica-
tions) as a ratio of the respective FL1-H values.
RESULTS
Generation of expression constructs containing the C5 atom
modifications of defined cytosines
We have previously generated the EGFP-encoding pCRE-
uno reporter vector in which the basal RNA polymerase II
promoter is coupled with a single CRE as a minimal up-
stream regulatory element. The CRE-motif is flanked by
strand-specific nicking sites for the endonuclease Nb.BsrDI
(Figure 1A), which are neutral for the regulation of gene
expression, whereas CRE itself measurably activates tran-
scription of the reporter EGFP gene (33). We sought to use
these properties for the investigation of consequences of de-
fined cytosine modifications at a single CpG dinucleotide
for the regulation of the CRE-driven gene expression. For
this purpose, we have introduced 5-mC (or 5-hmC/5-fC/5-
caC) into the vector DNA sequence by substitution of the
Nb.BsrDI-excised native DNA strand fragment for the syn-
thetic strands containing the respective modifications at the
central CG-dinucleotide of the CRE sequence.
As a proof of principle, we first generated expression con-
structs containing one or three 5-mC residues in the substi-
tuted DNA strand (Figure 1A). The pCRE-uno CRE se-
quence accommodates a unique recognition sequence for
the AatII restriction endonuclease, whose activity is in-
hibited by the CpG methylation (Figure 1B), which en-
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ables easy verification of the incorporation of 5-mC with
the synthetic oligonucleotide (Figure 1C). Subsequently, we
used the same approach for the incorporation of oligonu-
cleotides containing 5-hmC, 5-fC or 5-caC and demon-
strated that all the modifications were efficiently integrated
into vector DNA (Supplementary Figure S1).
CREB binding and gene expression in the presence of the CpG
hemi-methylation
We have analysed by the electrophoretic mobility shift as-
say the influence of single 5-mC in the central CpG dinu-
cleotide of the CRE consensus sequence on binding of the
transcription factor CREB (Figure 1D). Comparison with
the nearly identical vector pCRE-zero in which the CRE site
has been deleted showed that CREB binds specifically to
the restriction fragment containing the CRE-motif and that
single 5-mC in the central CpG dinucleotide significantly re-
duces the band shifting. The equivalent levels of band shift-
ing in the presence of 5-mC, were achieved by increasing the
CREB:DNA ratio by the factor of ∼2.5 (Figure 1D and not
shown data), suggesting that single methyl group causes a 2-
to 3-fold reduction of CREB affinity to its binding site.
To check whether the impaired CREB binding has a func-
tional significance for the gene transcription in cells, we
next measured the impact of CpG hemi-methylation on the
EGFP expression levels in transfected human cells. Anal-
yses in HeLa cells showed that single 5-mC incorporated
into the central CpG nucleotide decreased the expression by
approximately one quarter. Hemi-methylation of all three
CpG dinucleotides within the exchanged DNA fragment
resulted in the halved expression level with respect to the
expression of unmethylated control templates (Figure 1E).
This quantitatively corresponded to the expression level of
the CRE-less vector, suggesting that hemi-methylation at
these three positions reduces gene transcription to the basal
levels and, hence, nullifies the activatory effect of CREB.
Accordingly, we derive that hemi-methylation of the cen-
tral CpG alone caused an ∼2-fold reduction of the CREB-
dependent fraction of transcription. For comparison, to-
tal methylation of the pCRE-uno vector by M.SssI almost
completely obliterated the EGFP expression, thus indicat-
ing a very efficient repression of both induced and basal
transcription (Supplementary Figure S2). Together, the re-
sults indicate that even a single methyl group––if present at
the critical CpG dinucleotide––can measurably reduce the
level of gene transcription in cells by direct reduction of the
affinity of the transcription factor binding.
The impact of 5-hmC on the gene expression: comparison
with 5-mC
We have next generated expression constructs containing
synthetic 5-hmC at the same CpG dinucleotides as de-
scribed above for 5-mC and determined the expression lev-
els in Hela cells under the same conditions. As 5-mC, 5-
hmC caused a significant reduction in the EGFP expres-
sion levels if present in the central CpG dinucleotide of the
CRE sequence and even stronger reduction when all three
CpG dinucleotides of the incorporated synthetic DNA were
modified by the hydroxymethyl group (Figure 2A). Quanti-
Figure 2. Impacts of one or three 5-hmC in the minimal CRE promoter on
the EGFP gene expression and comparison with the respective effects of 5-
mC. (A) EGFP expression in HeLa cells transfected with pCRE-uno con-
taining none, one or three 5-hmC. Representative fluorescence scatter plots
and the correspondent overlaid fluorescence distribution plots of HeLa
cells 24 h after transfection (on the left) as well as mean EGFP expression
values determined relative to the construct containing unmodified oligonu-
cleotide (‘C’). Mean of nine independent experiments ± SD; P-values cal-
culated by the Student’s t-test. (B) CREB binding to CRE containing one
5-mC or 5-hmC in the central CG-dinucleotide detected by EMSA of the
pCRE-uno PciI/BmtI fragment. (C) EGFP expression in HeLa cells trans-
fected with pCRE-uno containing either one (1×) or three (3×) of the indi-
cated CpG modifications in the promoter fragment (relative to pCRE-uno
without CpG modifications). Lines represent independent transfections.
tatively, these effects were similar to the magnitude of the in-
hibitory effects of 5-mC at the same positions. CREB bind-
ing to the modified CRE was also impaired by single 5-hmC
to at least the same extent as by 5-mC (Figure 2B), which
suggests that the observed decrease in the gene transcription
levels in cells was caused primarily by the impaired binding
of the transcriptional activator. It has to be noted, however,
that the presence of additional methyl or hydroxymethyl
groups at the CpG sites outside from the minimal consensus
CRE sequence did not cause further prominent decrease of
CREB binding in the band-shifting assays (Supplementary
Figures S3 and S4), thus indicating that the binding mode
and the impact of 5-hmC on the gene expression in cells may
be additionally influenced by other factors.
Because 5-hmC has been proposed to play a functional
role in DNA demethylation (by either TDG-dependent
(16,17,21) or -independent (37,38) pathways, we wondered
whether the magnitudes of the repressory effects of both
CpG modifications (5-mC and 5-hmC) would vary in the
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Figure 3. Impacts of 5-mC and 5-hmC in the ‘bottom’ DNA strand of
the minimal CRE promoter on the EGFP gene expression. (A) Scheme of
the promoter fragment of the pCRE-uno-C vector used for modification
of CG-dinucleotides in the bottom strand (asterisks). (B) EGFP expres-
sion in HeLa cells transfected with pCRE-uno containing either one (1×)
or three (3×) of the indicated modifications in the promoter fragment (rel-
ative to pCRE-uno without modifications). Lines represent independent
transfections.
course of time. However, the results showed that the effects
of both modifications persisted for at least 48 hours post
transfection. During the whole time course, constructs with
5-mC and 5-hmC showed on average equal extents of tran-
scriptional inhibition (Figure 2C), suggesting that 5-hmC
has not been removed from CRE. The values for 5-hmC
had a somewhat higher interexperimental noise; however,
there was no clear tendency to recovery of the gene ex-
pression levels over the time course. The results thus indi-
cate that, at least in the cell model used, hemi-methylated
and hemi-hydroxymethylated CpG dinucleotides have over-
all very similar negative impacts on CREB binding and the
CRE-activated transcription.
The effects of 5-mC and 5-hmC are manifested in both DNA
strands
It is not known, whether biological consequences of hemi-
methylation (or hemi-hydroxymethylation) depend on the
DNA strand which is methylated. Because only one strand
of the pCRE-uno plasmid (Figure 1A, top strand) can be
substituted for a synthetic strand, we have generated an
analogous pCRE-uno-C plasmid with flipped BsrDI sites,
in which the complementary DNA strand can be replaced
(Figure 3A, bottom strand). With CRE sequence as a refer-
ence point, we introduced 5-mC and 5-hmC at exactly the
same CpG dinucleotides as previously in the top strand and
performed time course expression analyses in HeLa cells
(Figure 3B). Analogously to the previous experiments (Fig-
ure 2C), the results showed that either 5-mC or 5-hmC in
the central CpG of the CRE sequence resulted in losses
of approximately one fourth of the total gene expression
level. Additional modifications at the neighbouring CpG
dinucleotides caused ulterior decrease of the gene expres-
sion resulting in the loss of approximately half of the to-
tal transcriptional activity, which corresponds to residual
activity equivalent to the basal transcription level of the
CRE-less vector described above. Once again, the effects
of both modifications persisted for at least 48 hours. Over-
all, we conclude that the effects of 5-mC and 5-hmC at
the same hemi-modified CpG dyads on the transcriptional
activation/repression of the CRE-regulated promoter are
qualitatively and quantitatively very similar, regardless of
the DNA strand affected by the modification.
Potent and largely indirect repression by 5-fC and 5-caC
The TET-induced mechanism of enzymatic DNA demethy-
lation described previously (16–21) foresees transient gen-
eration of 5-fC and perhaps 5-caC. Although active DNA
demethylation is regarded as a potential mechanism for re-
expression of genes originally silenced by DNA methyla-
tion, functional impact of these oxidation products on gene
expression has not been sufficiently characterized to date.
We have used the experimental setup described above to
characterize the impacts of these cytosine modifications on
the CRE-driven gene transcription. Because of the variable
band-shifting activity between different batches of the re-
combinant CREB protein, we had to adjust the protein
amounts in these experiments with respect to the conditions
used in Figures 1D and 2B in order to achieve measurable
band shifting with unmodified (‘C’) DNA (Figures 4A and
5A). We found that both 5-fC and 5-caC to some extent in-
terfere with CREB-binding in vitro, however, do not pre-
vent the binding completely, i.e. CREB binding properties
to its target sequence were altered by these modifications to
similar extents as earlier observed for hemi-methylated and
hemi-hydroxymethylated CpG.
Expression analyses of the constructs containing one or
three 5-fC in and around the CRE sequence showed that
this modification leads to decreased reporter gene expres-
sion in the transfected HeLa cells (Figure 4B and C). The
impairment of the EGFP expression was initially very mild
(as judged from the fluorescence measured at the earliest
time point of 6 h); however, the magnitude of the negative
impact of 5-fC on the gene expression greatly increased by
the 24 h time point after transfection (Figure 4B). At 24 h
post-transfections, the degrees of the inhibition of gene ex-
pression by 5-fC and 5-caC clearly exceeded the respective
effects of 5-mC and 5-hmC reported above (Figures 1–3).
In-depth monitoring of the expression of constructs con-
taining one or three hemi-modified CpG sites over a time
span of 6–48 h post-transfection revealed a very strong and
steady decline of the EGFP expression with no signs of re-
covery over the whole observation period, suggesting that
5-fC induced persistent repression of the gene transcription
(Figure 4C). Thereby, the gene repression could not be ac-
counted solely to the inhibition of CREB binding, as con-
cluded from both strength and kinetics of the observed ef-
fects.
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Figure 4. Effects of 5-fC in the minimal CRE promoter. (A) CREB bind-
ing to CRE containing one 5-fC in the central CG-dinucleotide detected
by EMSA. (B) Representative fluorescence distribution plots of HeLa cells
24 h after transfection with constructs containing 5-fC in one (1×) or three
(3×) CG-dinucleotides (overlaid with the reference ‘C’ construct obtained
with unmodified synthetic oligonucleotide). (C) Time-course of the EGFP
expression (relative to ‘C’) in HeLa cells transfected with constructs con-
taining 1× or 3 × 5-fC. Lines show independent transfections. Mean val-
ues for each time point are highly significantly different from 1 (P < 0.001,
heteroscedastic Student’s t-test). (D) Time-course of the EGFP expression
in HeLa cells transfected with constructs containing single 8-oxoG in the
CRE (two independent experiments).
It is interesting to note that a similar gradual transcrip-
tional repression was previously reported for reporter con-
structs containing various nucleobase modifications and
has been identified as a hallmark of DNA lesions under-
going base excision repair (BER) (27,29,33). The role of
BER in the gene repression has been inferred based on the
requirements of the lesion-specific DNA glycosylases and
of the strand-cleaved reaction intermediate generated by
the apurinic/apyrimidinic site endonuclease APE1 (33). To
test whether BER of a modification situated in the CRE
sequence would affect the gene expression in a compara-
ble way, we have placed single 8-oxo-7,8-dihydroguanine (8-
oxoG) as a representative BER substrate into the CRE se-
quence. The results indeed showed a time-dependent decline
of the gene expression (Figure 4D). Thus, 8-oxoG and 5-
fC in the CRE sequence induced qualitatively similar tran-
Figure 5. Effects of 5-caC in the minimal CRE promoter. (A) CREB bind-
ing to CRE containing one 5-caC in the central CG-dinucleotide detected
by EMSA. (B) Representative fluorescence distribution plots of HeLa cells
24 h after transfection with constructs containing 5-caC in one (1×) or
three (3×) CG-dinucleotides overlaid with the reference ‘C’ construct. (C)
Time-course of the EGFP expression (relative to ‘C’) in HeLa cells trans-
fected with constructs containing 1× or 3 × 5-caC. Lines show indepen-
dent transfections. Mean values for each time point are highly significantly
different from 1 (P < 0.001, heteroscedastic Student’s t-test).
scriptional responses; however, the negative impact of 5-fC
on the gene expression was much more powerful.
Further, we have analysed the CREB binding (Figure 5A)
as well as the EGFP expression (Figure 5B and C) with 5-
caC incorporated into the pCRE-uno reporter vector. The
results showed that responses to 5-caC essentially recapit-
ulated the response to 5-fC, i.e. mild inhibition of CREB
binding and time-dependent progressive repression of tran-
scription in transfected HeLa cells. Together, the results
indicate that transcriptional responses to 5-fC and 5-caC
largely resemble the response to DNA lesions, as exempli-
fied by 8-oxoG. The observed transcriptional repression of
the reporter constructs containing 5-fC or 5-caC further
suggests that also oxidation of 5-mC/5-hmC to 5-fC/5-caC
in the process of TET-induced DNA demethylation may not
necessarily lead to transcriptional re-activation.
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TDG mediates BER-dependent transcriptional repression by
5-fC and 5-caC
Because BER intermediate has been previously implicated
in transcriptional repression or silencing induced by various
DNA lesions (27,29,33,36), we questioned whether the pro-
gressive inhibition of expression of the reporter vectors con-
taining 5-fC or 5-caC is similarly mediated by BER. Both 5-
fC and 5-caC are efficiently removed from DNA in vivo and
in vitro by TDG (16,18); therefore we performed gene ex-
pression analyses of vectors containing these modifications
in cells with knocked down TDG expression (Supplemen-
tary Figure S5). The negative effects of 5-caC in pCRE-uno
on the reporter gene expression were greatly reduced in the
cell line stably expressing the TDG-specific short hairpin
(sh) RNA but not in the isogenic cell lines with knocked
down UNG1/2 or SMUG1 DNA glycosylases and not in
the cell line stably transfected with non-specific shRNA
(Figure 6A, left panel). The results thus indicate that ex-
cision of 5-caC by TDG is a prerequisite of ulterior tran-
scriptional silencing of the CRE-controlled expression con-
structs. The magnitude of the inhibitory effects of 5-fC on
the gene expression was also significantly moderated by the
TDG knockdown, however to a lesser extent than it was
observed for 5-caC.
To verify whether the effects of TDG knockdown were
specific to 5-fC/5-caC, we further generated expression con-
structs carrying AP site (THF) in the same position in CRE
(Supplementary Figure S6). As expected, the expression
analyses showed a strong decrease of EGFP expression in-
duced by THF but not by the APE1-resistant AP site (S-
THF). Importantly, the magnitude of the effect of THF was
not at all alleviated by the TDG knockdown. We thus con-
clude that BER reactions downstream from the base exci-
sions step were not affected.
Because TDG knockdown had quantitatively only mod-
est impact on the expression of constructs containing 5-
caC and especially 5-fC, we sought to increase the dy-
namic range for measurements of the EGFP expression.
Therefore, we performed analogous experiments in the
pCMV1111 vector which contains a strong promoter with
multiple regulatory elements including four consensus CRE
sequences, one of which was chosen for targeted incorpo-
ration of synthetic C/5-fC/5-caC (Supplementary Figure
S1B). Remarkably, also in the context of the strong pro-
moter, both 5-caC and 5-fC induced dynamic decrease of
the gene expression and in both cases the effects were sig-
nificantly moderated by the TDG knockdown (Figure 6A,
right panel). Also in this promoter the effect of TDG knock-
down was somewhat smaller for 5-fC than 5-caC, but the
difference was far less pronounced than in pCRE-uno.
The results obtained in the TDG knockdown cells un-
derpinned the role of BER of 5-fC and 5-caC in the tran-
scriptional repression by these cytosine modifications (Fig-
ure 6A); however, since the recovery of gene expression
was not complete, they did not exclude a potential con-
tribution of other mechanisms. To eliminate the base ex-
cision activity completely, we have applied a chemical ap-
proach. It was previously reported that sugar 2′-fluorination
of the 5-fC and 5-caC nucleotides prevents the TDG exci-
sion activity completely while having only minimal impact
on the physical and functional properties of the DNA helix
(34). Therefore, we next generated the pCMV1111 expres-
sion constructs carrying single 5-fC/5-caC deoxyribonu-
cleotides or their 2′-fluorinated analogs in the specified po-
sition in CRE (Supplementary Figure S7). The expression
analyses in HeLa cells explicitly showed that 2′-fluorination
of deoxyribose fully reversed the gene repression by 5-fC
and 5-caC (Figure 6B and C). This effect was exactly repro-
duced in the pCRE-uno vector (Supplementary Figure S8).
The results thus show that regulatory promoter elements re-
tain their activatory functions and that 5-fC and 5-caC do
not lead to transcriptional repression when the base exci-
sion is inhibited, e.g. by the deoxyribose 2′-fluorination.
DISCUSSION
There are at least two mechanisms for regulation of gene
transcription by 5-mC in DNA. It was previously suggested
that selective methylation of CpG dinucleotides present in
upstream promoter elements can interfere with recruitment
of the specific transcription factors (6–8). On the other
hand, CpG methylation can recruit general co-repressors
via the MBD binding (1,2). Using a minimal CRE-driven
promoter with an artificially introduced hemi-methylated
CpGs in defined positions, we show here that a single methyl
group in the central CpG of the CRE sequence causes a
2- to 3-fold reduction of the specific CREB binding affin-
ity and an equivalent decrease in the CRE-dependent gene
expression in human cells (Figure 1). This proportional-
ity suggests that impaired CREB binding has direct func-
tional relationship with the gene expression. Nevertheless,
hemi-methylation of the neighboured CpGs clearly added
to the decreased gene expression in cells (Figures 2 and 3),
even though CREB binding was not further impaired by
the modifications outside of the CRE consensus sequence
(Figures 2 and 3, Supplementary Figures S3 and S4), which
indicates that impaired CREB binding is not the only mech-
anism for the declined gene expression if more than one
5-mC is present. Indeed, massive methylation of the re-
porter vector by M.SssI resulted in a complete transcrip-
tional silencing of the reporter constructs (Supplementary
Figure S2). This mechanism appears to dominate over the
CREB-induced transcriptional activation, since the enzy-
matic methylation eliminated both induced and basal ex-
pression. This notion is supported by further observation
that selective partial demethylation of the CRE region did
not rescue the expression of the M.SssI methylated re-
porter constructs (data not shown). In summary, the results
demonstrate that methylation and even hemi-methylation
of single CpG dinucleotides in critical gene regulatory ele-
ments can have substantial negative impacts on the gene ex-
pression by directly impeding the transcription factor bind-
ing. It is necessary to stress, however, that this effect can only
be functionally significant when the surrounding DNA se-
quence is unmethylated.
The outcome of CRE hydroxymethylation on the gene
expression was essentially the same as of methylation (Fig-
ures 1–3), thus suggesting that the functional modes of inhi-
bition of the activator-induced gene transcription by these
two modifications are similar or common. As for 5-mC, the
magnitude of negative effect of single 5-hmC on the gene ex-
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Figure 6. Impact of BER on the expression of reporter constructs containing single 5-fC/5-caC in the CRE sequence. (A) Effects of 5-fC and 5-caC on
EGFP expression in HeLa-derived cell lines with stable shRNA knockdown of the UNG1/2, TDG or SMUG1 DNA glycosylases as compared to the
control isogenic cell line (‘no sh’). Expression of the constructs containing 5-fC or 5-caC in the pCRE-uno (left panel) and pCMV1111 (right panel) vectors
at each time point is presented relative to the respective reference constructs containing cytosine (mean ± SD; P-values calculated by the Student’s t-test).
(B, C) EGFP expression in HeLa cells at the specified times after transfection with pCMV1111 containing single 5-fC or 5-caC as deoxyribonuceotides
(deoxy) or the respective 2′-(R)-fluorinated derivatives (2′F). Representative FACS data (B) and relative EGFP expression values (mean ±SD, n = 5,
P-values calculated by the Student’s t-test) (C).
pression is consistent with the impediment of CREB bind-
ing to CRE sequence by the modification. This result sug-
gests that the effects of both 5-mC and 5-hmC are likely me-
diated by prevention of binding of activatory proteins spe-
cific for unmodified CpG rather than by recruitment of co-
repressors via a specific interaction with 5-mC or 5-hmC.
Such a mechanism is in agreement with proteomics data
which identified little overlap between the spectra of specific
interactors of 5-mC and 5-hmC, whereas binding of a much
larger set of proteins, including several families of transcrip-
tional activators, was disrupted by either modification (22).
The degrees of inhibition of gene expression by single 5-
mC and 5-hmC stayed steady over the whole time-course of
the gene expression analyses (Figures 2 and 3), suggesting
that epigenetic state of the promoter region remained sta-
ble over at least 48 hours. In a marked contrast, the expres-
sion of constructs containing 5-fC or 5-caC showed strong
negative dynamics, indicating a progressive silencing of the
affected promoter (Figures 4 and 5). Intriguingly, the spec-
trum of putative 5-fC and 5-caC readers previously identi-
fied by the proteomics approaches includes candidates with
potential gene silencing functions such as DNMT1 and the
components of the Mi-2/NuRD nucleosome remodeling
deacetylase complex (22,39). On the other hand, the enrich-
ment of DNA repair proteins including TDG and MPG in
the sets of putative 5-fC and 5-caC readers raises the pos-
sibility that proteins bound to products or the DNA repair
reactions have been also classified as interactors in these ex-
perimental setups.
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We have previously reported that excision of various base
modifications by the specific DNA glycosylases in con-
cert with the apurinic/apyrimidinic site endonuclease com-
monly initiates transcriptional silencing (27,29,33). Now we
show that TDG clearly contributes to progressive transcrip-
tional silencing induced by 5-caC and 5-fC (Figure 6A),
which strongly suggests the key role of BER in this pro-
cess. Incomplete recovery of the gene expression levels un-
der the conditions of TDG knockdown should likely be at-
tributed to low residual TDG activity in cells, since com-
plete abolition of excision of 5-fC/5-caC by the deoxyri-
bose 2′-fluorination fully restored the expression (Figure
6B and C). Nevertheless, based on these results it still can-
not be ruled out that some other DNA glycosylase (or
endonuclease) could also contribute to processing of 5-fC
and/or 5-caC. Thus, NEIL1, NEIL2 and NEIL3 interact
with TET1 and have been implicated in transcriptional ac-
tivation of TET-oxidised M.SssI-methylated vector DNA in
the absence of TDG (40). Even though the evidence is miss-
ing that NEIL proteins autonomously excise 5-fC, another
study showed that NEIL1 and NEIL2 accelerate the TDG
turnover and thus may stimulate excision when TDG is lim-
ited (15). Since our findings implicate a BER intermediate
in transcriptional silencing induced by 5-fC and 5-caC, it is
intriguing to suggest that balance between the activity of in-
dividual enzymes within BER or coordination between the
BER steps in a given cell type or during a particular dif-
ferentiation phase may have profound consequences for the
regulation of gene expression by these DNA modifications.
In our system, both generation of AP site and subsequent
strand cleavage by APE1 are required for the gene silencing
(Figure 6, Supplementary Figure S6). Taking into account
intrinsically low processivity of TDG, it would be impor-
tant to investigate, whether the switches exist which would
halt one of these steps thereby possibly preventing the gene
silencing. Such mechanisms could be critical to safeguard
the proper gene function following the restoration of un-
methylated CpG in the genome.
In summary, our findings have implications for under-
standing of transcription regulatory functions of hemi-
methylated (or hemi-modified by 5-hmC, 5-fC or 5-caC)
CpG dinucleotides. Such CpG modifications can arise in
cells during DNA demethylation or de novo DNA methy-
lation reactions. The results indicate that 5-mC and 5-hmC
act as stable regulatory marks predominantly by decreasing
binding of transcriptional activator CREB to the modified
target motif. The results further suggest that 5-fC and 5-
caC trigger dynamic changes in the promoter activity. Strik-
ingly, in the minimal CRE-regulated promoter employed
here, both 5-fC and 5-caC functioned primarily as repres-
sory marks. The impacts of 5-fC and 5-caC on the promoter
activity are only partly attributable to the direct impairment
of CREB binding and the negative effects on the gene ex-
pression strongly advance with time in a TDG-dependent
fashion. Extrapolating present results to the situation dur-
ing active DNA demethylation in cells, we suggest that gen-
eration of 5-fC and 5-caC in the regulatory promoter ele-
ments and further processing of these modifications by BER
by default leads to perpetuation and enhancement of the
repressed transcriptional state and that transcriptional re-
activation would require additional signals.
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8 A Network of Metabolic Enzymes Controls Tet3
Activity in the Brain
8.1 Introduction
Tet enzymes are α-ketoglutarate-dependent dioxygenases, which oxidize the DNA base 5-
methylcytosine (mC) to 5-hydroxymethylcytosine (hmC)[78,79], 5-formylcytosine (fC)[80]
and 5-carboxycytosine (caC).[81,82] The currently available information suggests that
these bases have epigenetic functions[194,196,228,409] and are directly involved in active
demethylation processes.[217] In this respect it was shown that fC and caC are excised by
the thymine DNA glycosylase (TDG), resulting in abasic sites that are repaired by the
insertion of unmodified dC-bases.[82,222] High levels of hmC, fC and caC are observed in
mouse embryonic stem cells (mESC)[83], but the highest hmC levels were measured in
adult brain.[104,158,196] Here, hmC was found to affect transcription.[168,183,184,188,190] The
hmC levels are in addition dynamically regulated by neural activity.[346,410–412] In mam-
mals, three Tet enzymes are known (Tet1-3) of which Tet3 and a Tet3 isoform lacking
the CXXC domain (Tet3-CXXC) are the most abundant forms in differentiated tissues,
including brain.[265,413–416] The Tet-performed oxidation of mC requires α-ketoglutarate
as a co-substrate, which is converted to succinate and CO2.[251,268] This strict dependence
on α-ketoglutarate[256] creates an unsolved supply problem. α-ketoglutarate is typically
manufactured in the mitochondria and it is unclear how it reaches the Tet enzymes in
the cell nucleus. Since α-ketoglutarate availability was shown to be rate determining in
various tissues and mESC, the controlling of its supply could be a means for regulating
the Tet activity.[256,417]
8.2 Generation of Tet3 interactome fishing baits
In order to obtain information about Tet3 interaction partners in brain tissue that may
help supplying Tet3 with α-ketoglutarate, we performed an affinity proteomics study
and concentrated in our analysis on enzymes that are involved in the biosynthesis of
α-ketoglutarate. For the experiment, we developed the workflow depicted in Fig. 12A.
First, we overexpressed full length Tet3 and Tet3-CXXC as N-terminal GFP fusions (GFP-
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Tet3, GFP-Tet3 CXXC) in HEK293T cells. We next immobilized the GFP-Tet3 fusion
proteins on anti-GFP nanobody-coated magnetic beads. Contaminating HEK293T pro-
teins were removed by extensive washing with up to 1 M NaCl. This did not lead to Tet3
loss from the beads (Extended Data Fig. 1A). In order to verify that Tet3 was still bound
to the beads, we treated the beads subsequently with 200 mM glycine (pH = 2.5), which
led to the elution of a protein with a molecular weight of about 220 kDa, as expected
for the GFP-Tet3 fusion protein (Extended Data Fig. 1A). Next, we investigated if the
immobilized Tet3 proteins are functionally active. To this end, the stringently washed
Tet3-loaded beads were added to a solution of an oligonucleotide with a single mC in a
central position plus Fe2+ and α-ketoglutarate. Sucessful conversion of the mC base to
the oxidized forms hmC, fC and caC was determined by analysis on a triple quadrupole
mass spectrometer as described earlier.[83] For comparison, we performed the same ex-
periment with the immobilized catalytic domain of Tet1 (Tet1cd) as a positive control.
A sample without a Tet enzyme served as a negative control. As depicted in Extended
Data Fig. 1B, oxidation of mC within DNA is clearly observed for Tet1cd and also for
the beads covered with full length Tet3, but not for the negative control. As expected,
Tet1cd is more active. Importantly, the Tet3-covered beads oxidize the base mC to all
expected products hmC, fC and caC in the presence of α-ketoglutarate and Fe2+.
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Figure 12: Tet3 interacts with Glud1, Got 1/2 and enzymes from the citric acid cycle in
mouse brain. (A) Schematic representation of the modified co-immunoprecipitation (co-
IP) workflow. B: anti-GFP magnetic beads. (B) Volcano plots of the interaction partners
found in the modified Tet3-co-IPs in adult mouse brain for Tet3 and Tet3-CXXC (FDR
= 0.05; s0 = 2). (C) The citric acid cycle with the Tet3 interacting proteins marked in
red. Aco2 = aconitase 2; Cs = citrate synthase; Glud1 = glutamate dehydrogenase1;
Got1/2 = glutamic-oxaloacetic transaminase; Idh = isocitrate dehydrogenase; Mdh =
malate dehydrogenase. (D) Western blots of the modified Tet3-co-IP using antibodies
against Aco2 and Glud.
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8.3 Tet3 interacts with metabolic enzymes
The beads, coated with active Tet3 or Tet3-CXXC, were next used as baits to fish for
interacting proteins in nuclear lysates of whole adult mouse brains. The samples were
analysed using quantitative label-free mass spectrometry.[418] Four biological replicates
were measured in order to obtain statistically meaningful quantification data. In the
experiments, beads coated with unfused GFP were used as the negative control. The
statistical analysis of the data shows, that this method provides highly reproducible data
sets. The obtained data show a high correlation within the replicates as determined
by the Pearson correlation (Extended Data Fig. 2A). The intensity profiles show the
expected data distribution across the samples (Extended Data Fig. 2B). We detected
a number of interesting interactors such as Pura, Uba1, Uchl1 and Mark1-3 (Extended
Data Fig. 3). Particularly informative, however, is the detection of Ogt, which is a
known Tet interactor (Fig. 12B).[419] This observation provides a first validation of
the obtained data. In agreement with an earlier study[194], we also observed structural
and extracellular matrix proteins due to their sheer abundance in the histologically
heterogeneous brain samples. By focussing the analysis on interaction partners able to
supply α-ketoglutarate, we detected proteins of the citric acid cycle in the data set (TCA
cycle, Fig. 12B). We found specifically malate dehydrogenase (Mdh1/2), citrate synthase
(Cs) and aconitase2 (Aco2), all involved in the biosynthesis of α-ketoglutarate from
malate (Fig. 12C). The only other enzyme, which is needed to convert isocitrate into
α-ketoglutarate, isocitrate dehydrogenase (Idh), is suprisingly missing in the dataset.
The proteomics data show furthermore a potential association of Tet3 with the two
glutamate-oxaloacetate transaminases (Got1 and Got2), which convert aspartic acid into
oxaloacetate. If these found enzymes are indeed catalytically active in close association
with Tet3, this would consequently lead to an increased local concentration of isocitrate
in close vicinity of Tet3 (Fig. 12C). In the data set, we detected to our suprise in addition
the enzyme glutamate dehydrogenase (Glud1) as a potential Tet3 interactor (Fig. 12B).
Because Glud1 deaminates glutamate to α-ketoglutarate, this interaction would establish
a direct TCA-independent α-ketoglutarate supply (Fig. 12C). Glutamate is an abundant
amino acid but it is also a mediator of excitatory signals in the mammalian central
nervous system.[420] The interaction of Tet3 with Glud1 could therefore be a potential
link between neural activity and mC to hmC oxidation (Fig. 12C).[410,412]
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8.4 Verification of the interactions and localization of the
interactors
In order to gain support for the observed interactions, we used antibodies against Aco2
and Glud1 to verify their presence on the Tet3 covered beads. Fig. 12D (Extended
Data Fig. 4A) shows that both proteins are indeed clearly detectable. We next per-
formed co-IP of endogenous Tet3 using nuclear lysate from adult mouse brain. First, we
confirmed the specificity of the anti-Tet3 antibody (Fig. 13A and Extended Data Fig.
4B).28 We then confirmed the interaction of endogenous Tet3 with Glud1 and Aco2 by
western blotting analysis (Fig. 13B, Extended Data Fig. 4B). Additional investigation
of the proteins that co-precipitated with endogenous Tet3 using mass spectrometry and
LFQ confirmed also the presence of the previously identified α-ketoglutarate biosynthesis
enzymes Glud1, Aco2, Cs, Got2, Mdh2, which were significantly enriched in the endoge-
nous Tet3-co-IP compared to the negative control (Fig. 13C). The proteins Got1 and
Mdh1 were also found in the data-set, but they were not significantly enriched (p-value
0.0978 for Got1 and 0.1418 for Mdh1). We next investigated the interaction of Glud1,
Aco2 and Got2 with Tet3 directly in the nuclei of brain cells. To this end we performed
immunohistochemistry (IHC) experiments and proximity ligation assays (PLA).[421] We
used for the studies mouse hippocampus because of the high hmC content. We first
tested the Tet3 antibody regarding unspecific interactions in Tet-deficient mESCs and
found no unspecific signals at the applied concentrations (Extended Data Fig. 5A). In
the hippocampal slices, we detected for Tet3 and also for Glud1 clear localization in the
cell nucleus (Fig. 13D, Extended Data Fig. 5B). This is suprising for Glud1 given that
it is a mitochondrial protein. Some nuclear localization can also be detected for Aco2
(Fig. 13D, Extended Data Fig. 5B). Most important, however, are the PLA data, which
support for all three proteins Glud1, Aco2 and Got2 a direct interaction with Tet3.
We detected numerous PLA signals in the case of Tet3+Glud1 (Fig. 13E). Spots were
also detected for Tet3+Aco2 (Fig. 13E) and Tet3+Got2 (Extended Data Fig. 5D). No
spots were obtained in the corresponding negative control experiment (Extended Data
Fig. 5D). A positive control experiment with the known interactor Ogt provided spot
numbers comparable to Glud1 (Fig. 13E).
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Figure 13: Validation of Tet3 interactors. (A) Western blot shows the specificity
of the anti-Tet3 antibody. (B) Western blot results of the endogenous Tet3-co-
immunoprecipitation (co-IP) confirm Glud and Aco2 as Tet3 interactors in mouse brain.
(C) Mass spectrometry analysis of endogenous Tet3-co-IP and ctrl.-co-IP (with anti-goat
antibody). (D) Immunohistochemistry of Tet3, Glud1 and Aco2 in the mouse hippocam-
pus shows that Tet3 and Glud1 are present in the cell nucleus. Aco2 is mostly located
in the mitochondria. (E) In situ proximity ligation assay (PLA) shows the direct inter-
action (red signals; encircled for better visibility) between Glud1/Tet3 and Aco2/Tet3
in mouse hippocampal nuclei. Tet3/Ogt-PLA served as positive control.
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Taken together, co-IP and PLA show that in hippocampus, Tet3 associates with the
enzymes Aco, Cs, Mdh2 and Got2. Particular strong signals were detected with Glud1
confirming the possibility that in brain cells mC to hmC oxidation is performed with α-
ketoglutarate that is manufactured from the neurotransmitter amino acid glutamate.
8.5 Functional study of the Glud1-Tet3 interaction
We next studied the functional connection between Glud1 and Tet3. For the experi-
ment, we co-expressed GFP-Tet3FL together with FLAG-tagged Glud1 (FLAG-Glud1)
in HEK293T cells (Extended Data Fig. 6A). PLA shows that GFP-Tet3FL interacts
with FLAG-GLud1, whereas we could not observe an interaction in the control experi-
ment with GFP and FLAG-Glud1 (Fig. 14A). To study whether Glud1 influences Tet3
activity, we compared the levels of mC, hmC, fC and caC of HEK293T cell DNA of
cells that were either coexpressing GFP-Tet3FL and FLAG-Glud1 or only GFP-Tet3FL
after 24h and after 48h (Fig. 14B). Since the GFP-Tet3FL/FLAG-Glud1 coexpressing
cells did not express as much of the GFP-Tet3FL as the cells that were only expressing
GFP-Tet3FL, we normalized the hmC, fC and caC levels to the GFP-signal (relative
fluorescent unit (RFU)) that we determined using fluorescence-based flow cytometry.
The overall mC levels were lower for only GFP-Tet3FL-expressing HEKcells, but the
difference was not significant (24 h: unpaired t-test, n=3 GFP-Tet3FL, n=3 GFP-
Tet3FL+FLAG-Glud1, p-value 0.2507; 48h: unpaired t-test, n=4 GFP-Tet3FL, n=4
GFP-Tet3FL+FLAG-Glud1, p-value 0.2158). However, for hmC and fC, we measured
significant differences (24h: unpaired t-test with Welch’s correction, n=3 GFP-Tet3FL,
n=3 GFP-Tet3FL+FLAG-Glud1, p-values 0.0148 (hmC) and 0.0053 (fC); 48h: unpaired
t-test with Welch’s correction, n=4 GFP-Tet3FL, n=4 GFP-Tet3FL+FLAG-Glud1, p-
value 0.0073 (hmC) and 0.0494 (fC)). The data show that FLAG-Glud1 functionally
interacts with GFP-Tet3FL and that it strongly stimulates GFP-Tet3 activity. A simi-
lar stimulation was also observed in experiments with Tet1FL and Tet2FL showing that
the glutamate supply path provides α-ketoglutatrate not only for Tet3 (Extended Data
Fig. 6B/C).
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Figure 14: Functional interaction of Glud1 and Tet3. . (A) Proximity ligation assay in
HEK293 T cells either coexpressing GFP-Tet3FL and FLAG-Glud1 or GFP and FLAG-
Glud1. (B) Cytosine modification levels in HEK293T cells, co-transfected with either
GFP-Tet3FL and FLAG-Glud1 or GFP-Tet3FL and an empty vector (pESG iba45) after
24 h and 48 h; +: transfected, -: not transfected; ns = not significant; p-values *: p <
0.05, **: p< 0.01, ***: p < 0.001; plot presents mean with standard deviation (SD).
Each data point represents one biological replicate for each modification.
In order to obtain physiologically more relevant evidence of the Glud1-based Tet3 stimu-
lation, we next studied the hmC levels in mouse hippocampal slices (n=5) with and with-
out KCl-induced neuronal depolarization (25 mM versus 3 mM KCl, for 6 h, Fig.15A)
in presence and absence of the Glud1 inhibitor R16237. To test the inhibitor, we first
co-transfected HEK293T cells with GFP-Tet3 and FLAG-Glud1 and could see that
R162-treated cells showed a 60% lower hmC and a 40% lower fC level, compared to the
untreated cells (n=2, Fig. 15B, Extended Data Fig. 6B). The data show that the in-
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hibitor can effectively reduce Glud1 activity and that the stimulatory effect of Glud1 on
Tet3 activity depends on the catalytic activity of Glud1 and not only on its mere pres-
ence. Next, we tested the effect of R162 in the hippocampal slice experiment. While the
mC levels remain unchanged (Fig. 15C), we observed that the hmC levels increase sig-
nificantly (Fig. 15C) when the neurons are depolarized with 25 mM KCl (RM one-way
ANOVA Tukey’s multiple comparisons test, p-value 0.0007). This hmC-raising effect
could be again blocked with R162 (RM one-way ANOVA Tukey’s multiple comparisons
test, p-value 0.0094) showing that the catalytic activity of Glud1 is needed to raise the
hmC levels in response to neuronal depolarization. This is in perfect agreement with
the idea that the α-ketoglutarate is rate limiting.[256,417]
Figure 15: Interaction of Glud1 and Tet3 in the hippocampus. (B) HEK293T (n=2)
cells were co-transfected with GFP-Tet3FL and FLAG-Glud1 and fed with 20 µM Glud1
inhibitor R162. Bar graph presents mean and SD. (C) – (D) Tukey boxplot; hippocampal
neurons (n=5) were depolarized in 25 mM KCl buffer with and without 20 µM R162.
Neurons in physiological buffer served as control. (C) Levels of mC and hmC and (D)
relative expression levels of Tet3 and Glud1 (RT-qPCR data). •no addition, Xaddition
; ns = not significant; p-values *: p < 0.05, **: p< 0.01, ***: p < 0.001.
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8.6 Effect of TCA cycle intermediates on Tet3 activity
The observed association of Tet3 with Mdh, Got1/2, CS and Aco in absence of Idh
suggests the accumulation of isocitrate and to some extent oxaloacetate in close prox-
imity to Tet3. In order to investigate how these metabolites may affect Tet3 activity,
we incubated mC-containing DNA with GFP-Tet3cd loaded agarose beads in a buffer
system containing ascorbic acid and DTT, for keeping the iron in the active Fe2+-state
(Fig. 16A). While the DNA oligonucleotide (Fig. 16A 1-1) is stable in water under
these conditions (Fig. 16B), we noted to our surprise upon addition of Tet3cd (no
α-ketoglutarate) severe degradation of the oligonucleotide (MALDI-TOF analysis, Fig.
15C). This degradation was observed with other DNA sequences and other Tet enzymes
as well (Extended Data Fig. 8). Deeper analysis of the degradation reaction with an
oligonucleotide, in which we replaced the T bases with U in order to enable detection of
also mC-deamination reactions, showed predominant hydrolysis of the phosphodiesters
and cleavage of glycosidic bonds. These degradation pathways are explainable with
the known chemistry of high-spin Fe2+-centers, that are the reactive centers in active
Tet-enzymes. These centers are Lewis acidic, which causes phosphordiester hydroly-
sis[422], and redox active, which can explain the observed glycosidic bond cleavage (Fig.
16C).[423,424] Once we added α-ketoglutarate to the model study, DNA degradation was
fully stopped. Instead, the expected oxidation of mC to hmC and fC is detected (Fig.
16D). The observation of DNA degradation in the absence of α-ketoglutarate confirms
that the reactive Fe2+ center needs full coordination to prevent potential DNA dam-
age.[424–426] It is not clear which molecules coordinate in vivo to the Fe2+-center in the
absence of α-ketoglutarate, when the enzyme is in an inactive mode, but it is tempt-
ing to speculate that the TCA metabolites are to some extent involved. Indeed, when
we replaced in these studies the α-ketoglutarate by either oxaloacetate (Fig. 16E) or
isocitrate (Fig. 16F), we detected in both cases neither oxidation of mC nor DNA degra-
dation. Deeper analysis of the degradation reaction with an oligonucleotide, in which
we replaced the T bases with U in order to enable detection of also mC-deamination
reactions, showed predominant hydrolysis of the phosphodiesters.
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Figure 16: Tet activity influenced by metabolites (I). (A) DNA-oligonucleotide, includ-
ing degradation pathways (AP = abasic site), and buffer ingredients for in vitro activity
tests. (B) – (F) Metabolites prevent Tet3-induced decomposition of mC-containing
DNA. MALDI-TOF analysis shows peaks of mC- (3294.5 m/z) and hmC/fC-containing
DNA (3310.8 m/z). (G) – (I) In vitro assay with mC and only C-containing DNA
oligo. DNA oligo 5’-TTT TGmC GGT TG-3’ MALDI-TOF m/z mC: 3381.6; hmC/fC:
3397.6; 2-1 3381.6 Da; 2-2 3051 Da; 2-3 2746.3. DNA oligo 5’-TTT TGC GGT TG-3’
MALDI-TOF m/z 3367.5.
Ligand docking simulation using Maestro 10.7 (Extended Data Fig. 9A) with the crystal
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structure of the catalytic domain of Tet2 (PDB ID: 4NM6) confirm that both metabolites
are able to bind in the active site (Extended Data Fig. 9B). If binding in the active site
occurs, this has to induce a competitive inhibitory effect and indeed, when we added
increasing amounts of both metabolites to the oxidation assay containing the Tet3-beads,
the mC-containing oligonucleotide, and 1 mM α-ketoglutarate, we detected for both
metabolites at millimolar concentrations an inhibitory effect (Fig. 16A and Extended
Data Fig. 10) quite similar to what has been observed for 2-hydroxyglutarate[281] and
recently also for succinate and fumarate.[285] We next investigated, if isocitrate influences
the mC to hmC oxidation in cellulo (Fig. 15H, Extended Data Fig. 11). To this end,
HEK293T cells were transfected with Tet3FL and 10 mM of isocitrate was added to the
medium 4 h after transfection. Two days after transfection, we analysed the levels of
mC, hmC, fC and caC and detected a significant reduction of the hmC and caC values
(unpaired t-test, n=3, p-value = 0.0480 and 0.0493, resp.). The mC levels in contrast
did not change.
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Figure 17: Tet activity influenced by metabolites. ). (A) Oxaloacetate and isocitrate
decrease Tet3 activity in vitro. (B) Isocitrate lowers Tet3 activity in HEK293T cells,
which were transfected with GFP-Tet3 and fed with 10 mM or 20 mM isocitrate (+
X). Cells that were transfected, but not fed with isocitrate (+ •) served as controls.
ns = not significant; Unpaired t-test (n=3) *: p < 0.05, **: p< 0.01, ***: p < 0.001;
plot presents mean with SD. Each data point represents one biological replicate for each
modification.
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8.7 Conclusion
Tet enzymes oxidize mC to hmC and fC in the cell nucleus and for this oxidation they
need oxygen and α-ketoglutarate as essential co-substrates.[78–81] α-ketoglutarate is an
intermediate of the TCA cycle and hence manufactured predominantly in the mito-
chondrium. This generates a supply problem. Several recent studies show that the α-
ketoglutarate supply is rate limiting for Tet oxidation.[256,417] In this study, data from pro-
teomics experiments, endogenous co-IPs and PLAs show that in neurons Tet3 is directly
associated in the cell nucleus with some of the key TCA proteins involved in the biosyn-
thesis of α-ketoglutarate. In addition, we find Tet3 associated with Got1/2 and Glud1.
Glud1 uses NAD+ to oxidize and hydrolyse glutamate directly to α-ketoglutarate. Glu-
tamate is a major neurotransmitter and glutamatergic neurons are known to be the
dominant neurons that show synaptic plasicity, which in turn is a known trigger of
changing hmC levels.[412] Although glutamate is an abundant amino acid, it is tempting
to speculate that the direct Glud1-Tet3 interaction establishes a functional link between
brain function and epigenetics. We show that Glud1 and Tet3 are directly associated
with each other and that this connection stimulates Tet3, leading to a substantial in-
crease of the hmC-levels. Studies with the Glud1 inhibitor R162 show that this is caused
by the direct biosynthesis of α-ketoglutarate close to the active site of Tet3. This will
lead to a strongly increased effective molarity of the co-substrate. When α-ketoglutarate
is rate limiting[256,417], we have to ask the question what is bound to the reactive Fe2+-
center in its absence. We show that in the absence of a potential ligand, the Fe2+-center
has the tendency to damage DNA.[427] This degrading effect is totally stopped in the
presence of oxaloacetate and isocitrate, which are the biosynthesis intermediates that
are formed by Got2 and the other TCA proteins found associated with Tet3. Although
we are unable to study in vivo, which ligand is bound in the absence of α-ketoglutarate
to the Fe2+-center, it is conceivable that these TCA intermediates with their chemical
structures so close to α-ketoglutarate provide the needed protective function.
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8.8 Methods
8.8.1 Cell culture and transfection
The HEK293T cells (ATCC) were cultivated at 37 °C in water saturated, CO2-enriched
(5%) atmosphere. DMEM (10% FBS) or rpmI (10% FBS) was used as growing medium.
When reaching a confluence of 70% to 80% the cells were passaged. The transfection
was performed in p150-petri dishes. Five million cells were used in 20 mL of medium.
After seeding, the cells were incubated at previously described cultivation conditions for
24 h to reach a confluence of 40% to 80%. 10 µg of DNA and 30 µL of the transfection
reagent jetPRIME® purchased from Polyplus Transfection were used as described by
the manufacturer. All expression plasmids for GFP-Tet and CXXC-GFP constructs
were described previously.[265] To increase the transcription rate in transfected cells, 4 h
after transfection the medium was removed and sodium butyrate (final conc. 4 mM)
treated medium was added. After 48 h, the cells were harvested and immediately used
for nuclear extract preparation.
8.8.2 Nuclear extract preparation
Nuclear lysate of HEK293T cells was prepared as described previously.[194] The complete
adult mouse brains (Mus musculus, BL6J wt, female, 110 days old) were lysed according
to a protocol that was published before.[428] The resulting nuclear extract was then
treated with 25 U benzonase (Merck Millipore) for 30 min on ice and subsequently
centrifuged for 15 min at 15000 rpm. The supernatant containing the nuclear lysate
was transferred to a fresh tube. A Bradford protein assay (Bio-Rad) was performed
according to the manufacturer´s instructions to measure the protein concentration.
8.8.3 GFP-Tet saturated co-immunoprecipitation
20 µl of anti-GFP beads (Chromotek) were washed three times with wash buffer (10 mM
Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA) and then incubated for 15 min on ice with
nuclear extract of GFP-Tet overexpressing HEK293T cells. To ensure the saturation of
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the beads with the GFP fusion construct, different amounts of lysate were tested and
monitored using a Tecan Reader. The GFP-Tet loaded beads were then washed twice
with 150 mM NaCl solution containing 10 mM HEPES, pH 7.5. Another two wash
steps with 1 M NaCl solution containing 10 mM HEPES, pH 7.5 and two wash steps
with Lysis Buffer C (20 mM Hepes pH = 7.5, 420 mM NaCl, 2 mM MgCl2, 0.2 mM
EDTA, 20% (v/v) glycerol) followed. The saturated GFP-Tet beads were subsequently
incubated with 200 µg nuclear brain extract for 15 min on ice. Following, they were
washed twice with wash buffer. To elute the bound proteins, 50 µl of 200 mM glycine
pH 2.5 were added and the solution was vortexed for 30 seconds. In order to gain more
yield the elution step was repeated.
8.8.4 Co-IP of endogenous Tet3 protein
Co-IP of endogenous Tet3 was performed, using nuclear brain extract. When the interac-
tors were subsequently analysed by mass spectrometry, 250 µg of nuclear brain extract,
1 µg of antibody (anti-Tet3 antibody (Abiocode Tet3 (N1) antibody R1092-1, rabbit
polyclonal) or anti-goat antibody as negative control (SigmaAldrich G4018, rabbit poly-
clonal) and 10 µL of Dynabeads Protein G (ThermoFisher) were used per replicate; for
the analysis by Western Blot four times the amount of nuclear brain extract, antibodies
and Dynabeads Protein G were used. The nuclear brain extract was incubated with the
antibody for 1 h at 4 °C on a tube rotator and the Dynabeads Protein G were washed
three times with wash buffer (10 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM EDTA). Af-
terwards, the Dynabeads were added to the lysate and incubated for 30 min at 4 °C.
After incubation, the beads were washed three times with wash buffer. Last, proteins
were eluted with 30 µL of 1% (v/v) formic acid for 15 min at room temperature (mass
spectrometry analysis) or with 50 µL of SDS loading buffer (50 mM Tris pH 6.8, 100 mM
DTT, 2% (w/v) SDS, 10% (v/v) glycerol, 0.1% (w/v) bromphenolblue) for 10 min at
70 °C.
8.8.5 LC-MS/MS analysis
Samples for the mass spectrometer were reduced by the addition of 100 mM TCEP and
subsequent incubation for 1 h at 60 °C on a shaker at 650 rpm. They were then alkylated
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by adding 200 mM iodoacetamide and incubating for 30 min at room temperature in
the dark. Following, the samples were digested with 0.5 µg trypsin (Promega) at 37 °C
for 16 h. Afterwards, they were incubated for 5 min at 100 °C and subsequently 1 mM
phenylmethylsulphonylfluoride was added. StageTips were utilized to purify the samples
for mass spectrometry.[429] The samples were analyzed with an UltiMate 3000 nano liquid
chromatography system (Dionex, Fisher Scientific) attached to an LTQ-Orbitrap XL
(Fisher Scientific). They were desalted and concentrated on a µ-precolumn cartridge
(PepMap100, C18, 5 µM, 100 Å, size 300 µm i.d. x 5 mM) and further processed on
a custom made analytical column (ReproSil-Pur, C18, 3 µM, 120 Å, packed into a
75 µm i.d. x 150 mM and 8 µm picotip emitter). The samples were processed via a
127 min multi-step analytical separation at a flow rate of 300 nl/min. The gradient
with percentages of solvent B was programmed as follows: 1% for 1 minute; 1% - 4%
over 1 minute; 4% - 24% over 100 minutes; 24% - 60% over 8 minutes; 60% - 85% over
2 minutes; 85Mass spectrometric analysis was done with a full mass scan in the mass
range between m/z 300 and 1700 at a resolution of 60000. Following this survey scan five
scans were performed using the ion trap mass analyzer at a normal resolution setting
and wideband CID fragmentation with a normalized collision energy of 35. Signals with
an unrecognized charge state or a charge state of 1 weren’t picked for fragmentation.
To avoid supersampling of the peptides, an exclusion list was implemented with the
following settings: after 2 measurements in 30 seconds, the peptide was excluded for 90
seconds.
8.8.6 LFQ data processing
The MaxQuant software (version 1.5.0.25) was used for LFQ. Quantification was per-
formed with four biological replicates for Tet3-saturated co-IP. GFP alone served here
as control. Three biological replicates were used for the endogenous co-IP and the co-
IP with anti-goat antibody served as control. The Andromeda search engine was used
in combination with uniprot databases (Mus musculus). A maximum of two missed
cleavage sites was allowed. The main search peptide tolerance was set to 4.5 ppm. Car-
bamidomethyl (C) was set as static modification. Variable modifications were Acetyl
(Protein N-term) and Oxidation (M). The LFQ algorithm was applied with default
settings. The option “match between runs” was also used. The mass spectrometry pro-
teomics data have been deposited to the ProteomeXchange Consortium via the PRIDE48
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partner repository with the dataset identifier PXD004518. LFQ data was analyzed with
the Perseus software (version 1.5.0.9). The LFQ intensities were log transformed and
only proteins identified in at least three samples were retained. As one of the GFP
control quadruplicates contained only 64 proteins instead of >400, this replicate was re-
moved from the data set. Gene ontology analyses were performed with the Database for
Annotation, Visualization and Integrated Discovery (DAVID Bioinformatics Resources
6.7).
8.8.7 Western Blotting
When the GFP-Tet saturated co-IP was analyzed by western blotting (tank (wet) elec-
trotransfer) instead of mass spectrometry, the proteins were eluted at 70 °C for 15 min
with SDS loading buffer (100 mM Tris pH = 6.8, 100 mM DTT, 2% (w/v) SDS, 10%
(v/v) glycerol, 0.05% (w/v) bromphenol blue). The samples were loaded on a 4-15%
precast polyacrylamide gel (Bio-Rad) and MagicMark XP Standard (ThermoFisher)
was used as a protein standard. The gel was run at constant 150 V for 70 min. For
blotting, we used a PVDF blotting membrane (GE Healthcare) and pre-cooled Tow-
bin blotting buffer (25 mM Tris, 192 mM glycine, 20% (v/v) methanol, 0.038% (w/v)
SDS). The membrane was activated for 5 min in abs. methanol; the filter paper was
equilibrated for 15 min in Towbin buffer and the precast gel was equilibrated for 5 min
after running in Towbin buffer. Western blotting was performed at 4 °C for 11 h at
constant 35 V. After blotting, the PVDF membrane was blocked for 1 h at room tem-
perature using 5% (w/v) milk powder in TBS-T (20 mM Tris/Cl pH = 7.5, 150 mM
NaCl, 0.1% (v/v) Tween-20). The primary antibodies were diluted 1:1000 in 15 mL
of 5% (w/v) milk powder in TBS-T. After blocking, the membrane was cut in three
parts (part1: proteins < 40 kDa; part2: proteins > 40 kDa, but < 120 kDa; part3:
proteins > 120 kDa). The blocking suspension was discarded and the diluted primary
antibodies were added (anti-GFP antibody (CellSignaling 2555S, from mouse) to part1
and part3; anti-Aco2 antibody (Abcam ab110321, from mouse) or anti-Glud antibody
(Thermo Scientific PA5-19267, from goat) to part2) for 11 h at 4 °C. After incubation,
the primary antibodies were discarded and the membrane was washed three times with
TBS-T. HRP-conjugated secondary antibodies (all from Sigma-Aldrich) were diluted
1:10000 in 5% (w/v) milk powder in TBS-T and added for 1 h at room temperature.
Afterwards, the membrane was washed two times with TBS T and one time with TBS
77
Results and Publications
before SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) was used
for imaging. The western blots were performed twice (two biological replicates), yield-
ing the same result. When the endogenous co-IP was analyzed by western blotting,
the same conditions were used, but the membrane was not cut after blotting. To test
the specificity of the anti-Tet3 antibody used in the endogenous IP (Abiocode R1092),
the PVDF membrane was incubated with same anti-Tet3 antibody (Abiocode R1092).
To avoid detection of the antibody fragments, TidyBlot from Biorad (HRP conjugated
Western blot detection reagent) was used. To analyse the Tet3-Glud interaction, the
PVDF membrane was incubated with anti-Glud antibody; to analyse the Tet3-Aco2
interaction, the PVDF membrane was incubated with anti-Aco2 antibody. The western
blots were performed twice (two biological replicates), yielding the same result.
8.8.8 Immunohistochemistry
Immunohistochemistry (IHC) experiments were performed as previously described13
with minor modifications. In brief, 12 µm thick coronar cryo-sections of snap-frozen
adult mouse brain were fixed on slides using 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffered solution, pH 7.4 (0.1 M PB). After three times washing with 40 µL
0.1 M PB, the slices were incubated over night with primary antibody solution at 4 °C
in a humidity chamber. Anti-Tet3 antibody (Biomol AC-R1092-1, from rabbit or Sig-
maAldrich HPA050845, from rabbit), anti-Glutamate-Dehydrogenase antibody (Thermo
Scientific PA5-19267, from goat) and anti-Aconitase2 antibody (Abcam ab110321, from
mouse) were used as primary antibodies. The primary antibodies were diluted (anti-
Tet3 1:200, anti-Glud 1:100, anti-Aco2 1:200) in 0.1 M PB, containing 5% (v/v) block-
ing reagent (Chemiblocker, CB, Millipore) and 0.3% (v/v) Triton-X solution. For the
negative controls, no primary antibodies were added. For secondary detection we used
Alexa488-anti-rabbit (1:800, Cell Signaling Technologies), Cy2-anti-goat (1:200, Jackson
ImmunoResearch) and Cy3-anti-mouse (1:400, Jackson ImmunoResearch) diluted in 0.1
M PB, containing 3% (v/v) CB. Cell nuclei were stained with Hoechst 33342 (5 µg/mL),
which was applied for 5 min in the dark at room temperature. After mounting (Moun-
tant Permafluor, ThermoScientific), the slices were analyzed using a Leica SP8 confocal
laser scanning microscope (Leica, Wetzlar). The IHC experiments were performed in
two biological replicates, yielding the same result.
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8.8.9 Proximity Ligation Assay
The proximity ligation assay (PLA) was carried out as described[416] using Duolink InSitu
Orange Starter Kit (Sigma) with slight modifications. The slices were rehydrated and
fixed as described above. Before the anti-Glud and anti-Tet3 primary antibodies or
the anti-Aco2 and anti-Tet3 antibodies or the anti-Got2 (Thermo Scientific MA5-15595,
from mouse) and the anti-Tet3 primary antibodies were added, the slices were blocked
with 10% CB. Anti-Tet3, anti-Glud and anti-Aco2 antibodies were diluted as decribed in
the IHC; the anti-Got2 antibody was diluted 1:200 in 0.1 M PB containing 5% CB and
0.3% Triton-x 100. The primary antibodies were added over night at 4 °C in a humidity
chamber; for the negative control no primary antibody was added. The next day, the
slices were washed two times with Washbuffer A (Sigma). For the PLA Probe Solution,
10 µL of PLA Probe (+) Anti-Rabbit (Sigma), 10 µL of PLA Probe ( ) Anti-Mouse
(Sigma) (for anti-Aco2 and anti-Got2) or 10 µL of PLA Probe (-) Anti-Goat (Sigma)
(for anti-Glud) and 30 µL of Antibody Diluent were mixed and added. The slices were
incubated in a pre-warmed humidity chamber for 1 h at 37 °C. In the next step, the
slices were washed two times with Washbuffer A and the Ligation solution, which had
been prepared previously by mixing 1.0 µL of 1 U/µL Ligase, 10 µL of Ligation Stock
(all from Sigma) and 29 µL of bidest. H2O, were added. After 30 min of incubation
in a pre-warmed humidity chamber at 37 °C, the Ligation solution was tapped off and
the slices were washed two times with 100 µL of Washbuffer A. For the amplification
reaction, 0.5 µL of Polymerase 10 U/µL, 10 µL of Amplification Stock (all from Sigma)
and 39.5 µL of bidest. H2O were mixed and added. The slices were incubated for
100 min at 37 °C in a pre-warmed humidity chamber. The slices were washed two times
with Washbuffer B (Sigma), one time with 0.01% Washbuffer B and one time with 0.1
M PB. Cell nuclei were stained with Hoechst 33342 solution. After mounting (Mountant
Permafluor, ThermoScientific), the slices were analyzed using a Leica SP8 confocal laser
scanning microscope (Leica, Wetzlar). The PLA was performed once for Glud as well as
Aco2 and twice for Got, yielding the same results. The negative controls did not show
any signal.
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8.8.10 Isocitrate in vivo experiment
The experiment was done in three biological replicates and technical triplicates each.
3×105 HEK293T cells were seeded per 6-well. 24 h after seeding, the cells were trans-
fected with 600 ng of vector DNA coding for GFP-Tet3 (full-length construct). 4 h
after transfection, the medium was changed and 10 mM of isocitrate (DL-isocitric acid
trisodium salt, Sigma-Aldrich) were added from a 1 M stock solution to the medium. 24 h
after transfection, the medium was changed again and 10 mM of isocitrate were added.
48 h after transfection the genomic DNA was isolated and the subsequent analysis of the
mC-, hmC-, fC- and caC-levels were performed as described earlier. 3 5 µg of genomic
DNA were analysed per technical replicate. Levels of 8-oxoG were analysed to show that
random oxidation processes do not impair the result. Statistical analysis was done us-
ing GraphPad Prism 7.0. The samples were tested for normal distribution (D’Agostino
Pearson test) and a unpaired t-test was performed (n=3 for each condition; only bio-
logical replicates (means of the technical replicates) were taken into account). Variance
was determined by standard deviation, showing similarity between the groups.
8.8.11 In vitro activity test
For the activity tests, approximately 10 million HEK293T cells were used. The cells
were transfected with Tet3 catalytic domain (Tet3cd), according to the protocol above.
The cells were harvested, centrifuged and lysed with 5 mL of RIPA buffer (Chromotek),
supplemented with 250 U benzonase (Merck Millipore) and protease inhibitor (Roche).
After 30 min on ice the suspension was centrifuged at 10000 x g and 4 °C for 15 min.
The supernatant consisted of nuclear and cytoplasmic proteins. Per activity test, 100 µL
of anti-GFP beads (Chromotek) were washed three times with wash buffer (10 mM
Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA) and then incubated for 1 h at 4 °C
with the supernatant. The GFP-Tet3cd loaded beads were washed with GFP wash
buffer (Chromotek). For the second wash step GFP wash was supplemented with 2 mM
ZnSO4 and 10 µL Nuclease S1. The beads were incubated with this buffer for 30 min
on ice. Another two wash steps with 1 M NaCl solution containing 10 mM HEPES,
pH 7.5 and two wash steps with GFP wash buffer followed. The beads were centrifuged
at 2500 x g and 4 °C for 5 min and the supernatant discarded. Next, the beads were
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split into four test tubes and water and 0.1 mM Fe(II)(NH4)2(SO4)2 6 x H2O (final
conc.; total volume 50 µL) was added. 1 mM α-ketoglutarate (Na+ salt) were added to
sample1; 1 mM oxaloacetate were added to sample2 and 1 mM isocitrate was added to
sample3. To sample4, no cosubstrate was added. As an additional control, one sample
(sample 6) was prepared without Tet and without co-substrate. 1000 pmol of an Oligo
(5’–UUUUGmCGGUUG–3’) was added and the reaction mixture incubated at 37 °C for
1.5 h. After centrifugation (15000 rpm), the supernatant was desalted using a desalting
membrane and analyzed via MALDI-TOF. The in vitro activity test was performed five
times, yielding the same result.
8.8.12 In vitro activity test with inhibitors
The samples were prepared as described above, but reaction buffer (50 mM HEPES
pH=7.5, 100 mM NaCl, 2 mM Vitamin C, 1.2 mM ATP, 2.5 mM DTT) and 2000 pmol
of the oligo were used instead of 1000 pmol and the samples were incubated at 3 h at
37 °C. 1 mM of α-ketoglutarate were added to each sample. To the positive control,
neither oxaloacetate nor isocitrate was added. 10 mM and 100 mM of oxaloacetate or
isocitrate were added in order to test the inhibitory potential. After incubation, the
samples were centrifuged (rt, 5000 x g) and the supernatant was used for MALDI-TOF
analysis. In order to calculate the relation of mC-containing oligo (substrate) to hmC/fC-
containing oligo (product), OriginPro 2016G 64-bit software was used. The relation of
mC to hmC/fC was calculated from MALDI-TOF analysis via peak integration. Peaks
of the mC-containing oligo (3294.5 Da) were integrated from m/z 3290 – 3300 and peaks
of the hmC/fC-containing oligo (3310 Da) were integrated from m/z 3305 – 3312. The
in vitro activity test with inhibitors was performed twice, yielding the same result.
8.8.13 Co-expression of Tet3 and Glud1 in HEK293T cells
The experiment was done in three biological replicates. 3 x 105 HEK293T cells were
seeded per 6-well. 24 h after seeding, the cells were transfected with 2.0 µg of vec-
tor DNA coding for GFP-Tet3 (full-length construct or catalytic domain) and for the
co-transfection additionally with 2.0 µg of vector DNA coding for Glud1. 4 h after
transfection, the medium was changed. 36 h after transfection, cells were harvested and
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GFP-Tet3 levels were determined using fluorescence-activated cell sorting (BD FACS
Cantor II, BD Biosciences, USA; FACS parameters FSC 132 V, SSC 407 V, GFP 308
V). Next, the genomic DNA was isolated and the subsequent analysis of the mC-, hmC-
and fC- were performed in technical triplicates as described earlier.3 Levels of 8-oxoG
were analysed to show that random oxidation processes do not impair the result. 5 µg of
genomic DNA was analysed per technical replicate. Levels of hmC and fC of Tet3-Glud
co-transfected cells were normalized to Tet3 levels of only Tet3-transfected cells. Sta-
tistical analysis was done using GraphPad Prism 7.0. The samples (including biological
and technical replicates) were tested for normal distribution (D’Agostino Pearson test)
and an unpaired t-test was performed (only biological replicates (means of the technical
replicates), n=3 for each condition). Variance was determined by standard deviation,
showing similarity between the groups. If R162 was applied (two biological replicates),
it was added at a concentration of 20 µM 4 h after transfection.
8.8.14 Synthesis of the Glud1-inhibitor R162
Synthesis of the inhibitor R162 was done according to the literature.[430,431] Prior to use
for the cell culture, the compound was purified via preparative HPLC (Nucleosil VP
250/10 C18 column from Macherey Nagel, 100% MeCN for 10 minutes).
8.8.15 Depolarization of hippocampal neurons
Animals:
4 – 5 weeks old C57BL6/J (Charles River, Sulzfeld, Germany) wildtype mice (4 x male,
2 x female) were used. All procedures concerning animals conform to the German animal
protection laws and were approved by the local authority (Regierung von Oberbayern).
Hippocampal slices:
The mice (n=6) were euthanized by cervical dislocation. Acute transverse hippocampal
slices (400 µm thick) were prepared as described previously.[432,433] In brief, the brain
was removed, the hippocampi of each hemisphere were dissected and cut using a MX-
TS tissue slicer (Siskiyou Cooperation, OR). The slices were collected in an oxygenated
(95% O2, 5% CO2) physiological solution (118 mM NaCl, 3 mM KCl, 1 mM NaH2PO4,
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25 mM NaHCO3, 10 mM Glucose, 1.5 mM CaCl2, 1 mM MgCl2, 0.1% DMSO) at 37 °C
until the hippocampi of all replicates were cut. Then the slices were distributed to three
different conditions: oxygenated physiological solution, oxygenated 25 mM KCl solu-
tion (118 mM NaCl, 25 mM KCl, 1 mM NaH2PO4, 25 mM NaHCO3, 10 mM Glucose,
1.5 mM CaCl2, 1 mM MgCl2, 0.1 % DMSO) and oxygenated 25 mM KCl solution sup-
plemented with inhibitor R-162 (118 mM NaCl, 25 mM KCl, 1 mM NaH2PO4, 25 mM
NaHCO3, 10 mM Glucose, 1.5 mM CaCl2, 1 mM MgCl2, 20 µM R-162, 0.1 % DMSO).
6 – 10 slices were pooled for each replicate. After a 6 h incubation time, the slices were
transferred into reaction tubes, snap frozen in liquid nitrogen and stored at -80 °C until
use. DNA isolation and subsequent analysis of mC and hmC levels were performed as
described earlier.12, 13 Levels of 8-oxoG were analysed to show that random oxidation
processes do not impair the result. Measurements were done in technical duplicates
or triplicates, depending on the amount of isolated genomic DNA. Per replicate, 1 µg
of genomic DNA was analysed. Statistical analysis after Triple-Quad analysis of mC
and hmC levels: Statistical analysis was done using GraphPad Prism 7.0. For n=6,
p-values of 0.0091 (physiological conditions vs. 25 mM KCl) and 0.0193 (25 mM KCl
vs. 25 mM KCl + 20 µM R162) were calculated using repeated measures (RM) one-way
ANOVA Tukey’s multiple comparisons test. However, we excluded one mice (mouse 6)
from further analysis, since no change of the hmC levels upon KCl treatment could be
observed and therefore it was not possible to study the effect of R162 on hmC dynamics.
Three outliers within the technical replicates (mouse 3, physiological conditions, 0.00147
hmC/dN; mouse 5, 25 mM KCl 0.00113 hmC/dN and 0.00242 hmC/dN) were also ex-
cluded from further analysis. Assuming normal distribution of the mC and hmC levels
for the mouse hippocampal region, RM one-way ANOVA was statistically significant for
hmC: total number of values = 5 (p-value 0.0009) and there was significant matching
(p-value 0.0031). There was no significant difference between physiological conditions
and depolarization conditions with R162 (p-value 0.1583 physiological solution/25 mM
KCl + 20 µM R162). For the mC-levels, the RM one-way ANOVA was not statisti-
cally significant (p-value 0.5156), but the matching was also effective (p-value 0.0023).
Tukey’s multiple comparisons test did not show significant differences between the differ-
ent conditions (p-value 0.6054 physiological solution/25 mM KCl; p-value 0.5483 25 mM
KCl/25 mM KCl + 20 µM R162; p-value 0.9945 physiological solution/25 mM KCl +
20 µM R162). For the statistical analysis only biological replicates (means of the tech-
nical replicates) were considered.
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8.9 Contributions
Franziska Traube, Dr. Andrea Künzel, PD Dr. Stylianos Michalakis, Dr. Markus Müller
and Prof. Dr. Thomas Carell designed the experiments. Dr. Andrea Künzel developed
the saturated co-IP workflow and did the saturated co-IP, including the proteomics mea-
surement. Franziska Traube and Dr. Andrea Künzel did the endogenous co-IPs, includ-
ing the proteomics measurements, the Western blots, the IHC, the PLAs and analysed
the data. Edris Parsa developed the expression protocol in HEK cells. Franziska Traube
did the co-transfection experiments and the isocitrate feeding experiment. Franziska
Traube, Edris Parsa, Thomas Wildenhof performed the in vitro Tet activity assays.
Anna Geserich and PD Dr. Stylianos Michalakis performed and analysed the IHC and
PLA experiments. René Rahimoff synthesized R162. Constanze Scheel, Victoria Splith
and PD Dr. Stylianos Michalakis performed the depolarization of hippocampal neu-
rons. Franziska Traube, Angie Kirchner and Katharina Iwan isolated DNA, performed
Triple-Q experiments and analysed Triple-Q data. Michael Stadlmeier helped with the
mass spectrometry studies. PD Dr. Stylianos Michalakis provided mouse samples. Dr.
Markus Müller and Dr. Fabio Spada discussed and interpreted results. Prof. Jürgen
Cox, helped with the statistical analysis of the proteomics data. Prof. Dr. Thomas
Carell designed and supervised the whole study and interpreted data.
84
Results and Publications
8.10 Supllementary Data
Extended Data Fig. 1: Purification of GFP-Tet3. . (A) Complete Western Blot
showing the steps of Tet3FL purification using an anti-GFP antibody to detect GFP-
Tet3. In the wash fractions, no GFP-Tet3 could be detected. In the elution fraction,
only the GFP-Tet3 full-length was detected. (B) Tet3 is active on the GFP nanobeads.
The table shows the result of an in vitro activity assay in technical duplicates of Tet1
catalytic domain (Tet1cd) as a positive control and of Tet3 full length protein (Tet3FL)
on the beads.
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Extended Data Fig. 2: Data Quality. (A) Multi scatter plot comparing the LFQ
intensities from the four biological replicates of the Tet3 experiment with itself (red
rectangle) and the pull downs using beads loaded with GFP and Tet3 lacking the CXXC
domain. Blue numbers indicate the Pearson correlation. (B) Histograms showing counts
of label-free quantification (LFQ) intensities of the data set.
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Extended Data Fig. 3: Volcano plots of co-immunoprecipitation (co-IP)
experiments. Volcano plots of the interaction partners found in the modified Tet3-co-
IP proteomics study in adult mouse brain for Tet3 and Tet3-CXXC (FDR = 0.05; s0 =
2) and interactors found in Tet3 endogenous co-IP study.
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Extended Data Fig. 4: Complete Western Blots after Tet3 saturated and
endogenous co-immunoprecipitation (co-IP). (A) Western Blots after Tet3 satu-
rated co-IP using anti-aconitase2 antibody and anti-glutamate-dehydrogenase antibody.
(B) Western Blots after Tet3 endogenous co-IP using anti-aconitase2 antibody and anti-
glutamate-dehydrogenase antibody and anti-Tet3 antibody. Anti-GFP-antibody was
also used to detect GFP-Tet3FL in HEK293T cell lysate.
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Extended Data Fig. 5: Microscopy data.(A) Test of Tet3 antibody from Abiocode
and Sigma in Tet triple knock-out mouse embryonic stem cells. Chromatinmarker
H3K9me3 served as a positive control that the immunocytochemistry (ICC) worked
in principle. For all three ICCs the same secondary antibody was used. (B) Overview of
the hippocampal regions for immunohistochemistry (IHC) using either an anti-Tet3 or
an anti-Glud antibody or an anti-Aco2 antibody. ROI marks the region that was chosen
for close-up images in Fig. 2C. (C) PLAs in mouse hippocampi with different antibody
combinations. For the negative control, no primary antibody was used. The encirceled
red dots indicate a positive signal.
Extended Data Fig. 6: Effect of R162 on Tet3 activity.Cells that only expressed
Tet3 (+ - •/+ -X) served as a control that shows that R162 did not impair Tet3 activity.
All measurements were done in biological and technical duplicates (n = 2 for unpaired
t-test).
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Extended Data Fig. 7: Glud1 and Tet1/Tet2 co-transfections in HEK cells
and depolarization of hippocampal neurons. (A), (B) HEK293T cells were co-
transfected with GFP-Tet2 and Glud1 or GFP-Tet1 and Glud1. Global levels of mC,
hmC and fC were compared to each other. The measurement was done in biological and
technical triplicates.
91
Results and Publications
92
Results and Publications
Extended Data Fig. 8. Tet1cd activity in presence and absence of the
co-substrate. (A) Tet1cd was fully active in reaction buffer in the presence of α-
ketoglutarate (DNA oligo: 5’-UUU UGmC GGU UG-3’; MALDI-TOF m/z mC: 3294.5;
hmC/fC: 3310.8). When only Fe(II) and Tet1cd are present, the DNA oligo is hydrol-
ysed: 1-1 3294.5 Da; 1-2 3004.8 Da; 1-3 2714.6 Da; 1-4: 2424.4 Da; 1-5: 2134.3 Da. (B)
Tet1cd was also active on DNA-oligo 5’-GTA ATG mCGG TAG G-3’. MALDI-TOF
analysis shows a small peak of mC- (4066 m/z) and a large peak of hmC/fC-containing
DNA (4082 m/z). When no co-substrate is present, the oligomer was also hydrolysed:
3-1 4066.6 Da; 3-2 3737.3 Da; 3-3: 3431.1 Da. However, the degradation was to a
lesser extent than for the other oligomers. (C) If no Tet enzyme is present, both DNA
oligomers are stable in water in the presence of Fe(II).
Extended Data Fig. 9: Calculation of docking scores for different metabolites
in the binding pocket of Tet2. Different metabolites were fitted inside the cat-
alytic domain of Tet2 using Maestro 10.7 with standard settings (Glide ligand docking).
(A) upalpha-Ketoglutarate (blue), 2-hydroxyglutarate (red), isocitrate (yellow) and ox-
aloacetate (purple) fit inside the binding pocket. (B) The docking scores for the different
metabolites. The lower the score, the better the ligand fits in the binding pocket.
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Extended Data Fig. 10: MALDI-TOF spectra of in vitro inhibitor test.
The substrate peak (mC) was expected at 3294.5 Da, the product peak (hmC/fC) was
expected at 3310 Da. Peaks at m/z 3315 represent Na+ adduct peak of the original
substrate.
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Extended Data Fig. 11: Oxaloacetate feeding of Tet3-transfected HEK293T
cells.HEK293T cells were transfected with Tet3 and fed with 10 mM oxaloacetate (+X).
Global levels of mC, hmC, fC and caC were compared to cells that were transfected,
but not fed with oxaloacetate (+ •). Untransfected cells that were either fed with
oxaloacetate (-X) or not (- •) served as additional controls.
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9 The Functional Context of TET1 and TET3 in
Eu- and -Heterochromatin
9.1 Introduction
Tet enzymes are α-ketoglutarate dependent oxidases, which oxidize the DNA base
5-methylcytosine (mC) in a stepwise fashion to 5-hydroxymethylcytosine (hmC), 5-
formylcytosine (fC) and 5-carboxycytosine (caC).[78–81,188] Of these oxidation products,
hmC is the most abundant modification. It is strongly enriched in embryonic stem cells
and in brain.[104,160,196,414] fC was recently found in human brain as well, but in all ana-
lyzed samples the fC and particularly the caC levels are small in comparison to hmC.[159]
Three different Tet enzymes are known (Tet1-3) of which Tet1 and Tet3 show a dynamic
adjustment of their expression during differentiation. The highest expression levels of
Tet1 are found in mouse embryonic stem cells (mESCs), whereas its expression de-
creases during differentiation. Tet3 expression in contrast is weak in mESCs (Fig. S1),
but it is quickly upregulated during differentiation.[80,246,265,414,434] Two Tet3 isoforms,
one containing a CpG-binding CXXC domain (Tet3) and one lacking it (Tet3-CXXC), are
dominantly expressed in somatic cell types and tissues, including neural progenitor cells
(NPCs) and neurons.[187,265,413,415] The question of why vertebrates need different Tet
enzymes to perform the oxidation of mC to hmC and fC is a major unsolved problem.
9.2 Materials and Methods
9.2.1 Cell culture and transfection
The HEK293T cells were cultivated at 37 °C in water saturated, CO2-enriched (5%)
atmosphere. DMEM (10% FBS) was used as growing medium. When reaching a con-
fluence of 70% to 80% the cells were passaged. The transfection was performed in
p150-petri dishes. Five million cells were used in 20 mL of medium. After seeding,
the cells were incubated at previously described cultivation conditions for 24 hours to
reach a confluence of 60% to 80%. 10µg of DNA and 30µL of the transfection reagent
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jetPRIME® purchased from Polyplus Transfection were used as described by the manu-
facturer. All expression plasmids for GFP-Tet were described previously.[265] To increase
the transcription rate in transfected cells, 4 hours after transfection the medium was
removed and sodium butyrate (4 mM) treated medium was added. After 48 hours the
cells were harvested. mESCs were routinely passaged under FBS/2i conditions and were
weaned off 2i (partial priming) for four days as described[80] before preparation of nu-
clear extracts. Except for experiments shown in Fig. S4, wild type J1 mESCs were used
throughout this study. Tet TKO mESCs (Fig. S4) were described previously.[435] The
FGF-2/EGF-dependent NPC line ENC1 was cultured as previously described.[265]
9.2.2 Nuclear extract preparation
Nuclear lysate of cell lines (HEK293T, mESCs, NPCs) was prepared as described in.[194]
The complete adult mouse brains were lysed according to the protocol by.[428] The re-
sulting nuclear extract was then treated with 25 U Benzonase for 30 minutes on ice and
subsequently centrifuged for 15 minutes at 15000 rpm. The supernatant containing the
nuclear lysate was transferred to a fresh tube. A Bradford protein assay (Bio-Rad) was
performed according to the manufacturer´s instructions to measure the protein concen-
tration.
9.2.3 GFP-Tet saturated Co-Immunoprecipitation
20 µl anti-GFP beads (Chromotek) were washed three times with wash buffer (10 mM
Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA) and then incubated for 15 minutes
on ice with nuclear extract of GFP-Tet overexpressing HEK293T cells. To ensure the
saturation of the beads with the GFP fusion construct, different amounts of lysate and
different incubation times were tested and monitored using a Tecan Reader (Fig. S2A,
nonlinear fit using GraphPad Prism 7.02). The GFP-Tet loaded beads were then washed
twice with 150 mM NaCl solution containing 10 mM HEPES. Another two wash steps
with 1 M NaCl solution containing 10 mM HEPES and two wash steps with Lysis Buffer
C (20 mM Hepes pH = 7.5, 420 mM NaCl, 2 mM MgCl2, 0.2 mM EDTA, 20% (v/v)
glycerol) followed. The saturated GFP-Tet beads were subsequently incubated with
200 µg nuclear extract of choice (mESCs, NPCs) for 15 minutes on ice. Following, they
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were washed twice with wash buffer. To elute the bound proteins, 50 µl of 200 mM
glycine pH 2.5 was added and the solution was vortexed for 30 seconds. To gain more
yield the elution step was repeated.
9.2.4 GFP-Tet saturated Co-Immunoprecipitation
The reversed Co-IP was carried out with FACT/ Supt16H antibody (PA5-18443, Thermo
Scientific), PP1 gamma antibody (PA5-21671, Thermo Scientific) and Anti-Goat IgG
antibody (G4018, Sigma-Aldrich), which served as a negative control. For each reversed
Co-IP, 10 µL of Dynabeads Protein G (Life Technologies) were washed three times with
500 µL of Washbuffer 3 (PBS, 0.5% (w/v) octyl β-D-glucopyranosid) prior to addition
of 1 µg of antibody. The antibody was dissolved in 50 µL of Washbuffer 3, added to
the Dynabeads and mixed for 1 hour at room temperature on a tube rotator. Then, the
unbound antibody was removed and the beads with the bound antibody were washed
two times with 500 µL of Washbuffer 3. In the next step, 250 µg of nuclear lysate from
mESCs, when PP1 gamma antibody or anti-goat IgG antibody were used, or 250 µg
of nuclear lysate from NCPs, when FACT/Supt16H antibody was used, were added in
a total volume of 400 µL of Lysis Buffer C (20 mM Hepes pH = 7.5, 420 mM NaCl,
2 mM MgCl2, 0.2 mM EDTA, 20% (v/v) glycerol) to the beads and gently mixed by
pipetting up and down. The lysate was incubated with the beads for 1 hour at room
temperature on a tube rotator. In order to remove unbound and non-specifically bound
protein after incubation, the supernatant was discarded and the beads were washed two
times with 500 µL of Washbuffer 1 (10 mM Hepes pH = 7.5, 150 mM NaCl, 0.5 mM
EDTA), two times with 500 µL of Washbuffer 2 (10 mM Hepes pH = 7.5, 1 M NaCl,
0.5 mM EDTA) and two times with 500 µL of Washbuffer 3. Afterwards, 250 µg of
nuclear lysate from GFP-Tet3 transfected HEK293T cells, which had not been treated
previously with butyric acid, were added in a total volume of 400 µL of Lysis Buffer C
and gently mixed by pipetting up and down. The lysate and the beads were incubated
for 2 hours at 4 °C on a tube rotator. Finally, the supernatant was discarded, the beads
were washed three times with 500 µL of Washbuffer 3 and the bound protein complexes
were eluted by addition of 30 µL of 1% (v/v) formic acid and incubation for 15 minutes
at room temperature in a thermomixer (700 rpm). The eluate was collected and 10 µL
of 1 M Tris were added in order to neutralize the pH; then the samples were prepared
for LC-MS/MS analysis.
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9.2.5 LC-MS/MS analysis
Samples for the mass spectrometer were reduced by the addition of 100 mM TCEP and
subsequent incubation for 1 hour at 60 °C on a shaker at 650 rpm. They were then
alkylated by adding 200 mM iodoacetamide and incubating for 30 minutes at room tem-
perature in the dark. Following, the samples were digested with 0.5 µg trypsin (Promega)
at 37 °C for 16 hours. Afterwards, they were incubated for 5 minutes at 100 °C and
subsequently 1 mM phenylmethylsulphonylfluoride was added. StageTips were utilized
to purify the samples for mass spectrometry.[429] The samples were analyzed with an
UltiMate 3000 nano liquid chromatography system (Dionex, Fisher Scientific) attached
to an LTQ-Orbitrap XL (Fisher Scientific). They were desalted and concentrated on
a µ-precolumn cartridge (PepMap100, C18, 5 µM, 100 Å, size 300 µm i.d. x 5 mM) and
further processed on a custom made analytical column (ReproSil-Pur, C18, 3 µM, 120
Å, packed into a 75 µm i.d. x 150 mM and 8 µm picotip emitter). The samples were
processed via a 127 minutes multi-step analytical separation described below at a flow
rate of 300 nl/min. Only LC-MS grade solvents were used (solvent A: water + 0.1%
formic acid; solvent B: acetonitrile + 0.1% formic acid). The gradient with percentages
of solvent B was programmed as follows: 1% for 1 minute; 1% - 4% over 1 minute; 4%
- 24% over 100 minutes; 24% - 60% over 8 minutes; 60% - 85% over 2 minutes; 85% for
5 minutes; 85% - 1% over 2 minutes; 1% for 8 minutes. Mass spectrometric analysis was
done with a full mass scan in the mass range between m/z 300 and 1700 at a resolution
of 60000. Following this survey scan, five scans were performed using the ion trap mass
analyzer at a normal resolution setting and wideband CID fragmentation with a normal-
ized collision energy of 35. Signals with an unrecognized charge state or a charge state
of 1 were not picked for fragmentation. A dynamic exclusion list was implemented with
the following settings: after two measurements in 30 seconds, the peptide was excluded
from selection and fragmentation for 90 seconds.
9.2.6 Mass spectrometric data processing
The MaxQuant software (version 1.5.0.25) was used for the mass spectrometric data pro-
cessing. The Andromeda search engine was used in combination with Uniprot databases
(Mus musculus). A maximum of two missed cleavage sites was allowed. The main search
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peptide tolerance was set to 4.5 ppm. Carbamidomethyl (C) was set as static modifica-
tion. Variable modifications were Acetyl (Protein N-term) and Oxidation (M). minimal
peptide length was set to 7.
9.2.7 LFQ data processing
For LFQ, mass spectrometric data processing was used in combination with the LFQ
option in the MaxQuant software (version 1.5.0.25). Quantification was performed with
four biological replicates. The Co-IP with GFP alone served as control. The LFQ algo-
rithm was applied with default settings (LFQ min. ratio count: 2, Fast LFQ, LFQ min.
number of neighbours: 3, LFQ average number of neighbours: 6). The option “match
between runs” was also used. The mass spectrometry proteomics data have been de-
posited to the ProteomeXchange Consortium via the PRIDE[436] partner repository with
the dataset identifier PXD005711. LFQ data was analyzed with the Perseus software
(version 1.5.0.9). The LFQ intensities were log transformed and only proteins identified
in at least three samples were retained. Gene ontology analyses were performed with
the Database for Annotation, Visualization and Integrated Discovery (DAVID Bioinfor-
matics Resources 6.7).
9.2.8 Proximity Ligation Assay
The proximity ligation assay (PLA) was carried out using Duolink InSitu Orange Starter
Kit (Sigma). 30000 2d primed mESCs were seeded in each µ-plate well (ibidi) and trans-
fected with GFP-Tet3 and GFP as control using lipofectamine 2000 (Life Technologies).
The cells were then incubated for 2 days at 37 °C. Afterwards, the medium was removed
and 200 µL of Washbuffer A (PBS, 0.9 mM CaCl2, 0.5 mM MgCl2, 0.02% (v/v) Tween-
20) were added immediately in order to prevent the cells from drying out. The cells
were washed two times with 200 µL of Washbuffer A and then fixed on the surface. For
the fixation, 200 µL of 3.7% (v/v) paraformaldehyde in Washbuffer B (PBS, 0.9 mM
CaCl2, 0.5 mM MgCl2) were added and the cells were incubated for 15 minutes at room
temperature. Afterwards, the fixation solution was removed and the cells were washed
two times with 200 µL of Washbuffer A. In the next step, the cells were incubated for 1
hour at room temperature in 200 µL of Blocking Solution (3% (w/v) BSA in Washbuffer
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B). In the meantime, the antibody solutions were prepared. 1 µL of PP1 gamma anti-
body (PA5-21671, Thermo Scientific) and 1 µL of GFP (4B10) Mouse antibody (2955S,
Cell Signaling) were dissolved in 100 µL of Antibody Diluent (Sigma), respectively. The
antibodies were added after having removed the Blocking Solution and the cells were
incubated overnight at 4 °C in a humid atmosphere. The next day, the Antibody Diluent
was discarded and the cells were washed two times with 200 µL of Washbuffer A. For
the PLA Probe Solution, 10 µL of PLA Probe (+) Anti-Rabbit (Sigma), 10 µL of PLA
Probe (-) Anti-Mouse (Sigma) and 30 µL of Antibody Diluent were mixed and added.
The cells were incubated in a humidity chamber for 1 hour at 37 °C. In the next step,
the PLA Probe Solution was removed, the cells were washed two times with 200 µL of
Washbuffer A and 50 µL of the Ligation Solution, which had been prepared previously
by mixing 1.0 µL of 1U/µL Ligase, 10 µL of Ligation Stock (all from Sigma) and 29 µL
of bidest. H2O, were added. After 30 minutes of incubation in a humidity chamber
at 37 °C, the Ligation Solution was discarded and the cells were washed two times
with 200 µL of Washbuffer A. For the amplification reaction, 0.5 µL of Polymerase 10
U/µL, 10 µL of Amplification Stock (all from Sigma) and 39.5 µL of bidest. H2O were
mixed and added to the cells. The cells were incubated for 100 minutes at 37 °C in
a humidity chamber. The Amplification Solution was discarded; the cells were washed
two times with 200 µL of Washbuffer B and one time with 200 µL of 0.01% Washbuffer
B. Finally, 100 µL of Washbuffer B were added and the cells were analyzed by confocal
microscopy in the fluorescence modus (Leica DMI4000B, filter I3 for GFP, filter N2.1
for PLA amplification product).
9.2.9 RNA isolation
RNA from mESC and ENC1 was isolated using peqGold Total RNA Kit (peqLab)
according to the manufacturer’s manual.
9.2.10 Real-time quantitative polymerase chain reaction (qPCR)
Prior to the qPCR, 1 µg of RNA was transcribed to 1µg of cDNA using the iScript
cDNA Synthesis Kit (BioRad) according to the manufacturer’s manual. The final cDNA
concentration was 50 ng/µL. For the qPCR, the cDNA was diluted to 25 ng/µL with
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nuclease-free bidest. H2O and 10 µL of iTaq Universal SYBR Green Supermix (Bio-
Rad) were added per 2 µL of cDNA dilution. For each primer pair, the forward and
the reverse primer were mixed together in equal amounts and diluted with nuclease-free
bidest. H2O to a final concentration of 1.25 µM. 12µL of cDNA/iTaq mastermix and
8 µL of primer mix were added per well. 96-well PCR plates (Axygen Scientific) were
used in combination with Flat 8 Cap Strips and the samples were spun down at 2000 x g
for 5 minutes using an Eppendorf centrifuge 5810 R. Each sample was measured in trip-
licates using an Eppendorf Mastercycler Realplex4 with the following PCR conditions:
Step 1 95 °C (2:00 min), Step 2 95 °C (0:15 min), Step 3 55 °C (0:15 min), Step 4 72 °C
(0:20 min); Step 2 – 4 were repeated 40 times.
Tet1 forward primer: 5’ CCA GGA AGA GGC GAC TAC GTT 3’
Tet1 reverse primer: 5’ TTA GTG TTG TGT GAA CCT GAT TTA TTG T 3’
Tet2 forward primer: 5’ ACT TCT CTG CTC ATT CCC ACA GA 3’
Tet2 reverse primer: 5’ TTA GCT CCG ACT TCT CGA TTG TC 3’
Tet3 (all) forward primer: 5’ GAG CAC GCC AGA GAA GAT CAA 3’
Tet3 (all) reverse primer: 5’ CAG GCT TTG CTG GGA CAA TC 3’
9.2.11 In vitro activity test
For the activity tests, approximately 10 million HEK293T cells were used. The cells were
transfected with Tet1 catalytic domain (Tet1cd) or Tet3 full length protein (Tet3FL),
according to the protocol above. The cells were harvested, centrifuged and lysed with 5
mL of RIPA buffer (Chromotek), supplemented with 250 U benzonase (Merck Millipore)
and protease inhibitor (Roche). After 30 minutes on ice the suspension was centrifuged at
10000 x g and 4 °C for 15 minutes. The supernatant consisted of nuclear and cytoplasmic
proteins. Per activity test, 100µL of anti-GFP beads (Chromotek) were washed three
times with wash buffer (10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA) and
then incubated for 1 hour at 4 °C with the supernatant. The GFP-Tet loaded beads
were washed with GFP wash buffer (Chromotek). For the second wash step GFP wash
was supplemented with 2 mM ZnSO4 and 10µL Nuclease S1. The beads were incubated
with this buffer for 30 minutes on ice. Another two wash steps with 1 M NaCl solution
containing 10 mM HEPES, pH 7.5 and two wash steps with GFP wash buffer followed.
The beads were centrifuged at 2500 x g and 4 °C for 5 minutes and the supernatant
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discarded. Next, reaction buffer (50 mM HEPES pH=7.5, 100 mM NaCl, 2 mM Vitamin
C, 1.2 mM ATP, 2.5 mM DTT, 0.1 mM Fe(II)(NH4)2(SO4)2 6 x H2O) and 1 mM α-
ketoglutarate (Na+ salt) was added. As an additional control, one sample was prepared
without Tet. 1000 pmol of an Oligo (5’-UUUUGmCGGUUG–3’) was added and the
reaction mixture incubated at 37 °C for 1.5 hours. After centrifugation (15000 rpm),
the supernatant containing the oligonucleotide was transferred into a new tube. The
DNA was precipitated from 3 M NaOAc (pH = 5.2) and dissolved in 30µL of water.
9.2.12 Immunocytochemistry
Immunocytochemistry (ICC) experiments were performed as previously described with mi-
nor modifications. In brief, 30000 3 d primed mESCs or ENC1 cells were seeded in
eachµ-plate well (ibidi). The next day (4 d priming for mESC), cells were fixed (10 min)
on slides using 4% (v/v) paraformaldehyde (PFA) in 0.1 M phosphate buffered saline
with 0.5 mM MgCl2 and 0.9 mM CaCl2, pH 7.4 (0.1 M PBS). After three times washing
with 0.1 M PBS, the cells were permeabilized using 0.3% (v/v) TritonX in 0.1M PBS.
After washing for three times, cells were incubated with 0.1 M PBS with 5% block-
ing reagent (Chemiblocker, CB, Millipore) for 30 min. Primary antibodies were added
and incubated for two hours at room temperature in a humidity chamber. Anti-Tet3
antibody (Abiocode M1092-3 (dilution 1:500), from mouse), anti-Tet1 antibody (Ac-
tive Motif 61741 (dilution 1:300), from rat) and anti-H3K9me3 antibody (Active Motif
H3K9me3 (dilution 1:500), from rabbit) were used as primary antibodies for ICC with
chromatin markers. Anti-Tet3 antibody (Abiocode M1092-4a (dilution 1:2000), from
mouse), anti-Ppp1cc antibody (Thermo Scientific PA5-21671 (dilution 1:100), from rab-
bit), anti-Tet1 antibody (Active Motif Active Motif 61741 (dilution 1:50), from rat) and
anti-Ywhag antibody (Thermo Scientific PA5-29690 (dilution 1:100), from rabbit) were
used as primary antibodies for validation of previously discovered Tet interactors in
mESC. Anti-Tet3 antibody (Sigma HPA050845 (dilution 1:100), from rabbit) and anti-
Supt16 antibody (Thermo Scientific PA5-18443 (dilution 1:200), from goat) were used as
primary antibodies for validation of previously discovered Tet interactors in ENC1. The
primary antibodies were diluted in 0.1 M PBS, containing 5% (v/v) blocking reagent
and 0.3% (v/v) Triton-X solution. For the negative controls, no primary antibodies
were added. After incubation, cells were washed three times with 0.1 M PBS, con-
taining 2% (v/v) blocking reagent. For detection, we used Alexa488-anti-rat (1:600,
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Cell Signaling Technologies), Alexa488-anti-mouse (1:600, Cell Signaling Technologies),
Alexa555-anti-rat (1:600, Cell Signaling Technologies), Alexa555-anti-rabbit (1:600, Cell
Signaling Technologies), Alexa555-anti-mouse (1:600, Cell Signaling Technologies) and
Cy3-anti-goat (1:400, Jackson ImmunoResearch) diluted in 0.1 M PBS, containing 3%
(v/v) CB as secondary antibodies and incubated for 1 h at room temperature. After
incubation, cells were washed three times with 0.1 M PBS. Cell nuclei were stained with
Hoechst 33342 (5µg/mL), which was applied for 5 min in the dark at room temperature.
After mounting (Mountant Permafluor, ThermoScientific), the slides were analyzed us-
ing a Leica SP8 confocal laser scanning microscope (Leica, Wetzlar). Co-localization
was analyzed using ImageJ 2.0.0, Colocalization Threshold. The ICC experiments were
performed in two biological replicates, yielding the same result.
9.3 Results
In order to clarify the functional roles of Tet1 and both Tet3 isoforms, we performed
an affinity proteomics study to decipher the interacting proteins and protein complexes.
To allow a direct comparison between different cell types, we used a Tet saturated co-
immunoprecipitation (Co-IP) workflow as recently reported and as depicted in Fig. 16A.
In short, GFP-Tet fusion protein coated magnetic beads were generated. The beads were
intensively washed with up to 1 M NaCl in order remove unspecifically bound proteins.
This intensive washing removed contaminating HEK proteins efficiently but did not im-
pair the binding of GFP-Tet to the GFP-nanobody beads (Fig. S2B). We showed that
the different Tet proteins bound to the beads possess the expected catalytic activity
proving that the Tet enzymes are functional intact. Importantly, we see oxidation by
the different Tet-covered beads of mC to all expected products hmC, fC and caC in the
presence of -ketoglutarate and Fe2+. These functional Tet-loaded beads are used as baits
for Co-IP of Tet interactors in lysates of different cell types. This target protein satu-
rated Co-IP workflow enables not only a robust comparison between samples but also
the study of low abundant bait proteins. We analyzed the interactomes of Tet1, Tet3
and Tet3-CXXC (Fig. 16B) in mESCs and NPCs. For quantitative analysis, label-free
quantification technology[418] was applied with GFP-covered beads as controls. In each
case, we analyzed four biological replicates to enable statistically reliable quantification.
The data show a close correlation within the replicates as determined by the Pearson
correlation (Fig. S3A), proving high data quality. The LFQ intensities for each sample
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are distributed as expected (Fig. S3B). The principle component analysis of the data
shows the clustering of the different Tet Co-IPs and GFP control in mESCs as expected
(Fig. S3C). In total, 1497 proteins were identified, of which 61 are enriched with a
-log(two-way ANOVA p-value interaction) parameter of > 2 (Fig. 16C). The correla-
tion analysis of the obtained data uncovers distinct interactomes of the individual Tet
enzymes in the two investigated cell types. Interestingly, we found the cell type specific
differences of the interactomes most pronounced, but identified also Tet paralog-specific
clusters. A strong cell-type specific cluster contains proteins involved in gene expression
and nucleic acid binding, which are strongly enriched in NPCs, but depleted in mESCs
(green box). The cluster contains proteins involved in gene expression and nucleic acid
and protein binding (Table S1). Analysis of individual proteins shows that the kinase
Camk2b is enriched. Another identified protein is Suds3, which is part of the Sin3a
complex. SudS3 was already discovered as an interactor of Tet1[188], which supports our
data. Furthermore, Hmgb1 is strongly enriched in the NPC data set, which is involved
in the organization of DNA and regulation of transcription. Hmga1 is another high
mobility group protein regulating transcription and is highly enriched in NPCs in con-
trast to mESCs. The cell-type specific cluster for mESCs (cyan box) shows nucleic acid
binding in the nucleus as significant gene ontology (GO) terms for molecular function
and cellular compartment (Table S2).
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Figure 18: Experimental design and data overview. (A) Tet-saturated co-
immunoprecipitation workflow. (B) Schematic representation of the Tet constructs used
for this study. aa = amino acids; SB = substrate binding; CB = co-substrate binding
(C) Correlation-based clustering of the log2 transformed label-free quantification (LFQ)
intensities normalized by row mean subtraction of the GFP control. A selection of
Gene Ontology (GO) terms are given (BP = biological process, CC = cellular compart-
ment, MF = molecular function). The gradient from blue to red indicates the increase
of enrichment ascertained by a two-way ANOVA test (-log(two-way ANOVA p-value
interaction) > 2); mESC = mouse embryonic stem cells; NPC = neural progenitor cells.
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For example, Nono is a strong Tet interactor in contrast to NPCs. This protein is in-
volved in transcriptional regulation. Strikingly, Kpna3 is especially enriched in mESCs
as well. This protein functions in nuclear protein import by binding to NLS motifs.
Moreover, Rfc2, which is involved in replication, is also enriched.
The paralog specific clusters are less pronounced and show significant separation only in
mESCs. Most interesting is the observation that in mESCs, proteins involved in chro-
matin remodeling are enriched in experiments performed with Tet3-CXXC and they are
repelled in the case of Tet1 (purple box, Table S3)). Another observation is that Tet3
seems to be less involved in gene expression than Tet1 and Tet3-CXXC (red box, Table
S4). A detailed analysis of individual reader proteins is shown in Fig. 18.
Figure 19: Interaction partners of Tet family members in mouse embryonic stem cells
(mESCs). (A-C) Volcano plots of the Co-IP experiments with Tet1, Tet3 and Tet3-CXXC
in mESCs. (D) Venn diagram showing the interaction partners of Tet1, Tet3 and
Tet3-CXXC in mESCs.
The Tet1 interactome in mESCs reveals 22 attracted proteins (Fig. 17A), twelve of
which bind to Tet1 only (Fig. 17D yellow box). Two of those proteins are involved in
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transcription regulation in combination with chromatin remodeling (Hmgn2, Smarcc2).
Three of the enriched proteins have functions in transcription initiation and regulation
of cell differentiation (Hmga1, Edf1, Taf15). Regarding the specific Tet1 interactors,
enrichment of Hmgn2 is notable because this protein stabilizes open chromatin struc-
tures. Additionally, the protein Alyref (Gm6763), which is part of the TREX complex,
is found to interact specifically with Tet1. TREX is coupling mRNA transcription to
mRNA processing and nuclear export. Other components of this complex (Chtop and
Ddx39b) are found to interact with all Tet proteins in mESCs. Skp1, which is found
both in the Tet1 and Tet3-CXXC interactomes, is part of the SCF ubiquitin ligase com-
plex. This complex mediates the ubiquitination of proteins involved in transcription
as well as signal transduction and cell cycle progression. The combined data therefore
suggest that Tet1 acts in transcriptional regulation.[437] Another Tet1 interactor, which
was also found for Tet3 and Tet3-CXXC, is Ywhag. This protein is a phosphopeptide
binding regulatory adapter protein and we could confirm the interaction in mESC us-
ing immunocytochemistry (ICC) (Fig. S4). We next studied the interaction partners
of Tet3-CXXC (Fig. 17C). With this experiment, we also wanted to exclude the possi-
bility that the CXXC domain, which is known to mediate binding to CpG containing
DNA, pulls down general DNA binding proteins that are not Tet3 specific. Upon com-
paring the interaction partners of Tet3 and Tet3-CXXC, it is evident that more proteins
and especially a larger set of DNA-binding proteins are enriched in the Co-IPs with
Tet3-CXXC. This excludes the possibility that the DNA-binding capability of the CXXC
domain distorts our experimental results (Fig. 17D). In total, we detected 12 proteins
that bind to both Tet3 and Tet3-CXXC, while 24 proteins are specifically enriched for
Tet3-CXXC. Some of these exclusive Tet3-CXXC interactors are transcriptional repressors
(Znf706, Eno1, Hdgf). Besides this, many identified proteins are involved in chromatin
remodeling (Kdm1a, Hdac2, Dmap1, Meaf6, Mrgbp, Ino80c, Rbbp5, Rbbp7). The data
show that among all the Tet proteins, Tet3-CXXC specifically recruits proteins that inter-
act with histones, perform DNA modification and are histone modification reader. This
idea is supported by a GO analysis that reveals gene expression (p-value = 5.4 x 10−0)
and chromatin modification (p-value = 5.1 x 10−4) as significantly enriched biological
processes. Analysis of the interactome of Tet3 in mESCs reveals a slightly richer interac-
tome with nine proteins previously identified in the Tet1 pulldown and an additional 19
interaction partners (Fig. 17B, D). Strikingly, we detected a specific interaction of Tet3
with the pluripotency and transcription factor Sox2.[438] Regarding the other pluripo-
tency factors already known to interact with Tet proteins, (Nanog and Oct4), we were
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able to confirm Oct4 as a weak Tet3 interaction partner (log2(GFP-Tet3/GFP) = 2.5;
–log(p-value) = 1.1).[439,440] Other Tet3 interactors are Ywhag and Csnk2a1, which is
the catalytic subunit of a serine/threonine-protein kinase complex, indicating a possible
regulation via phosphorylation. In the Tet3 interactome in mESCs, proteins involved in
regulation of transcription (Mta3, Btf3, Sox2, Nono) and replication (Rfc1, Rfc2, Orc6)
dominate. Moreover, the histone-binding protein Rbbp7 could be identified as a Tet3 in-
teractor, together with Glyr1, which binds chromatin modifications. These data indicate
that Tet3 has a higher tendency to interact with proteins associated with chromatinized
DNA than Tet1. Interestingly, we detected Chtop as an interactor of all investigated Tet
proteins, which supports the recent discovery that hmC recruits the Chtop-methylosome
complex to initiate transcription.[441] Weak interactions may not be detectable when the
exogenous bead-bound protein has to compete with endogenously expressed Tet protein.
We therefore repeated the Tet1 experiment in Tet triple knockout cells to see if proteins
would appear that were otherwise not identified by our method because the exogenous
Tet-bait may be unable to disrupt existing complexes. This experiment, however, pro-
vided no significant differences, arguing that our Tet-baits are correctly presenting the
interaction profiles (Fig. S5). It is to be expected that interaction profiles change in
the course of differentiation. To investigate this process, we analyzed NPCs, which
are more differentiated compared to mESCs. For this study, we used both Tet3 and
Tet3-CXXC as they are the dominant isoforms in these cells.[265] Again, Tet3-CXXC has
more interaction partners than Tet3 (Fig. 18A and 18B). Among the proteins, which
bind to both Tet3 isoforms, the Hmg proteins (Hmgn1, Hmgn2, Hmgb1) are abundant
(Fig. 18C). These proteins alter the accessibility of the DNA duplex in the chromatin
environment. One of the interactors of Tet3 is Lgals1, which is involved in the regulation
of apoptosis, proliferation and differentiation. Another enriched protein is Sub1, which
is a general co-activator cooperating with TAFs as a mediator between activators and
the transcriptional machinery.
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Figure 20: Interaction partners of Tet family members in neural progenitor cells
(NPCs). (A-B) Volcano plots of the results from the modified co-immunoprecipitations
with Tet3 and Tet3-CXXC in NPCs (s0 = 2; false discovery rate (FDR) = 0.05). (C)
Venn diagram showing the interaction partners of Tet3 and Tet3-CXXC in NPCs.
Seven of the nine proteins enriched in the Tet3 dataset are also interactors of Tet3-CXXC.
The observation that Tet3-CXXC has more interaction partners, might find its rationale in
the fact that Tet3-CXXC is more abundant in neuronal cells.[265] A protein that specifically
interacts with Tet3-CXXC is Dnmt1, responsible for maintenance of DNA methylation and
itself a CXXC domain containing protein. Another protein that binds to Tet3-CXXC is
Rcc2, which is a regulator of chromosome condensation. Other Tet3-CXXC interacting
proteins are Ogt, Hdac1, Rbbp7, Hmgb2, Wdr82 and Supt16, which are all involved
in chromatin organization and nucleosome modification. Notably, Ogt is present in
our data, which is a well-known binder of the Tet enzymes. This again supports our
data.[302,419] Tet3-CXXC interactors also include proteins involved in DNA transcription
regulation and replication such as Rfc1, Tceb3 and Nfia. Furthermore, Eno1 is found,
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which acts as transcriptional repressor binding to the myc promoter. Another interaction
partner is Eif5a that regulates apoptosis. This protein is thought to play a major role
in brain development, possibly connecting Tet3-CXXC with neuronal development.[413,415]
In order to uncover general trends behind the data, we analyzed the statistically en-
riched Tet1, Tet3 and Tet3-CXXC interactors in the respective volcano plots. As most of
the interacting proteins are associated with chromatin modification, we focused particu-
larly on protein complexes involved in chromatin remodeling such as NuA4, SWI/SNF,
NuRD, FACT and PTW/PP1 (Fig. 19A, Table S5). Proteins, which show a strong
interaction (more than twofold enriched with a p-value < 0.05) are color-coded (Ta-
ble S6). This analysis confirms that Tet1 has only weak interactions with chromatin
remodeling complexes. Only few contacts are observed with the SWI/SNF chromatin
remodeling complex (Smarcc1, Smarcc2, Smarcd1), the NuA4 histone acetylase com-
plex (Ruvbl2), the PTW/PP1 complex (Ppp1ca) and the NuRD deacetylase complex
(Rbbp4, Mbd3). In contrast to Tet1, the data reveal a statistically highly significant
enrichment of chromatin remodelers for Tet3 (student´s t-test p-value = 0.0096 for Tet3
and student´s t-test p-value = 0.0004 for Tet3-CXXC) (Fig. 19C). This finding supports
the idea that a function of Tet3 is to operate on more chromatinized DNA. Particularly
strong Tet3 interactions are Arid1a of the SWI/SNF complex, Dmap1 and Ruvbl2 of the
NuA4 complex, Wdr82, Ppp1ca and Ppp1cc of the PTW/PP1 complex and Mta3 and
Rbbp7 of the NuRD complex. An even stronger correlation with chromatin remodeling
is detected for Tet3-CXXC that extends also to the FACT complex, arguing that Tet3 and
particularly Tet3-CXXC operate in stronger chromatinized DNA.
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Figure 21: Chromatin modifying complexes interact with Tets. (A) Complexes associ-
ated with Tet1, Tet3 and Tet3-CXXC in mouse embryonic stem cells (mESC) and neural
progenitor cells (NPC) (B). Colored proteins have a p-value < 0.05 and are more than
twofold enriched. (C) Boxplot of the log2(GFP-Tet/GFP) values normalized for Tet1,
Tet3 and Tet3-CXXC of the significantly enriched complex members from (A). (D) List of
the Tet interactors that have already been identified.[188,271,442] (E) Tet3 was identified
(+) in the reversed Co-IP experiments with Supt16 and Ppp1cc. The intensity and the
number of unique peptides of Tet3 are indicated. (F) Immunocytochemistry experiments
show co-localization of Ppp1cc and Tet3 in mESC and Supt16 and Tet3 in NPC. (G)
Proximity Ligation Assay of GFP-Tet3 and Ppp1cc in mESCs. Green signals represent
GFP-Tet3, whereas the red spots mark the interaction of Tet3 with Ppp1cc.
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Most of the NuRD complex members have already been discovered as Tet interactors,
validating our data (Fig. 19D). Therefore, we chose Ppp1cc of the PTW/PP1 complex
to further validate the proteomics data. This complex is of particular interest as it con-
sists of many phosphatases of the Ppp1 family, which could be involved in the regulation
of the Tet proteins. We performed a reversed pull down experiment with an antibody
against Ppp1cc. As shown in Fig. 19E, Tet3 was indeed identified in the Ppp1cc Co-
IP dataset. It was identified based on 13 unique peptides. The interaction of Tet3
with Ppp1cc in mESCs was further confirmed by ICC and fluorescence microscopy (Fig.
19F). The colocalized pixel map shows overlapping signals of two different antibodies
from grey to white. A white dot signifies that the signal of both antibodies is very strong
at this spot, which indicates a clear co-localization. Moreover, we conducted a proximity
ligation assay (PLA) in primed to substantiate further the physical interaction of Tet3
with Ppp1cc. The confocal analysis indeed provided a strong co-localization signal (Fig.
19G). Interesting are also the data that we obtained for Tet3 and Tet3-CXXC in NPCs.
Here, a strong interaction with Supt16 and Ssrp1, which are the components of the
FACT complex (Fig. 19B, Table S5, S6), is detected. The FACT complex is essential
for productive RNA Pol-II transcription on chromatinized DNA in non-terminally differ-
entiated cells.[443] This result supports the idea that the function of Tet3 and Tet3-CXXC
is to operate on chromatinized DNA. In order to gain independent support for the Tet3-
FACT interaction, we performed again a reversed Co-IP experiment (Fig. 19E) with
an anti-Supt16 antibody and ICC in NPC (Fig. 19F) confirming Tet3 as an interaction
partner of Supt16. To gain further support for the association of Tet3 with heterochro-
matinized DNA, we used ICC to examine the nuclear localization of Tet1 and Tet3 in
heterochromatin. We used an antibody against the heterochromatin marker H3K9me3
to localize heterochromatin areas inside the cell nucleus (Fig. 20). A second antibody
against Tet1 and Tet3 was used to localize the different Tet enzymes. As depicted in
Fig. 20, the obtained data confirm that Tet3 in contrast to Tet1 indeed co-localizes with
the heterochromatin marker H3K9me3. Which fully supports the proteomics data.
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Figure 22: Tet3 co-localizes with the heterochromatin marker H3K9me3 in the nucleus
of mouse embryonic stem cells (mESCs). The cells were treated with anti-H3K9me3 anti-
bodies (red) and anti-Tet1 (green) or anti-Tet3 (green) antibodies respectively. Hoechst
33342 was used to stain DNA. The negative control was performed by using only sec-
ondary antibodies and were recorded with the same settings.
9.4 Discussion
The large-scale proteomics data show distinct cell type specific and Tet paralog-specific
interactomes for Tet1, Tet3 and Tet3-CXXC. Notably, we found many interactors involved
in the transfer and recognition of phosphate groups. By adding (kinases Camk2b and
Csnk2a1), removing (phosphatases Ppp1cc and Ppp1ca) or protecting (Ywhag) phos-
phate groups, the activity of the Tet enzymes could be modulated. Another interesting
interactor is Dnmt1, which maintains the methylation status after replication. Further
experiments are needed to prove that this is a functional interaction in vivo, which
could be a way to inherit not only the methylation, but also the hydroxymethylation
status of the DNA. Moreover, our data uncover that the Tet3 interactome is dominated
by proteins regulating chromatin structure and DNA accessibility in a chromatinized
environment. Furthermore, the data suggest that Tet1 operates mainly on DNA that
is present in an open, active chromatin structure to maintain the hmC levels.[437] This
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is in accord with its dominant expression in mESCs, where the genome has been pro-
posed to be only loosely chromatinized.[444–446] During the differentiation process, which
involves both gene activation and silencing, Tet3 is upregulated.[80,246,265,414,434] In agree-
ment with this expression profile, we observe that Tet3 is able to interact intensively
with chromatin remodeling factors (SWI/SNF), histone-modifying complexes (NuRD,
NuA4) and with proteins of the PTW/PP1 complex. All of these regulate chromatin
structure and DNA accessibility. Although a few of these interactions were also ob-
served with Tet1, they are significantly stronger for Tet3 (student´s t-test p-value <
0.01). Upregulation of Tet3 during stem cell development finds a rationale in this way
as it allows accessing more strongly chromatinized genome areas. The idea that Tet3
operates on chromatinized DNA was finally confirmed by immunocytochemistry and
fluorescence microscopy showing that Tet3 colocalizes with the heterochromatin maker
H3K9me3. In support of this conclusion, the NPC data show a robust interaction of Tet3
and Tet3-CXXC with Ssrp1 and Supt16, which form the FACT complex that is required
for transcription on chromatinized DNA. Our data thus support the idea that Tet3 and
Tet3-CXXC in NPCs are the Tet family members responsible for the production of hmC
in transcribed gene bodies.[434,447]
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9.6 Supplementary Data
Table S1:Selection of gene ontology (GO) terms for the proteins in the green
box of the cluster analysis in Fig. 16C
GO term protein count (GO
term)
p% (count GO ter-
min/count total list)
p-value
BP: gene expression 8 80 3.4 x 10−3
CC: chromosome 3 30 7.1 x 10−2
MF: nucleic acid binding 8 80 9.0 x 10−4
MF: protein binding 8 80 5.4 x 10−2
The number of proteins enriched for a specific GO term (protein count), the percentage
of the protein count enriched for the specific GO term compared to the total number
of proteins in the box and the p-value for the enrichment are given. BP = biological
process, CC = cellular compartment, MF = molecular function
Table 1: Table S2: Selection of gene ontology (GO) terms for the proteins in
the cyan box of the cluster analysis in Fig. 16C.
GO term protein count (GO
term)
p% (count GO ter-
min/count total list)
p-value
CC: nucleus 9 90 1.2 x 10−3
MF: nucleic acid binding 9 90 6.6 x 10−5
The number of proteins enriched for a specific GO term (protein count), the percentage
of the protein count enriched for the specific GO term compared to the total number
of proteins in the box and the p-value for the enrichment are given. CC = cellular
compartment, MF = molecular function
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Table S3: Selection of gene ontology (GO) terms for the proteins in the
purple box of the cluster analysis in Fig. 16C.
GO term protein count
(GO term)
p% (count GO
termin/count to-
tal list)
p-value
BP: chromatin remod-
eling
2 29 4.2 x 10−2
CC: chromosome 4 57 2.2 x 10−3
MF: transcription
coactivator activity
3 43 5.5 x 10−4
The number of proteins enriched for a specific GO term (protein count), the percentage
of the protein count enriched for the specific GO term compared to the total number
of proteins in the box and the p-value for the enrichment are given. BP = biological
process, CC = cellular compartment, MF = molecular function
Table S4: Selection of gene ontology (GO) terms for the proteins in the green
box of the cluster analysis in Fig. 16C.
GO term protein count (GO
term)
p% (count GO ter-
min/count total list)
p-value
BP: gene expression 7 88 3.1 x 10−3
CC: nucleus 2 88 7.8 x 10−3
MF: DNA binding 4 50 4.5 x 10−2
The number of proteins enriched for a specific GO term (protein count), the percentage
of the protein count enriched for the specific GO term compared to the total number
of proteins in the box and the p-value for the enrichment are given. BP = biological
process, CC = cellular compartment, MF = molecular function
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Table S5: Log2(GFP-Tet/GFP) values of the chromatin remodelling complex
members which are more than twofold enriched and have a p-value < 0.05
in at least one of the Tet co-IPs compared to the control.
Complex
Members
Tet1 Co-IP
mESC
Tet3-CXXC
Co-IP mESC
Tet3 Co-IP
mESC
Tet1 Co-IP
NPC
Tet3-CXXC
Co-IP NPC
Actl6a pos 1.34 pos neg neg
Arid1a pos 0.92 1.67 neg neg
Dmap1 pos 3.00 1.84 pos pos
Hdac2 pos 2.23 neg 1.98 1.98
Mbd3 1.11 pos neg pos 1.92
Mta3 pos 1.66 3.20 neg neg
Ppp1cc neg 1.84 1.99 neg neg
Rbbp7 pos 2.39 3.02 pos 3.25
Ruvbl2 0.99 0.86 1.07 neg neg
Smarcc1 0.62 0.99 0.89 pos pos
Tox4 pos neg neg 1.09 pos
Wdr82 pos pos 1.69 pos 3.09
Ruvbl1 pos 1.34 pos neg neg
Morf4l1 pos 1.63 neg neg pos
Ppp1ca 0.83 1.31 0.87 neg pos
Rbbp4 1.08 1.51 0.94 pos pos
Mta2 pos pos pos neg pos
Ppp1r12a neg neg neg pos pos
Smarcd1 0.51 0.83 pos neg neg
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Complex
Members
Tet1 Co-IP
mESC
Tet3-CXXC
Co-IP mESC
Tet3 Co-IP
mESC
Tet1 Co-IP
NPC
Tet3-CXXC
Co-IP NPC
Smarcc2 2.24 neg pos neg pos
Smarca4 pos pos pos neg pos
Ppp1r10 neg pos pos neg neg
Smarcb1 neg pos pos neg neg
Gatad2a neg neg neg pos pos
Chd4 pos pos pos pos pos
Mta1 pos pos pos pos pos
Hdac1 pos pos neg pos 2.57
Meaf6 pos 2.27 neg pos pos
Smarce1 neg pos neg pos neg
Supt16 pos pos neg 1.75 2.36
Ssrp1 pos 1.42 pos 1.84 1.84
log2(GFP-Tet/GFP) values for the Tet1, Tet3 and Tet3-CXXC Co-IPs in mouse embryonal
stem cells (mESCs) and neural progenitor cells (NPCs) are given.
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Table S6: Tet normalized values of the chromatin remodelling complex mem-
bers which are more than twofold enriched and have a p-value < 0.05 in at
least one of the Tet Co-IPs compared to the control.
Complex
Members
Tet1 mESC
normalized
Tet3-CXXC
mESC nor-
malized
Tet3 mESC
normalized
Tet3 NPC
normalized
Tet3-CXXC
NPC normal-
ized
Ppp1cc 0.30 0.28
Actl6a 0.22
Arid1a 0.15 0.24
Dmap1 0.48 0.26
Hdac2 0.36 0.21 0.21
Mbd3 0.12 0.20
Mta3 0.27 0.45
Rbbp7 0.38 0.43 0.34
Ruvbl2 0.10 0.14 0.15
Smarcc1 0.06 0.16 0.13
Tox4 0.12
Wdr82 0.24 0.32
Ruvbl1 0.22
Morf4l1 0.26
Ppp1ca 0.09 0.21 0.12
Rbbp4 0.11 0.24 0.13
Smarcc2 0.23
Smarcd1 0.05 0.13
Meaf6 0.37
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Complex
Members
Tet1 mESC
normalized
Tet3-CXXC
mESC nor-
malized
Tet3 mESC
normalized
Tet3 NPC
normalized
Tet3-CXXC
NPC normal-
ized
Ssrp1 0.23 0.20 0.19
Supt16 0.19 0.24
The normalized values for the Tet1, Tet3 and Tet3−CXXC Co-IPs in mouse embryonal
stem cells (mESCs) and neural progenitor cells (NPCs) were calculated by dividing the
log2 value of the complex member by the log2 value of Tet1, Tet3 or Tet3−CXXC .
Figure S1:Tet levels in mouse embryonic stem cells (mESC). RT-qPCR analysis of Tet1,
Tet2 and Tet3 mRNA levels in mESCs shows that Tet1 and Tet2 are highly expressed
whereas the amount of Tet3 mRNA is reduced but not zero.
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Figure S2: Validation of the Co-Immunoprecipitation workflow using Tet-loaded beads.
(A) Saturation of GFP-Tet1cd on GFP nanobody magnetic beads. (B) Successful pu-
rification of GFP-Tet1cd shown by Coomassie stained 5% SDS PAGE gel.
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Figure S3:Data quality.(A) Multi scatter plot comparing the LFQ intensities from
the four biological replicates of the Tet1 experiment with itself (red rectangle) and the
control GFP Co-Immunoprecipitation (Co-IP) in mouse embryonic stem cells (mESCs).
Blue numbers indicate the Pearson correlation. (B) Histograms showing counts of LFQ
intensities in the four different biological replicates of the control (GFP) and the Tet1
Co-IPs in mESCs. (C) Principal component analysis of the data from the different Tet
Co-IPs and the GFP control experiment in mESCs.
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Figure S4: Co-localization of Tet1 and Ywhag in the mouse embryonic stem cells
(mESCs). Immunocytochemistry in combination with fluorescence microscopy confirms
that Tet1 and Ywhag interact in mESCs.
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Figure S5:The Co-Immunoprecipitation workflow using Tet-covered beads is not biased
by competing endogenous Tet.(A) Multi scatter plot comparing the LFQ intensities from
the four biological replicates of the Tet1 experiment with itself (reCluster heat map
comparing three replicates of the Tet1 Co-IP and the GFP control in wildtype (wt) and
triple knockout (TKO) mouse embryonic stem cells.
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10 Conserved Phosphorylations of TET Enzymes in
the Active Center control their activity
10.1 Introduction
Research in DNA epigenetics gained new focus when Tahiliani et al. and Kriaucio-
nis et al. identified 5-hydroxymethylcytosine (hmC) as the direct, enzymatic oxidation
product of 5-methylcytosine (mC).[78,79] The methylation of cytosine at position 5 by
DNA methyltransferases (DNMTs) contributes significantly to the epigenetic machinery
in higher organisms. The subsequent oxidation to hmC, fC and caC is carried out by a
family of α-ketoglutarate dependent oxygenases, namely TET enzymes.[80–82,239] In verte-
brates, three TET enzymes are known with distinct expression patterns and functions.
While TET1 and TET2 are expressed in murine embryonic stem cells (mESCs) and
are considered to oxidize transcription start sites (TSS) and gene bodies, TET3 is ex-
pressed in the brain and oocyte where it oxidizes the paternal pronuclear DNA.[326,327,448]
Controlling the activity of these oxidation events is critical both in a spatial and timely
manner. Several small molecules like 2-hydroxyglutarate or ascorbate can influence TET
activity.[281,286,287,449–451] Unpublished work by the Carell group further investigated the
regulation of TET enzymes by metabolites and interacting proteins (see chapter 8 and 9).
Another general possibility for the control of an enzymes activity are post-translational
modifications (PTMs). They are dynamic and easy to write and erase. PTMs have
diverse roles and are ubiquitous in nature. A wide range of modifications are known,
e.g. methylation, acylation, glycosylation, ubiquitination and phosphorylation.[452–457]
One prominent example for the impact of post-translational modifications upon cellular
processes, is the phosphorylation of the C-terminal domain (CTD) of RNA polymerase
II (RNAPII). The CTD of RNAPII is modified at various sites at different time points of
transcription, resulting in diverse effects.[458,459] As the CTD of RNAPII exhibits a ho-
mology to parts of the C-terminal catalytic domain of TET1 it is intriguing to investigate
this motif for phosphorylation patterns.[263]
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10.2 Results
We first characterized the phosphorylation patterns of TET1, TET2 and TET3 in full
length and also the catalytic domain of TET1 (TET1cd). These proteins were either
expressed, as described in chapter 8.8, via overexpression in HEK293T cells or isolated
in a more native state from mESCs without overexpression (in collaboration with the
Leonhardt group, LMU Munich).[460] Subsequently the enzymes were analyzed by LC-
MS/MS together with Michael Stadlmeier for their PTMs. As we were interested in
general mechanistic insights, we focused our interest on the catalytic domain of the
TET enzymes and concentrated on highly conserved motifs, between mouse, human and
all three TET enzymes. A small excerpt of the region of interest is depicted in Figure
21. One specific amino acid, S1874, located in a highly conserved peptide (WSDSFE)
was found to be phosphorylated in TET1, in all peptides. In case of TET2 and TET3
this motif was identified in both, the phosphorylated state and unmodified.
Figure 23: TET enzymes were isolated from different cell lines and analyzed for phos-
phorylation sites. Fully conserved amino acids are marked in red. Two phosphorylations
in highly conserved regions were identified, namely Serin 1874 and either threonine 1909
or 1910. In part phosphorylated species as well as unphosphorylated peptides were
identified.
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Also the endogenous full-length TET1, isolated from mESCs was phosphorylated at
S1874. In this sample however, another conserved peptide, HATT could be identified
in both, the phosphorylated, as well as the unmodified state. It was, however, not clear,
whether the first or second threonine was phosphorylated. Samples isolated out of HEK
cells did not show this phosphorylation. In order to gain insight into the function of these
phosphorylations we conducted mutation studies. We started our study by mutating
S1874, which, in case of TET1, was always observed in a phosphorylated state. We
generated both, the alanine and glutamate mutant, mimicking the non-phosphorylated
and phosphorylated state of the amino acid, respectively. After transient expression of
the mutated protein constructs, we measured the levels of the oxidation products of mC,
as described earlier by Carell and co-workers.[83] The expression levels of the wild type
and mutants were normalized to the GFP-fluorescence, as described in chapter 8.8
Figure 24: Mutating S1874 to either alanine or glutamate impacts TET activity.
S1874A is more active, while the phosphorylation-mimic S1874E behaves almost like
the wild type. The enhanced activity of S1874A may be explained by its position.
S1874 is located opposite of K1887 in a groove. A phosphorylation (S1874E) could
"close" this groove, which is located near the active center. This groove may be involved
in co-substrate supply, hence by the attraction of the negatively charged phosphate
and positively charged lysine residue, this supply may be limited. This is not possible
for S1874A, hence the groove would permanently be "open", therefore enhancing TET
activity.
The alanine mutant (S1874A) increases TET activity, while the activity of the gluta-
mate mutant (S1874E) is comparable to the wild type. The latter was expected, as this
site was (in case for TET1) always characterized in a phosphorylated state. The posi-
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tion of S1874 in the TET2 crystal structure may explain these results. S1874 is located
opposite of a lysine (K1887) in a groove. This structural element is located near the
active center, where the iron is coordinated by the co-substrate α-ketoglutarate (2-OG)
(see Figure 22). It is possible that this groove is involved in co-substrate supply and
therefore it may be involved in TET regulation. If S1874 is phosphorylated (pS1874)
it may attract, with its negatively charged phosphate group, the positively charged,
flexible lysine side-chain. This could close the cavity, hence perturbating the supply of
α-ketoglutarate to the active center. As no phosphorylation is possible for S1874A, the
groove would always be in an "open" state, which may explain the enhanced activity of
TET.
Besides the EWSDS-motif, we identified a phosphorylated threonine in the HATT mo-
tif from stem-cell TET1 full length. This site was found in both, a phosphorylated and
unphosphorylated state. As the exact position of the phosphorylation was not clear,
both sites were subjected to mutation studies.
Figure 25: Mutating T1909 to either alanine or glutamate impacts TET activity. While
T1909A behaves like the wild type, T1909E is catalytically almost inactive. The crystal
structure reveals the close proximity of T1909 to the iron center, which is coordinated
with α-ketoglutarate (2-OG). If T1909 is phosphorylated (pT1909) the binding of α-
ketoglutarate may be disturbed, due to the negative charges and steric demand of the
phosphate group. This could explain the inactive enzyme, as no oxidation is possible
without the co-substrate.
The phospho-mimic T1909E has a negative effect upon oxidation of mC. Localizing
T1909 in the crystal structure reveals a very close proximity to the iron center, where
α-ketoglutarate is coordinated. If phosphorylated (pT1909), there might be repelling
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effects of the negatively charged phosphate and the negativity charged α-ketoglutarate.
Also the large phosphate group may sterically hinder the coordination of α-ketoglutarate
to the iron. This would explain the almost catalytically dead T1909E mutant. As the
position of the phosphorylation was not certain, we also investigated the effects of the
mutations on the amino acid T1910. Based on its position in the crystal structure, the
same trend as for T1909 is expected for T1910. It is also in close proximity to the iron
center (see Figure 24).
Figure 26: Mutating T1910 to either alanine or glutamate does show the expected
trend. As for T1909 the alanine mutant of T1910 is more active than the glutamate
mutant. However the general activity of both mutants was lower compared to the wild
type, which may be due to structural perturbations of the mutants.
As depicted in Figure 24, the same effect as for T1909 (T1880 in TET2) is visible,
however the general activity of the mutated TET enzymes was lower. This may be due
to several reason, e.g. the mutation may interfere with protein folding.
10.3 Summary and Outlook
It is to date an unsolved question how TET enzymes are fine-tuned in their activity. Be-
sides the regulation on the transcription/translation level, it seems plausible to regulate
the activity of TET enzymes in a reversible, dynamic way, by post-translational modifi-
cations. A comprehensive analysis of the phosphorylation patterns of TET1, TET2 and
TET3 identified highly conserved motifs that are (in part) dynamically phosphorylated.
This study could, for the first time, demonstrate how single phosphorylations in the
131
Results and Publications
active center of TET enzymes can alter their activity significantly. Highly conserved
motifs around the active site (WSDSE, HATT) may therefore be involved in regulating
the activity of TET enzymes. In all three investigated amino acid positions (S1874,
T1909 and T1910), the mutation to glutamate (phosphorylation-mimic) had a negative
effect on the oxidation of mC. It seems plausible that the cell may "activate" TET en-
zymes by removing a phosphate in the active center and subsequently "switching it off"
by a simple phosphorylation, e.g. at T1909. A dephosphorylation of S1874 may boost
TET activity, if massive oxidation is necessary.
Further research should concentrate on elucidating how these phosphorylation patterns
are established and controlled, both in regard of the responsible kinases and phos-
phatases, but also regarding the time-points. Initial proteomic studies performed by
Dr. Andrea Künzel and Franziska Traube identified several kinases and phosphatases,
which interact with TET1cd and indeed preliminary data suggest that CDK11 may be
responsible for TET1cd phosphorylation (see Figure 25). Franziska Traube performed
Figure 27: esi-RNA mediated knock-down of CDK11 results in elevated levels of hmC
and fC compared to the control, supporting the data obtained by mutation studies.
esi-RNA mediated knock-down experiments for CDK11, resulting in elevated levels of
hmC and fC. This fits well to the mutation studies, as a knock-down of CDK11 would
result in less phosphorylations. The mutations of TET1cd (Figure 22, Figure 23 and
Figure 24) all show that a phosphorylation has a negative impact upon oxidation of
mC. However, more detailed studies are necessary in order to validate the interaction
between TET1cd and CDK11 and to further elucidate the biochemical mechanism of
TET1cd phosphorylation.
132
Results and Publications
10.4 Experimental Procedures
Michael Stadlmeier performed LC-MS sample preparations, measurements and data
evaluation. Franziska Traube assisted by cell culture- and protein purification-support.
The initial development of the transfection and purification protocol, as described in
chapter 8.8 and Schröder et al. was supported by Dr. Benjamin Hackner.[461]
10.4.1 Transfection and flow cytometric measurements
The GFP-TET1cd construct[83] was transfected according and subsequently the GFP
levels were determined by flow cytometry as described in chapter 8.8. The following
isolation of genomic DNA and quantification was conducted as described in Pfaffeneder
et al. and chapter 8.8.[83]
10.4.2 Generation of mutated versions of TET1cd
The GFP-TET1cd construct[83] was too large in order to directly generate mutated
versions of the protein by means of site directed mutagenesis. Therefore a small fragment
of the DNA sequence was synthesized de novo (GeneArt) and used for site directed
mutagenesis (Agilent Quick Change II) according to the manufacturers protocol. This
fragment was cloned into the TET1cd-backbone by the use of NotI and SpeI.
TET1cd fragment (base 4008-4588 of the GFP-Tet1cd construct[83])
DNA sequence
The restriction sites are depicted bold.
ACTAGTCCATCTGAGCAGCTAACTTCTAACCAGTCAAACCAGCAGCTCCCTCT
CCTCAGCAATTCTCAGAAACTGGCTTCCTGTCAGGTGGAAGATGAGCGGCACC
CTGAAGCGGATGAGCCTCAGCACCCCGAGGACGATAACTTGCCTCAACTTGAT
GAATTCTGGTCAGACAGTGAGGAGATCTACGCCGATCCTTCCTTTGGTGGCGT
GGCGATAGCACCCATTCACGGCTCGGTGCTCATTGAGTGCGCTCGGAAGGAGC
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TTCATGCTACCACCTCTTTGCGCTCCCCCAAACGAGGGGTCCCTTTTCGTGTG
TCCCTTGTATTCTACCAGCACAAAAGCCTAAACAAGCCTAATCATGGTTTTGA
TATCAACAAAATTAAGTGTAAATGCAAAAAAGTAACGAAAAAAAAGCCCGCAG
ACCGGGAGTGTCCTGATGTATCCCCCGAAGCCAATTTATCACACCAAATTCCT
TCTCGAGTTGCATCAACCTTAACCCGAGACAATGTTGTTACCGTGTCCCCATA
CTCTCTCACTCATGTTGCGGGACCCTACAATCGTTGGGTCTAAGCGGCCGC
Protein sequence
UniProtKB-Q3URK3 (TET1 - MOUSE)
T S P S E Q L T S N Q S N Q Q L P L L S N S Q K L A S C Q V E D E R
H P E A D E P Q H P E D D N L P Q L D E F W S D S E E I Y A D P S F G G V
A I A P I H G S V L I E C A R K E L H A T T S L R S P K R G V P F R V S L V
F Y Q H K S L N K P N H G F D I N K I K C K C K K V T K K K P A D R E C P
D V S P E A N L S H Q I P S R V A S T L T R D N V V T V S P Y S L T H V A G
P Y N R W V
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DNA Primers used for the site directed mutagenesis
Primer Sequence (5’-3’)
S1874A-FWD AGATCTCCTCACTGTCTGCCCAGAATTCATCAAGTTG
S1874A-REV CAACTTGATGAATTCTGGGCAGACAGTGAGGAGATCT
S1874E-FWD GGCGTAGATCTCCTCACTGTCCTCCCAGAATTCATCAAGTTGAGG
S1874E-REV CCTCAACTTGATGAATTCTGGGAGGACAGTGAGGAGATCTACGCC
T1909A-FWD CGCAAAGAGGTGGCAGCATGAAGCTCCTTCCG
T1909A-REV CGGAAGGAGCTTCATGCTGCCACCTCTTTGCG
T1909E-FWD -GCGCAAAGAGGTCTCAGCATGAAGCTCCTTCCGAGCGC
T1909E-REV GCGCTCGGAAGGAGCTTCATGCTGAGACCTCTTTGCGC
T1910A-FWD GGGAGCGCAAAGAGGCGGTAGCATGAAGCTC
T1910A-REV GAGCTTCATGCTACCGCCTCTTTGCGCTCCC
T1910E-FWD GTTTGGGGGAGCGCAAAGACTCGGTAGCATGAAGCTCCTTC
T1910E-REV GAAGGAGCTTCATGCTACCGAGTCTTTGCGCTCCCCCAAAC
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Ja, wir werden alles, alles noch einmal in Frage stellen. Und wir werden nicht mit Sieben-
meilenstiefeln vorwärtsgehen, sondern im Schneckentempo. Und was wir heute finden,
werden wir morgen von der Tafel streichen und erst wieder anschreiben, wenn wir es noch
einmal gefunden haben. Und was wir zu finden wünschen, das werden wir, gefunden,
mit besonderem Misstrauen ansehen. Also werden wir an die Beobachtung der Sonne
herangehen mit dem unerbittlichen Entschluss, den Stillstand der Erde nachzuweisen!
Und erst wenn wir gescheitert sind, vollständig und hoffnungslos geschlagen und unsere
Wunden leckend, in traurigster Verfassung, werden wir zu fragen anfangen, ob wir nicht
doch recht gehabt haben und die Erde sich dreht! Sollte uns aber dann jede andere An-
nahme als diese unter den Händen zerronnen sein, dann keine Gnade mehr mit denen,
die nicht geforscht haben und doch reden.
Bertolt Brecht, Leben des Galilei
